Session » ACR Convergence 2023
-
Abstract Number: L01
Analysis of 245,388 Diverse Participants in the NIH All of Us Cohort Identifies VEXAS Resiliency in UBA1 M41L Somatic Mutation Carriers
-
Abstract Number: L02
Mutational Analysis of UNC93B1 Identifies Regulatory Regions Mutated in Human SLE
-
Abstract Number: L03
Efficacy and Safety of Targeted Therapies in VEXAS Syndrome: Retrospective Study from the French VEXAS Group
-
Abstract Number: L05
DICKENS: A Multicentre Randomised Controlled Trial of Diacerein for Knee Osteoarthritis with Effusion-Synovitis
-
Abstract Number: L06
Improvement in Clinical and Patient-Reported Outcomes for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) 6 Months to 2 Years After Autologous Stem Cell Transplantation (ASCT)
-
Abstract Number: L07
3-year Results of Tapering TNFi to Withdrawal Compared to Stable TNFi Among Rheumatoid Arthritis Patients in Sustained Remission: A Multicenter Randomized Trial
-
Abstract Number: L11
Risk of Cardiovascular Events According to Biological Agent Exposure in Patients with Ankylosing Spondylitis: A Korean Population-based Study
-
Abstract Number: L18
Immune-metabolic Heterogeneity and Clinical Implications in Primary Sjogren’s Syndrome Revealed by Molecular Classification of Salivary Glands
-
Abstract Number: L19
A Phase 3 Study of Repeat Injection of TLC599 in Osteoarthritis of the Knee: Benefits to 52 Weeks
-
Abstract Number: PP01
You Can’t Get This from a Doctor: The Role of Support Groups for Adults Aged 25-55 Living with Arthritis
-
Abstract Number: PP02
Patient Centered Care: The Complete Picture
-
Abstract Number: PP03
Lupus with Slime: Improve QOL and Increase ROM in SLE with Slime
-
Abstract Number: PP04
Bouncing Back: How I Found My Running Shoes Using a Rebounder for My Psoriatic Arthritis
-
Abstract Number: PP05
Relief Redefined: A Patient’s Journey to Reducing the Impact of Her PsA Flare Ups
-
Abstract Number: PP06
Dana’s Data Dashboard: Applying a Familiar Framework for Efficient and Effective Health Management
-
Abstract Number: PP07
How “Coming Out” About My Lupus Diagnosis Allowed Me to Connect With Patients, Get Involved With Research, and Spread Awareness
-
Abstract Number: PP08
Finding Gratitude in Adversity: The Impact of Finding the Right Rheumatologist
-
Abstract Number: PP09
Practicing Mindfulness to Improve Quality of Life
-
Abstract Number: PP10
Saved by Plants: How a Necessary Lifestyle Change Led to a Happier Life with Decreased Rheumatoid Arthritis Pain and Fatigue
-
Abstract Number: PP11
We Suffered For Decades, But Then She Was Born
-
Abstract Number: PP12
Sjögren’s-Fatigue: Non-Therapeutic Lifestyle Adjustments to Help Manage My Most Problematic Symptom
-
Abstract Number: PP13
My Four Pillars of Wellness: How Sleep, Diet, Exercise and Stress Reduction Enable Me to Define My Life and not let Sjögren’s Define Me
-
Abstract Number: PP14
Putting Lived Experience into Action: Flipping the Script on Living with a Chronic Disease
-
Abstract Number: PP15
Toward a Frontier Beyond the Barriers of Position and Prejudice
-
Abstract Number: PP16
Peer Health Coaches Help Scleroderma Patients Cope with Isolation
-
Abstract Number: PP17
Utilizing Support Networks to Improve Patient Outcomes
-
Abstract Number: 0001
Loss of the Complement Regulator CD55 Alters Marginal Zone B Cell Homeostasis
-
Abstract Number: 0002
Population Pharmacokinetic and Pharmacodynamic Analyses of Obexelimab in Healthy Volunteers and in Patients with Rheumatoid Arthritis or IgG4-Related Diseases
-
Abstract Number: 0003
Expanded Extrafollicular B Cells Were Improved by RTX in IgG4-related Disease
-
Abstract Number: 0004
CD22 X CD79b Bispecific Ab Potently Inhibits B Cell Activation and Plasmablast Accumulation
-
Abstract Number: 0005
Obexelimab Inhibits B Cell Activation and May Interfere with B Cell Chemotaxis in IgG4-Related Disease
-
Abstract Number: 0006
Preclinical Characterization of a Novel anti-CD40 Antagonist Antibody-glucocorticoid Conjugate with Superior Preclinical Efficacy and Favorable Safety Profile
-
Abstract Number: 0007
Targeting NF-κB Signalling in B Cells from ANCA-associated Vasculitis Impairs B Cell Biology as a Potential Novel Target
-
Abstract Number: 0008
Differential Induction of Anti-Muscarinic Type-3-Receptor Antibodies by Immunization with 4-Hydroxy-2-nonenal-Modified Ro60 in BALB/c Mice
-
Abstract Number: 0009
Impact of Psilocybin on Peripheral Cytokine Production
-
Abstract Number: 0010
A Potential Mechanism for Major Adverse Cardiac Events Associated with JAK Inhibitors: JAK Inhibitor Withdrawal Causes Urokinase Release by Primed STAT Signaling
-
Abstract Number: 0011
Clock Gene Bmal1 Promotes Transcriptional Activity of NF-κB to Regulate Production of Inflammatory Mediators in RA-FLS
-
Abstract Number: 0012
Immune-cell Derived Cytokines Synergistically Interact to Drive Synovial Fibroblast Invasive Function and Metabolic Capacity
-
Abstract Number: 0013
A Proliferating T Cell Signature in Blood Is Associated with Response to JAK Inhibitor Therapy in Rheumatoid Arthritis Patients
-
Abstract Number: 0015
Genetic Predisposition to a Positive Antinuclear Antibody Test Is Not Associated with Increased Risk of Disease
-
Abstract Number: 0016
Role of TP53 in Inflammatory Reprogramming of Rheumatoid Arthritis Synovial Fibroblasts
-
Abstract Number: 0017
Xist Ribonucleoproteins Promote Female Sex-biased Autoimmunity
-
Abstract Number: 0018
Alternative Splicing and Expected Protein Changes in Muscle Biopsies from Different Types of Idiopathic Inflammatory Myopathies
-
Abstract Number: 0019
Use of High-plex Data Reveals Novel Insights into the Temporal Artery Processus of Giant Cell Arteritis
-
Abstract Number: 0020
The Inflammatory Proteome in Sjögren’s Syndrome Identifies New Biomarkers and Relevant Clinical Subgroups
-
Abstract Number: 0021
Shared Genetic Susceptibility Between Rheumatoid Arthritis and Bipolar Disorder: Analyses from Genome-Wide Association Studies
-
Abstract Number: 0022
Validation of a Transcriptomic-Based Machine Learning Model to Establish the Endotype of SLE Patients
-
Abstract Number: 0023
Proteomic Analysis of Plasma-derived Extracellular Vesicles Renders Glutathione Peroxidase 3 a Biomarker for Dermatomyositis
-
Abstract Number: 0024
Detection of Synovial Signatures in Peripheral Blood of Patients with Rheumatoid Arthritis via a Novel Blood-Based DNA Capture Assay
-
Abstract Number: 0025
Relationship Between Genetic Variants in Cannabinoid Receptor 2 and Self-Reported Effectiveness of Cannabis for Pain Management in Rheumatoid Arthritis
-
Abstract Number: 0026
Mapping Cellular Landscape of Esophageal Epithelium in Systemic Sclerosis Using Single-cell Transcriptomics
-
Abstract Number: 0027
Association of HLA-DRB1 and ANKRD55/IL6ST Regions with Polymyalgia Rheumatica Diagnosis: A Genome Wide Association Study from UK Biobank and FinnGen
-
Abstract Number: 0028
Adenosine Deaminase 2 Is Expressed as a Short Isoform Lacking Deaminase Activity in the Endothelium: Implications for DADA2 Vasculitis
-
Abstract Number: 0029
Post-translationally Modified Fibrinogen Activated Macrophages Drive the Expression of Fibrotic Genes in Human Lung Fibroblasts
-
Abstract Number: 0030
A Pathogenetic Model of IgG4-related Disease Developed from Familial IKZF1 and UBR4 Gene Variants
-
Abstract Number: 0031
A Systematic Approach for Identifying Causal Variants and Their Target Genes on JIA Risk Haplotypes
-
Abstract Number: 0033
A Novel Transcriptome-Based Machine Learning Pipeline Predicts Phenotypes of Lupus Patients
-
Abstract Number: 0034
Genome-Wide Association Study for Loci Associated with Positive Antinuclear Antibodies in a Large Hospital Biobank
-
Abstract Number: 0035
Using Genotyping and Functional Data from Monocytes to Identify Risk-Driving SNPs on JIA Risk Haplotypes
-
Abstract Number: 0036
Using Genotyping and Chromatin Data in CD4+ T Cells to Nominate Causal Variants on JIA Risk Haplotypes and to Identify Their Target Genes
-
Abstract Number: 0037
New Histological Approach in Spatial Transcriptomics Implicates Glandular Cell Involvement in Pathophysiology of Sjögren’s Disease
-
Abstract Number: 0038
Specific Binding of Uric Acid to NDFIP1 Associates with Hyperuricemia-induced Ferroptosis
-
Abstract Number: 0039
Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis
-
Abstract Number: 0039.5
Cytokine-induced Transcriptome Modification Elucidates the Similarity and Dissimilarity Across 10 Immune-related Diseases
-
Abstract Number: 0040
Non-canonical NF-κB Signalling Is Required for Extrathymic AIRE Expression and Immunoregulatory Molecules in Cells of the Dendritic Lineage
-
Abstract Number: 0042
Effect of the Inflammatory Microenvironment Induced by Monocytes on Fibroblasts and Modulatory Action of Human Dental Pulp Stem Cells
-
Abstract Number: 0043
Assessing the Ability of Human Dental Pulp Stem Cells to Modulate the Macrophages Phenotype
-
Abstract Number: 0044
Aberrant Mevalonate Metabolite Farnesyl Pyrophosphate-Induced Neutrophil Hyperactivation in Behçet’s Disease Pathogenesis
-
Abstract Number: 0045
Discovery and Characterization of a Selective, Orally Bioavailable PAD4 Inhibitor to Target NETs Driven Autoimmune and Inflammatory Diseases
-
Abstract Number: 0046
Circulating Monocytes in RA, SSc, and SLE Have Radically Altered and Unique Transcriptional & Epigenetic Profiles
-
Abstract Number: 0047
Identification of Specific Monocyte Epigenetic Signatures in Sarcoidosis and Tuberculosis
-
Abstract Number: 0048
Monosodium Urate Crystals Activate an Immune Tolerance Program That Restrains the Activation of Inflammatory Signaling in Macrophages During Gout Flares
-
Abstract Number: 0049
Soluble Uric Acid Is an Endogenous Inhibitor of CD38
-
Abstract Number: 0050
Anti-Citrullinated Histone Antibody CIT-013, a Dual Action Therapeutic for Neutrophil Extracellular Trap Associated Autoimmune Disease
-
Abstract Number: 0051
CD14+CD64+ Classical Monocytes Are the Main Producers of IL-23 at the Enthesis
-
Abstract Number: 0052
Possible Involvement of TLR4 in the Pathogenesis of Primary Sjögren’s Syndrome Through Induction of the Expression of BAFF Receptor, BR3 in Peripheral Monocytes
-
Abstract Number: 0053
Nintedanib Downregulates the Profibrotic M2 Phenotype of Macrophages Obtained from Systemic Sclerosis Patients Affected by Interstitial Lung Disease
-
Abstract Number: 0054
RA Monocytes and Monocyte-Derived Macrophages Display Heightened Inflammatory Responses, Reduced Endocytic Capacity and Distinct TET Expression Compared to PsA Monocytes
-
Abstract Number: 0055
Elevated LINE-1 Expression in SLE Keratinocytes Leads to LINE-1 Reverse Transcriptase-dependent Type I Interferon Responses
-
Abstract Number: 0056
The Activation of cGAS-STING Pathway in Systemic Lupus Erythematosus
-
Abstract Number: 0057
GM-CSF receptor/SYK/JNK/FOXO1/CD11c Signaling Enhances Cell Migration to Promote Atherosclerosis
-
Abstract Number: 0058
Macrophage Extracellular Traps Induced by Monosodium Urate or Calcium Pyrophosphate Crystals Form Independently of NLRP3 Inflammasome Activation
-
Abstract Number: 0059
GM-CSF by Natural Killer Cells Drives Inflammatory Arthritis in HIV-Infected Humanized Mice
-
Abstract Number: 0060
Serpin B1 Modulation of Immune Complex-Mediated Neutrophil Activation and NET-formation Requires Its Chymotrypsin-like Inhibitory Activity
-
Abstract Number: 0061
Discovery of a RIPK2 Scaffolding Inhibitor for the Treatment of Joint Autoimmune Diseases
-
Abstract Number: 0062
Differential Metabolic Profiles, Activation and Circadian Dynamics in Rheumatoid Arthritis and Psoriatic Arthritis Circulatory Monocytes
-
Abstract Number: 0063
Investigating Macrophage Repopulation in the Synovium
-
Abstract Number: 0064
Correlation of Anti-DFS70 Autoantibodies by ELISA with HEp-2 Cells DFS Pattern by IFA
-
Abstract Number: 0066
Mitochondrial Dysfunction and Fatigue in Sjögren’s Disease
-
Abstract Number: 0067
Dimethyl Fumarate Modulates T Cell Metabolism and Function in Systemic Lupus Erythematosus Patient Samples
-
Abstract Number: 0068
Anti-TNFR2 VHH Agonistic Antibodies Promote and Stabilize Treg Immunosuppressive Activity
-
Abstract Number: 0069
All-trans Retinoic Acid (atRA) Enhances FoxP3 Protein Stability Under Inflammatory Conditions Through Altering the FoxP3 Protein-interactome
-
Abstract Number: 0070
Activation of Joint CD8+ TRM Localize Autoantibody Mediated Arthritis
-
Abstract Number: 0071
Sex Based Differences in Morphological and Functional Niches of the Human Thymus, Identified by Non-supervised Spatial Transcriptomic Profiling, May Underlie Sex Bias in Autoimmune Disease
-
Abstract Number: 0072
Circulating T-cell Immunosenescence Is High in Patients with Immune-Mediated Inflammatory Diseases (IMIDs) and Is Associated with Interferons
-
Abstract Number: 0073
PD-1hi Cells Are Highly Present in the Rheumatoid Joint, and Express Regulatory Capacities
-
Abstract Number: 0074
Distinct PD-1 Receptor Engagement Leads to Different Pharmacodynamic Effects
-
Abstract Number: 0075
Proteomic, Transcriptomic, and T-Cell Receptor (TCR) Profiling of Synovial Integrin-Expressing (InEx) T Cells in Axial Spondyloarthritis (axSpA)
-
Abstract Number: 0076
Characterizing GMCSF Producing T-cells in Rheumatoid Arthritis and Effect of Methotrexate on Them
-
Abstract Number: 0077
Circulating CD4+CXCR5-PD-1hiICOS+ Cells Are Elevated in Patients with Newly Diagnosed Giant Cell Arteritis and Associate with the Clinical Outcome
-
Abstract Number: 0078
Circulating CD4+CXCR5+PD-1hi Follicular Helper T Cells Are Elevated in Patients with Rheumatoid Arthritis and Predict Treatment Response to Abatacept or TNF Blockers
-
Abstract Number: 0079
CD4 T Cell Repertoire Features in RA Patients with High-risk HLA-DRB1 Alleles
-
Abstract Number: 0080
Pharmacological Inhibition of PRMT5 Demonstrates Broad Efficacy in Multiple Preclinical Models of Autoimmunity and Inflammation by Suppressing Th1, Th17 and TNF-Mediated Inflammatory Responses
-
Abstract Number: 0081
RA Disease Activity Influence the Frequency and Phenotype of Citrulline Reactive CD4 T Cells in DRB1*04:04 ACPA+ RA Patients
-
Abstract Number: 0082
A VAV1-Directed Molecular Glue Degrader, MRT-6160, Reduces Joint Inflammation in a Collagen-Induced Arthritis Autoimmune Disease Model
-
Abstract Number: 0083
Expression of mRNA Vaccine Antigen in Hematopoietic Cells Is Necessary for Induction of Optimal Vaccine-Specific CD4+ T Cell Responses
-
Abstract Number: 0084
Excess IL-18 Protects from Experimental Autoimmune Encephalomyelitis Mainly via Preferential Augmentation of Suppressor/Regulatory over Autoreactive T-cell Function
-
Abstract Number: 0085
Fibroblasts Promote Upregulation of Cannabinoid Type 2 Receptor on Inflammatory Cells in Dermatomyositis
-
Abstract Number: 0086
Optimizing PD-1 Agonist Signaling with Membrane Proximal Binding of Rosnilimab, a Clinical Stage PD-1 Agonist IgG1 Antibody
-
Abstract Number: 0087
Immune Checkpoint Inhibitor Therapy Expands an Activated, anti-PD-1 Drug-bound CD8 T Cell Population That Is Clonally Linked in Blood and Synovial Fluid of ICI-arthritis Patients
-
Abstract Number: 0088
SLAMF4 Orchestrates the Pathological Cytotoxic Response of CD4+ T Cells in Rheumatoid Arthritis
-
Abstract Number: 0089
Pre-Clinical Characterization of MTX-101, a Novel Bispecific CD8 Treg Modulator with the Potential to Restore CD8 Treg Functions in Patients with Rheumatological Autoimmune Diseases
-
Abstract Number: 0090
Reduced Frequency of RORγt+ Regulatory T Cells Is Associated with Secukinumab Response in Axial Spondyloarthritis
-
Abstract Number: 0091
Impaired X-Chromosome Inactivation Maintenance in T Cells Is Associated with Features of Reduced Disease Severity in a Toll-Like Receptor 7-Driven Model of Systemic Autoimmunity
-
Abstract Number: 0092
Multi-omics Immune Profiling of Cytotoxic T Cells from Ankylosing Spondylitis Patients Identified a Subset of Clonally Exapnded CTLs That Evade Immune Exhaustion
-
Abstract Number: 0093
Single Cell RNA-seq and Mass Cytometry Reveal a Cytotoxic CD8 Effector T Cell Population Associated with Interstitial Lung Disease in Systemic Sclerosis Patients
-
Abstract Number: 0094
Granzyme K Elicits a New Pathway for Complement Activation in RA Synovium
-
Abstract Number: 0095
Kynurenine Is a Proinflammatory Metabolite That Activates a Positive Feedback Loop of Rab4A-dependent CD98 Expression and mTORC1 and mTORC2 Activation in SLE
-
Abstract Number: 0099
Cell-bound Complement Activation Products in Antiphospholipid Antibody-positive Patients Without Other Systemic Autoimmune Diseases
-
Abstract Number: 0100
The Clinical Relevance of Different Antiphospholipid Antibody Profiles in Pediatric Rheumatology Patients
-
Abstract Number: 0101
Non-Criteria Antiphospholipid Antibodies and Calprotectin as Potential Biomarkers in Pediatric Antiphospholipid Syndrome
-
Abstract Number: 0102
The Subtype and Prognosis of Acute Myocardial Infarction in Antiphospholipid Syndrome Patients
-
Abstract Number: 0103
Criteria and Non-criteria Antiphospholipid Autoantibodies Screening in Women with Unexplained Fetal Death, Pre-eclampsia And/or Fetal Growth Restriction: A Cross-sectional Study
-
Abstract Number: 0104
Cluster Analysis of Antiphospholipid Antibodies Associated Adverse Pregnancy Outcome Patients: Based on a 13-year Longitudinal Cohort Study
-
Abstract Number: 0105
Characterization of B-Cell Subsets in Antiphospholipid Syndrome Patients: Implications for Disease Phenotype and Pathogenesis
-
Abstract Number: 0106
Positive Antiphospholipid Antibodies Are Associated with a Higher Risk of Cerebral Microbleeds
-
Abstract Number: 0107
Impact of Antiphospholipid Syndrome on Mortality of Hospitalized Ischemic Stroke Patients: A Retrospective Analysis of the National Inpatient Sample Database 2020
-
Abstract Number: 0108
Decoding Antiphospholipid Syndrome Laboratory Test Outcomes in a Large Multicenter Electronic Health Record Database
-
Abstract Number: 0109
Persistent Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome
-
Abstract Number: 0110
Neutrophil Extracellular Traps as Mediators of Antiphospholipid Antibody-Induced Trophoblast Dysfunction and Fetal Loss
-
Abstract Number: 0111
Hippo-YAP1-CCN2 Signaling by Microvascular Endothelial Cells Licenses Vascular Smooth Muscle Cell Proliferation in Antiphospholipid Syndrome
-
Abstract Number: 0112
Molecular Stratification of Antiphospholipid Syndrome Patients Through Integrative Analysis of the Whole-blood RNA Transcriptome
-
Abstract Number: 0113
Serum Myeloperoxidase (MPO)-DNA Complexes and Serum Calprotectin Differentiate Isolated Thrombotic Antiphospholipid Syndrome from Isolated Obstetric Antiphospholipid Syndrome
-
Abstract Number: 0114
Platelets Are Highly Activated and Could Participate in Immune Abnormality of APS
-
Abstract Number: 0115
Risk Factors of First Thrombosis in Obstetric Antiphospholipid Syndrome
-
Abstract Number: 0116
Integrated Metabolomic and Proteomic Analyses Stratified Patients with Antiphospholipid Syndrome According to Their Atherothrombotic Risk
-
Abstract Number: 0117
The Patient Journey to a First Diagnosis of Systemic Sclerosis: Temporal Disease Pattern Identification Using Machine Learning and Data Mining Among US and Japanese Patients
-
Abstract Number: 0118
Physical Performance Among Individuals with Systemic Lupus Erythematosus in a Diverse Population-Based Cohort
-
Abstract Number: 0119
Mortality-related Health Metrics in Systemic Autoimmune Diseases: An Epidemiological Analysis of a Nationwide Register-based Cohort
-
Abstract Number: 0120
Incidence and Prevalence of Systemic Lupus Erythematosus in Urban China, 2013-2017: A Nationwide Population-based Study
-
Abstract Number: 0121
High Prevalence of Mental Health Disorders Among Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
-
Abstract Number: 0123
Improving Interpretation of Work Outcomes in Patients with Inflammatory Rheumatic Musculoskeletal Disease: General Population Reference Curves for Work Ability and At-work Productivity
-
Abstract Number: 0124
Utility of the 2019 EULAR/ACR SLE Classification Criteria Score as Predictor for Mortality and Hospitalizations in a Population-Based Cohort: The Lupus Midwest Network
-
Abstract Number: 0125
Decreasing Ischemic Heart Disease, but Increasing Cancer Among the Underlying Causes of Death in Decedents with Lupus Nephritis
-
Abstract Number: 0126
Epidemiology and Retrospective Case-Control Analysis of IIM in the US Veteran Population
-
Abstract Number: 0127
Time Trends, Cumulative Incidence, and Impact on Survival of Interstitial Lung Disease in Systemic Sclerosis: Results from a Population-based Cohort Study
-
Abstract Number: 0128
Incidence, Trends, and Determinants of Multimorbidity in Systemic Sclerosis: Data from a Population-based Cohort
-
Abstract Number: 0129
Rising Incidence and High Mortality of Systemic Sclerosis: A Population-based Cohort Study (2010-2020)
-
Abstract Number: 0130
Association of HLA-DRB1 Alleles with Coronary Artery Calcium, Abdominal Aortic Calcium, and Carotid Intima-media Thickness in a Multi-ethnic Community-living Population
-
Abstract Number: 0131
Identifying Antinuclear Antibody Positive Individuals at Risk for Systemic Autoimmune Disease: Development and Validation of a Real-Time Risk Model
-
Abstract Number: 0132
Feasibility of a Real-Time Risk Model to Identify Antinuclear Antibody Positive Individuals at Risk for Systemic Autoimmune Disease
-
Abstract Number: 0133
COVID-19 Vaccination-related Delayed Adverse Events Among Patients with Systemic Lupus Erythematosus: Results from the COVAD Study
-
Abstract Number: 0134
Stressful Life Events in the Year Prior to Their Diagnosis Are Associated with Adult and Pediatric Systemic Rheumatic Diseases
-
Abstract Number: 0135
Cancer Incidence and Risk Factors in Patients with Newly Diagnosed Systemic Lupus Erythematosus
-
Abstract Number: 0136
The Prevalence and Risk Factors of Retinal Toxicity Associated with Long-term Hydroxychloroquine Use
-
Abstract Number: 0137
Incidence of and Risk Factors for Myelodysplastic Syndromes in Patients with Rheumatologic Diseases
-
Abstract Number: 0138
Prevalence and Incidence of Sjögren’s Syndrome: A Systematic Literature Review
-
Abstract Number: 0139
Systemic Vasculitides in Portugal and Brazil: Preliminary Results from the Reuma.pt/vasculitis Registry
-
Abstract Number: 0140
Extent of Recording of 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a UK Healthcare Database
-
Abstract Number: 0141
In-patient Outcome Difference in Systemic Lupus Erythematous Patient Between Medicare and Non-Medicare Group, a Nationwide Analysis
-
Abstract Number: 0142
New-Onset Systemic Autoimmune Diseases Following COVID-19 Vaccination – Results from the COVAD Study
-
Abstract Number: 0143
Cancer Incidence in Familial Mediterranean Fever
-
Abstract Number: 0144
COVID-19 Infection in People with Immune Mediated Inflammatory Diseases Who Received SARSCo-V2 Vaccines
-
Abstract Number: 0145
Sexual Health and Function Screening in Patients with Rheumatic Diseases
-
Abstract Number: 0146
Sexual Health and Self-Perception in Rheumatologic Patients: Has Your Rheumatologist Ever Talked to You About Sexual Health?
-
Abstract Number: 0147
Leukotriene Inhibitors Effect on Post-Traumatic Osteoarthritis: A Real-World Evidence Comparative Effectiveness Study
-
Abstract Number: 0148
Recreational Activities in Adults with Rheumatoid Arthritis: Relevance, Difficulty, and Associations with Clinical Outcomes
-
Abstract Number: 0149
Impacts of Social Determinants of Health and the Immune System in Adults with Acute-to-Chronic Low Back Pain: An Observational Study
-
Abstract Number: 0150
Self-reported Levels of Physical Activity and the Association to Pain, Fatigue, Anxiety and Depression Among Patients with Idiopathic Inflammatory Myopathies
-
Abstract Number: 0151
Arthritis: A Wealth Gap
-
Abstract Number: 0152
Long Covid in Persons with Self-Reported Arthritis – Symptoms, Associated Factors and Functional Limitations
-
Abstract Number: 0153
Diminished Vibration Perception and Greater Pressure Pain Sensitivity Are Associated with Worse Knee Osteoarthritis Outcomes Across Sex and Race
-
Abstract Number: 0154
Impact of Social Determinants of Health (SDoH) on Survey Response Times Among Lupus Patients
-
Abstract Number: 0155
Cost Analysis of Subcutaneous Methotrexate Compared to Oral Methotrexate Treatment for Rheumatoid Arthritis
-
Abstract Number: 0156
Factors Associated with Adherence to Cervical Cancer Screening in Ethnically Diverse Women with Systemic Lupus Erythematosus
-
Abstract Number: 0158
Analyzing User Log Data to Track Provider Use of an EHR-based Dashboard for Rheumatoid Arthritis Outcomes
-
Abstract Number: 0159
Understanding the Economic Impact of Autoimmune Eye Disease in the United States
-
Abstract Number: 0160
Spine and Sacroiliac Joints Findings in Young Males and Females with Chronic Back Pain Undergoing Magnetic Resonance Imaging in Clinical Practice
-
Abstract Number: 0161
Differences and Similarities Between the EULAR/ASAS-EULAR Recommendations and National Recommendations for Treatment of Patients with Psoriatic Arthritis and Axial Spondyloarthritis Across Europe
-
Abstract Number: 0162
Assessing Reproductive Health Counseling and Provider Attitudes in Rheumatology Post Roe v. Wade in Houston, Texas
-
Abstract Number: 0163
Uncovering Discrepancies: Analysis of Glucocorticoid Exposure Among Patients with Rheumatoid Arthritis in Electronic Health Record Data versus Medicare Claims
-
Abstract Number: 0164
Development and Validation of a Virtual Musculoskeletal Examination Method for Disease Activity Assessment in Rheumatoid Arthritis Patients
-
Abstract Number: 0165
Hypothyroidism Is Associated with Worse Clinical and Utilization Outcomes After Primary Total Knee Arthroplasty
-
Abstract Number: 0166
Annual Economic Burden for Patients with Familial Hypophosphatemia in the United States
-
Abstract Number: 0167
Healthcare Resource Utilization Associated with Tumor-Induced Osteomalacia: Review of Patient Histories Prior to Entry in Clinical Trial UX023T-CL201
-
Abstract Number: 0168
What Are the Characteristics of a Cost-Effective Psoriatic Arthritis Biomarker Test? An Early Health Technology Assessment
-
Abstract Number: 0169
Added Value of Anti-HMGCR and Anti-SRP Antibodies in the Diagnosis of Immune Mediated Necrotizing Myopathy: An Outcome and Cost Comparison from the USA Perspective
-
Abstract Number: 0170
Gender Equity Amongst Rheumatology Professionals: Preliminary Findings of the Coalition for Health and Gender Equity E-survey (CHANGE Group)
-
Abstract Number: 0171
A Conceptual Framework to Characterize the Indirect Burden of Systemic Lupus Erythematosus (SLE): Findings from Qualitative Patient Interviews
-
Abstract Number: 0172
Barriers and Strategies to Enhance Patient Research Partner Involvement in Rheumatology Research: A Systematic Literature Review
-
Abstract Number: 0173
Review of Published Literature Reporting Economic Burden of Treatment Switching in Rheumatoid Arthritis
-
Abstract Number: 0174
Evaluation of Healthcare Utilization in Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus
-
Abstract Number: 0175
Predicting Cost-Related Medication Non-Adherence in US Adults with Chronic Arthritis: A Machine Learning Approach
-
Abstract Number: 0176
Impact of Social Determinants of Health Factors on Medication Adherence in Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus
-
Abstract Number: 0177
Cost-Related Medication Non-Adherence Among US Adults with Chronic Arthritis: Trends, Comparisons, and Disparities
-
Abstract Number: 0178
Traditional and Lupus-Specific Risk Factors for Cardiovascular Events Among Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0179
Social Disparities and Pathology Markers at Lupus Nephritis Diagnosis Predict Worse Kidney Outcomes
-
Abstract Number: 0180
Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta-analysis and Systematic Review
-
Abstract Number: 0181
Increased Prevalence of and Acute Hospital Events Among Medicare Systemic Lupus Erythematosus Patients Living in Socially Vulnerable Counties in the United States
-
Abstract Number: 0182
Impact of Neighborhood-level Child Opportunity on Disease Activity in Children with Lupus
-
Abstract Number: 0183
Barriers and Facilitators to Recruiting Underrepresented Participants for Clinical Trials: Insights from the Lupus Clinical Investigators Network (LuCIN)
-
Abstract Number: 0184
Material Need Insecurities Are Associated with Worse Patient-Reported Outcomes Among Individuals with SLE
-
Abstract Number: 0185
Classifying Individuals with Rheumatic Conditions as Financially Insecure Using Electronic Health Record Data and Natural Language Processing: Algorithm Derivation and Validation
-
Abstract Number: 0186
Retention in Rheumatology Care and on Hydroxychloroquine and SLE Outcomes by Neighborhood Disadvantage: A Medicare Cohort Study of Acute Care and Kidney Failure
-
Abstract Number: 0187
Advancing Health Equity with Lupus Stakeholders to Close Care Gaps and Disparities
-
Abstract Number: 0188
Association Between Area Deprivation Index and Organ Damage Accumulation in a Statewide Incident Lupus Cohort
-
Abstract Number: 0189
Influence of Social Support on Systemic Lupus Erythematosus (SLE) Outcomes in a Health Disparity Population
-
Abstract Number: 0190
Racial Disparities in Self-reported Extent and Reasons for Nonadherence in SLE
-
Abstract Number: 0191
Reproductive Health Discussions Between Rheumatology Providers and Systemic Lupus Erythematosus Patients: A Survey of English and Spanish-Speaking Patients
-
Abstract Number: 0192
Demographic and Clinical Factors That Contribute to Clinical Study Enrollment in Systemic Lupus Erythematosus
-
Abstract Number: 0193
Social Vulnerability Associations with Mortality in a Lupus Cohort
-
Abstract Number: 0194
Reproductive Health Conversations with a Primarily Hispanic Systemic Lupus Erythematosus Population: Influences and Barriers
-
Abstract Number: 0195
Assessing Cardiovascular Risk in Black and Latino Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0196
Limited Regulatory T Cell Response in Post-Chikungunya Viral Arthritis: A Therapeutic Opportunity?
-
Abstract Number: 0197
Development of a Chikungunya Arthritis Disease Activity Score
-
Abstract Number: 0198
Improving Vaccination Uptake of Herpes Zoster in Young Rheumatic Disease Patients Ages 18-49 Using Specialty Pharmacy Partnership
-
Abstract Number: 0199
Experience in Real-World Conditions of the Effectiveness of the Vaccine Against Herpes Zoster Virus
-
Abstract Number: 0200
Herpes Zoster Prevalence in Patients with Rheumatic Diseases
-
Abstract Number: 0201
Tolerability and Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Rheumatic Musculoskeletal Diseases – A Prospective Longitudinal Study over 12 Months
-
Abstract Number: 0202
Analysis of the Effects of Immunosuppressive Therapy on Herpes Zoster Events After Each of Three Doses of the BNT162b2 mRNA Vaccine in Patients with Spondyloarthritis (SpA)
-
Abstract Number: 0203
Projecting the Impact on Clinical Outcomes in ANCA-Associated Vasculitis of Delaying Retreatment with Rituximab for Vaccine Optimization
-
Abstract Number: 0204
Risk of Severe Infections Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune Mediated Inflammatory Diseases
-
Abstract Number: 0205
Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection with Interferon or Direct Antiviral Therapy
-
Abstract Number: 0206
Risk of Hepatitis B Virus Reactivation in Patients with Rheumatoid Arthritis Receiving JAK Inhibitor or IL-6 Inhibitor: A Systematic Review and Meta-Analysis
-
Abstract Number: 0208
Pneumocystis Jirovecii Pneumonia (PJP) Prophylaxis (PPX), Investigating the Practice Patterns of Providers for Patients on Chronic, High-Dose Immunosuppression in a Rural Integrated Health System
-
Abstract Number: 0209
Safety of Bivalent SARS-CoV-2 Vaccines as a Second Booster Dose in Arthritis Patients on Immunosuppressive Therapies
-
Abstract Number: 0210
Longitudinal T Cell Responses to a Series of Four SARS-CoV-2 Vaccine Doses or COVID-19 in Patients on TNF Inhibitors
-
Abstract Number: 0211
COVID-19 Outcome and Association to Anti-Spike Antibody Levels in Patients on Immunosuppressive Therapy; A Prospective Cohort Study
-
Abstract Number: 0212
The Impact of Immunosuppression on the Humoral Immunogenicity of SARS-CoV-2 mRNA Vaccines in SLE
-
Abstract Number: 0213
When Should I Get My Next Booster? Active Surveillance of COVID-19 Breakthrough Infections in Canadian Patients with Immune-Mediated Inflammatory Diseases
-
Abstract Number: 0214
COVID-19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice Network
-
Abstract Number: 0215
Effectiveness of Three Doses of SARS-CoV-2 Vaccines in Brazilian Patients with Systemic Vasculitides: Preliminary Results of a Real-life Prospective Cohort
-
Abstract Number: 0216
High Immunogenicity of mRNA Covid-19 Vaccine Booster in Immune Mediated Inflammatory Disease
-
Abstract Number: 0217
Safety and Efficacy of Tixagevimab/Cilgavimab (Evusheld) in Autoimmune Inflammatory Rheumatic Disease Patients – a Prospective Multicenter Open-label Study
-
Abstract Number: 0218
Incidence and Risk Factors for Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients with Systemic Autoimmune Rheumatic Diseases
-
Abstract Number: 0219
Safety and Efficacy of Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab (Evusheld) in Patients with Autoimmune Diseases and Renal Involvement Who Received Rituximab
-
Abstract Number: 0220
Paxlovid (Nirmatrelvir Plus Ritonavir) in Patients with Underlying Rheumatological Diseases, in Preventing COVID-19 Related Hospitalization and Death
-
Abstract Number: 0221
Post-COVID-19 Autoimmune Serologies and Immunophenotypes
-
Abstract Number: 0222
Predictors of Adverse Prognosis Following Hospitalization for COVID-19 Infection in Patients with Immune Mediated Inflammatory Diseases Treated with Rituximab
-
Abstract Number: 0223
Severity and Risk Factors of Hospitalization of Omicron in Patients with Rheumatoid Arthritis
-
Abstract Number: 0224
Risk Factors and Outcomes for Repeat COVID-19 Infection Among Patients with Systemic Autoimmune Rheumatic Diseases: A Case-control Study
-
Abstract Number: 0225
Breakthrough SARS-Cov-2 Infection and Disease Flares in Patients with Rheumatoid Arthritis: Result from COVAD E-Survey Study
-
Abstract Number: 0226
Relationships Among Parameters of Mineral Metabolism and Bone Turnover During Acute COVID-related Hospitalization and Subsequent Follow Up: A Pilot Study
-
Abstract Number: 0227
Associations of DMARDs with Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases: A Prospective Study
-
Abstract Number: 0228
A Comprehensive Retrospective Analysis of Polymyalgia Rheumatica in Long COVID Patients at an Academic Medical Center in the Midwest
-
Abstract Number: 0229
Vegetable Consumption and Regular Exercise Are Associated with Better Quality of Life in Gout
-
Abstract Number: 0230
Looking Beyond Infections in Job Syndrome: Peripheral Calcium Pyrophosphate Deposition Disease in a Cohort of Patients with Job Syndrome
-
Abstract Number: 0231
Febuxostat Dose Requirement for Achieving Target Serum Urate Levels According to Renal Function: A Retrospective Cohort Study
-
Abstract Number: 0232
Incident Gout After Recombinant Zoster Vaccination in Adults Aged ≥65 Years in the USA
-
Abstract Number: 0233
Impaired Anti-oxidant Function of HDL and Its Associated Protein, Paraoxonase-1, in Patients with Gout
-
Abstract Number: 0234
Identifying Optimal Serum Urate Levels to Reduce Gout Flares in Patients Taking Urate Lowering Therapy: A Post-hoc Cohort Analysis of CARES with Consideration of Drop-out
-
Abstract Number: 0235
Fractures in Patients with Acute CPP Crystal Arthritis versus Matched Comparators in a Large Cohort Study
-
Abstract Number: 0236
Treatment-emergent Major Adverse Cardiovascular and Thromboembolic Events Were Infrequent During Pegloticase Therapy: Pooled Clinical Trial Findings
-
Abstract Number: 0237
Oral Urate-Lowering Therapy Use and Efficacy Following Pegloticase Treatment: Findings from a Rheumatology Network Database
-
Abstract Number: 0238
Adherence to the Gout and Crystal Arthritis Network (G-CAN) Consensus Statements for Gout Nomenclature
-
Abstract Number: 0239
Incidence and Prevalence of Cardiovascular and Metabolic Diseases Following Gout Diagnosis in the United Kingdom Using the THIN Database
-
Abstract Number: 0240
Gout: A Gateway to Chronic Opioid Use?
-
Abstract Number: 0241
Gout Flares During the Initiation and Escalation of Treat-to-Target Urate Lowering Therapy: A Post-hoc Analysis of a Randomized Multicenter Comparative Effectiveness Trial
-
Abstract Number: 0242
Venous Thromboembolism in Patients with Gout in the US
-
Abstract Number: 0243
Decreased Incidence of Gout After Kidney Transplant over the Last Decade: An Analysis from a Large Academic Renal Transplant Center
-
Abstract Number: 0244
Efficacy and Safety of AR882, a Selective Uric Acid Transporter 1 (URAT1) Inhibitor, in Gout Patients with Various Baseline Characteristics Following 12-Week Treatment in Patients
-
Abstract Number: 0245
Impact of Combined Intervention with Clinical Nurse Specialist in the Management of Cardiovascular Risk in Patients with Gout
-
Abstract Number: 0246
Safety & Efficacy of SEL-212 in Patients with Gout Refractory to Conventional Treatment: Primary Outcomes from Two Randomized, Double Blind, Placebo-Controlled, Multicenter Phase 3 Studies
-
Abstract Number: 0247
Risk of Incident Gout Following Exposure to Recombinant Zoster Vaccine in Adults Aged ≥50 Years in the United States
-
Abstract Number: 0248
In-hospital Treatment, Secondary Prevention, and Mortality After First-ever Acute Myocardial Infarction in Patients with Gout
-
Abstract Number: 0249
Comorbidities of Gout: Results from the Korean National Health and Nutrition Examination Survey
-
Abstract Number: 0250
Validation of Singe-Shot Computational Polarized Microscopy for Crystal Analysis of Synovial Fluid
-
Abstract Number: 0251
Sodium-glucose Cotransporter-2 Inhibitor Initiation, Risk of Recurrent Gout Flares, and Mortality in Patients with Gout and Type 2 Diabetes: A Population-based Cohort Study
-
Abstract Number: 0252
Characterizing Granulomatous Mastitis: A Retrospective, Single-Institutional Case Series of a Racially and Ethnically Diverse Cohort
-
Abstract Number: 0253
Clinical Phenotypes in Patients with Isolated Anti-Sm/RNP Common Motif Antibody Positivity, Compared to Those with or Without Associated Anti-RNP Antibody Reactivity
-
Abstract Number: 0254
Microvascular and Cutaneous Assessment in Adult Patients with Hypermobile Ehlers-Danlos Syndrome
-
Abstract Number: 0255
Lymphoid Mass in the Inferior Turbinate with IgG4 Producing Cells: A Nasal Manifestation of IgG4-RD or a Distinct Chronic Inflammatory Disease?
-
Abstract Number: 0256
Nintedanib in Combination with Immunosuppressive Agents Improves Forced Vital Capacity in Connective Tissue Disease-associated PF-ILD: A Single-center Study
-
Abstract Number: 0257
Activity of IgG4-related Disease Differs Depending on the Presence or Absence of Concomitant Hypocomplementemia
-
Abstract Number: 0258
Understanding Monogenic Behçet’s Disease Pathophysiology: Impact of Pathogenic Variant L227X Associated with Autoinflammatory A20 Haploinsufficiency on Cellular Survival and Proliferation
-
Abstract Number: 0259
Preliminary Experience with a Novel “Fix” for Deep Epitope and Transcriptional Phenotyping of Fragile Cells from Autoinflammatory Flares
-
Abstract Number: 0260
Phenotypes of the Patients with More Than One Autoinflammatory Gene Variant: Classified Diseases and Mixed Autoinflammatory Disorders (MAID)
-
Abstract Number: 0261
Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results
-
Abstract Number: 0262
Destructive Arthritis in Whipple Disease. a Single-center Case Series of 14 Patients
-
Abstract Number: 0263
Patient, Disease, and Treatment Factors in Remission of Inflammatory Eye Disease
-
Abstract Number: 0264
A Novel Role for Rheumatologists: Managing Idiopathic Granulomatous Mastitis
-
Abstract Number: 0265
Differential and Combinatorial Mechanism of Action of Golimumab and Guselkumab in Ulcerative Colitis Induction Therapy: IL-23 Blockade Drives Restoration of Normal Epithelium and Mucosal Healing
-
Abstract Number: 0266
E-selectin, ICAM-1 and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases
-
Abstract Number: 0267
Variations in Approach to the Diagnosis and Management of Polymyalgia Rheumatica Among Australian Rheumatologists
-
Abstract Number: 0268
Safety and Efficacy of CT-guided Percutaneous Infra-Renal Periaortic Biopsies in Suspected Retroperitoneal Fibrosis
-
Abstract Number: 0269
Acute Kidney Injury and Plasma Cell-Rich Acute Interstitial Nephritis in VEXAS Syndrome: An Under-recognized Disease Feature
-
Abstract Number: 0271
Successful Treatment of Refractory IgG4-Related Disease with Tofacitinib: Experiences from 7 Patients
-
Abstract Number: 0272
Risk Factors for Severe Outcome in Susac Syndrome: A National Cohort Study
-
Abstract Number: 0273
Disease Characteristics and Pancreatic Damage in IgG4-Related Disease with Pancreatic Involvement
-
Abstract Number: 0274
A Mix-and-match COVID-19 Vaccination Strategy in Patients with Rheumatic Diseases on Rituximab
-
Abstract Number: 0275
No Cumulative Effect of Infection Rates in Children Receiving Long-term Canakinumab Treatment in Autoinflammatory Periodic Fever Syndromes − Data from the RELIANCE Registry
-
Abstract Number: 0276
Disease Control in Patients with Monogenetic Autoinflammatory Diseases Under Canakinumab Treatment – Comparison of 30 Months Interim Data from the RELIANCE Registry
-
Abstract Number: 0277
Anti-carbamylated Antibodies in Autoimmunity – Focus on Their Diagnostic and Prognostic Value: A Systematic Review and Meta-analysis
-
Abstract Number: 0278
NOD2 Genotyping Landscape in Yao Syndrome
-
Abstract Number: 0279
Therapeutic Exploration of Immune Checkpoint Inhibitor Induced Inflammatory Arthritis In Vivo
-
Abstract Number: 0280
Immunosuppression in the Treatment of Susac Syndrome: A Retrospective Evaluation of the Largest Cohort of Susac Syndrome
-
Abstract Number: 0281
Is There a Decreased Risk of Developing CF Arthropathy in CF Patients Undergoing Treatment That Targets the F508del Mutation?
-
Abstract Number: 0282
DNA Methylation Markers in Peripheral Blood as Effective Diagnostic Biomarkers for Adult-onset Still’s Disease
-
Abstract Number: 0283
Transcriptomic Profiles in Muscle Biopsies from Systemic Sclerosis Patients with Different Autoantibodies
-
Abstract Number: 0284
Phenotyping Calcinosis: A Rare Manifestation of Rare Diseases
-
Abstract Number: 0285
Patient Reported Physical Function, Mental Health, and Treatment Patterns in Dermatomyositis
-
Abstract Number: 0286
Relationship Between High Resolution Computed Tomography(HRCT) Quantitative Scores and Physiological and Clinical Features in Antisynthetase Syndrome Related Interstitial Lung Disease
-
Abstract Number: 0287
6-Minute Walk Distance Associates with Physiologic Measures and Physician/Patient Reported Outcomes in Myositis Related Interstitial Lung Disease
-
Abstract Number: 0288
Proinflammatory Bioactive Lipid Mediators (BLM) Are Associated with Worse Anti-Oxidant Function of High Density Lipoproteins (HDL) in Patients with Idiopathic Inflammatory Myopathies (IIM)
-
Abstract Number: 0289
Markers of Endothelial Damage Are Elevated in Patients with Dermatomyositis Associated Interstitial Lung Disease and Associated with Low Paraoxonase-1 Activity
-
Abstract Number: 0290
Patient-reported Quality of Life and Working Status Outcomes in Ambulatory Patients with Idiopathic Inflammatory Myopathy
-
Abstract Number: 0291
Myopathy Related to Small-to-medium-sized Vessel Vasculitis: Immunopathological Characteristics
-
Abstract Number: 0292
Comparison of Cardiovascular Risk of Myositis Patients and the General Population
-
Abstract Number: 0293
Characteristics and Outcomes of Idiopathic Inflammatory Myositis Associated Interstitial Lung Disease in Rural Appalachia
-
Abstract Number: 0294
Tofacitinib Treatment in Rheumatoid Arthritis Is Associated with Increased Lower Limb Muscle Volume: The Rheumatoid Arthritis and Muscle (RAMUS) Study
-
Abstract Number: 0295
Pneumocystis Jirovecii Pneumonia in Patients with Inflammatory Myopathies
-
Abstract Number: 0296
Does Presence of Anti-SSa and Ro52 Influence the Progression of Interstitial Lung Disease (ILD) in Idiopathic Inflammatory Myopathies (IIM)
-
Abstract Number: 0297
Characteristics of Anti-MDA-5 Associated Dermatomyositis in Southern California with a Large Hispanic Population: Case Series
-
Abstract Number: 0299
Trends and Outcomes of Hospitalized Patients with Idiopathic Inflammatory Myopathy and Venous Thromboembolism: A Nationwide Inpatient Sample Analysis from US (2016-2019)
-
Abstract Number: 0300
Nailfold Videocapillaroscopy in Idiopathic Inflammatory Myopathy Compared with Healthy Controls
-
Abstract Number: 0301
Inflammatory Myopathies and Their Relationship with Cancer in a Colombian Cohort
-
Abstract Number: 0302
Remission in Anti-HMGCR Positive Immune-mediated Necrotizing Myopathy Without the Use of Glucocorticoids: A Multicentric Study of 24 Patients
-
Abstract Number: 0303
Development of a Human Cytotoxic Myoinjury Model with CD8+ T Cells and Muscle Cells Differentiated from Human Induced Pluripotent Stem Cells
-
Abstract Number: 0304
Incidence of Disease Flares Following COVID-19 Vaccination in a Diverse Idiopathic Inflammatory Myopathy Cohort
-
Abstract Number: 0305
Prevalence and Clinical Significance of anti-Ro52 Antibodies in Antisynthetase Syndrome
-
Abstract Number: 0306
Fitbit Is a Valid and Reliable Physical Activity Monitor in Idiopathic Inflammatory Myopathy
-
Abstract Number: 0307
Long-term Prognosis and Recurrence in anti-MDA-5 Antibody-positive Dermatomyositis
-
Abstract Number: 0308
Burden of Osteoarthritis Attributable to High BMI in 38 OECD Countries: A Benchmarking Analysis
-
Abstract Number: 0309
Efficacy, Safety, Pharmacokinetics and Immunogenicity of Repeated Dosing of GSK3858279 in Patients with Knee Osteoarthritis: A Phase I, Randomized, Double-Blind, Placebo-Controlled Study
-
Abstract Number: 0310
Implementing an Osteoarthritis Management Program to Deliver Guideline-Driven Care for Knee and Hip Osteoarthritis in a U.S. Academic Health System
-
Abstract Number: 0311
Heterogeneity and Natural History of Medial Fixed Joint Space Width in Healthy Knees Among Women and Men: Data from Three Large Cohort Studies
-
Abstract Number: 0312
Frontal Lobe Activation and Gait Alterations During Single- and Dual-task Walking in People with Knee Osteoarthritis: A Functional Near-infrared Spectroscopy Study
-
Abstract Number: 0313
The Influence of Pain Catastrophizing on Pain and Function After Knee Arthroplasty for Osteoarthritis
-
Abstract Number: 0314
Lack of Systemic Effects from Intra-articular XT-150 for the Treatment of Moderate to Severe Pain Due to OA of the Knee: Safety Results from a Phase 2 Trial
-
Abstract Number: 0315
Identification of Calcium Crystals in End-Stage Osteoarthritis with Raman Spectroscopy
-
Abstract Number: 0316
Relationship of Sensitization to Pain Severity in Patients with Knee Osteoarthritis
-
Abstract Number: 0317
Long-term Effectiveness of a Lifestyle Program for Osteoarthritis: One-year Follow-up of the “Plants for Joints” Randomized Clinical Trial
-
Abstract Number: 0318
The Association of CT-Detected Intra-Articular Mineralization with MRI-Detected Effusion-Synovitis and Hoffa’s Synovitis in Knee OA: The Multicenter Osteoarthritis Study
-
Abstract Number: 0319
Knee Flexion Contracture Was Associated with Articular Cartilage Loss in the Central Region but Cartilage Preservation in the Posterior Region of the Tibia: Data from the Osteoarthritis Initiative
-
Abstract Number: 0320
Feasibility and Acceptability of Geniculate Artery Embolization for the Treatment of Painful Knee Osteoarthritis
-
Abstract Number: 0321
Use of Proton Pump Inhibitors and Risk of Hip/knee Joint Replacement Among Patients with Osteoarthritis and Rheumatoid Arthritis
-
Abstract Number: 0322
Validation of NICE Criteria for the Diagnosis of Knee Osteoarthritis
-
Abstract Number: 0325
Understanding the Burden of Cutaneous Lupus: A Subset Analysis from the 2022 World Lupus Federation Global Impact (WLFGI) Patient Survey
-
Abstract Number: 0326
Assessment of Depression in Ankylosing Spondylitis Using Center for Epidemiologic Studies Depression Scale
-
Abstract Number: 0327
Self-management Strategies and Self-efficacy in Patients Living with Inflammatory Arthritis: Findings from a Quality Improvement Project in a Tertiary Centre
-
Abstract Number: 0328
From Patient Needs to Platform Design: Using Patient Preference to Guide the Development of a Post-Viral Fibromyalgia Management App
-
Abstract Number: 0329
Factors Associated with Suicidal Ideation Among Patients with Inflammatory Rheumatic Musculoskeletal Disease: A Case-Control Study
-
Abstract Number: 0330
Patient-Reported Experiences and Comorbidities in Patients with IgG4-Related Disease with and Without Pancreatic Involvement
-
Abstract Number: 0331
Assessment of Patient Adherence to “Sick Day Rules”: A Cross-sectional Study of Rheumatology Outpatients Prescribed Immunosuppressive Medications
-
Abstract Number: 0332
Initial Characterization of a Skin Symptom Questionnaire for Patients with Systemic Sclerosis
-
Abstract Number: 0333
Ankylosing Spondylitis Patient Perspective on Living with Flares and Impact on Quality of Life
-
Abstract Number: 0334
Association of a Self-Report Screening Tool for Sarcopenia (SARC-F) with Functional Status Outcomes in Systemic Lupus Erythematosus
-
Abstract Number: 0335
Meta-Analysis of the Cost-Effectiveness of Social Media Advertising as a Recruitment Tool
-
Abstract Number: 0336
Core Signs Associated with the Subtypes of Cutaneous Lupus Erythematosus: Concept Elicitation Interviews with Dermatologists and Rheumatologists
-
Abstract Number: 0337
Impact of Photosensitivity on Quality of Life in Dermatomyositis
-
Abstract Number: 0338
Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis: Data from COVAD Patient-reported E-survey
-
Abstract Number: 0339
Longitudinal Glucocorticoid Toxicity in Rheumatic Disease Patients (LONG-TOX) and Associations with Quality of Life and Healthcare Resource Utilization: Interim Analysis from a Prospective Cohort
-
Abstract Number: 0340
Rheumatology Patients’ Experiences of a Nationwide Transition to an Adalimumab Biosimilar: A Cross-Sectional Study
-
Abstract Number: 0341
Patient Perspectives on the Usability of a Rheumatoid Arthritis Patient-reported Outcomes Electronic Health Record-based Dashboard: A Mixed-Methods Study
-
Abstract Number: 0342
Assessing the Known-group Validity of the IDEOM MSK-Q Using Data from the National Psoriasis Foundation Annual Survey
-
Abstract Number: 0343
Sjögren’s Disease Patient Experiences with Dry Mouth and Content Validity of the Xerostomia Inventory
-
Abstract Number: 0345
Jadas10- and cjadas10-based Disease Activity States for Psoriatic Arthritis, Enthesitis-related Arthritis, and Rf+ Polyarthritis
-
Abstract Number: 0347
Towards Effective Shared Decision Making – Development and Validation of a Prediction Model for Personalized Probabilities of Side Effects in the Initial Treatment of Juvenile Idiopathic Arthritis
-
Abstract Number: 0348
The Use of Ruxolitinib for Improved Disease Control in Systemic Juvenile Idiopathic Arthritis (sJIA) and Recurrent Macrophage Activation Syndrome (MAS)
-
Abstract Number: 0349
Disease Activity of Juvenil Idiopathic Arthritis in Transitional Care
-
Abstract Number: 0350
Presentation, Management, and Outcomes of Systemic JIA-Associated Lung Disease: A Single Center Experience
-
Abstract Number: 0351
Needs Assessment Survey of Critical Data Element Completion in Telemedicine Visits for Juvenile Idiopathic Arthritis in the Post-Pandemic Period
-
Abstract Number: 0352
Musculoskeletal Ultrasound Findings in Children with Psoriasis
-
Abstract Number: 0353
Validation of Claims-based Algorithms for Newly Diagnosed Juvenile Idiopathic Arthritis Using Machine Learning Methods
-
Abstract Number: 0354
Open-label Phase 3 Study of Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Pharmacokinetics, Effectiveness, Safety, and Immunogenicity over 252 Weeks
-
Abstract Number: 0355
Long Term Safety of Drugs in Systemic Juvenile Idiopathic Arthritis
-
Abstract Number: 0356
PRINTO Provisional Enthesitis/Spondylitis-Related JIA Criteria: Performance in Youth Classified as Axial Disease in Juvenile Spondyloarthritis
-
Abstract Number: 0357
Validation of the Juvenile Spondyloarthritis Disease Activity Index in a Prospective Clinical Trial Setting
-
Abstract Number: 0359
Clinical Characteristics of Patients with Juvenile Idiopathic Arthritis Who Undergo Adalimumab Drug Level Testing and Anti-Drug Antibody Assessment
-
Abstract Number: 0360
Increasing the Etanercept Dose in Juvenile Idiopathic Arthritis Patients: Does It Help Reaching the Treatment Target? A Post-hoc Analysis of the Best4Kids Randomised Clinical Trial
-
Abstract Number: 0361
Safety of Golimumab Dose Escalation in Pediatric Autoimmunity: A Single Institution Retrospective Experience
-
Abstract Number: 0362
Adverse Childhood Experiences Are Associated with Disease Outcomes in Youth with Juvenile Idiopathic Arthritis
-
Abstract Number: 0364
Sex Differences in Clinical and Imaging Characteristics of Axial Juvenile Spondyloarthritis
-
Abstract Number: 0365
Establishing a Multidisciplinary Registry for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis: Insights into Patient Outcomes and Management Challenges
-
Abstract Number: 0366
Active Joint Acoustic Emissions on the Achilles Tendon: A Digital Biomarker of Enthesitis Related Arthritis
-
Abstract Number: 0367
Adolescents and Young Adults Taking Methotrexate: Knowledge and Behaviours
-
Abstract Number: 0368
Surveying Psychological Resilience and Pain in a Cross-Section of JIA Patients
-
Abstract Number: 0369
Trajectory of Progression in Transition Readiness in Adolescents with JIA and jSLE
-
Abstract Number: 0370
Clinical Disease Manifestations Associated with TNF Inhibitor Non-Response in Juvenile Spondyloarthritis
-
Abstract Number: 0371
Assessing Methotrexate Adherence in JIA Using Electronic Health Record-Linked Pharmacy Dispensing Data
-
Abstract Number: 0372
Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial
-
Abstract Number: 0373
Potential Tear-Based Uveitis Biomarkers in Children with JIA: A Pilot Study
-
Abstract Number: 0374
Actionable Adverse Events in a Real-Practice Cohort of Children with Juvenile Idiopathic Arthritis. Results from the CAPRI Registry
-
Abstract Number: 0376
Switching Patterns of Biological and Targeted Synthetic Therapies in Juvenile Idiopathic Arthritis
-
Abstract Number: 0377
Disease Activity and New Medication Start at Two Consecutive Registry Visits for Patients with Juvenile Idiopathic Arthritis
-
Abstract Number: 0378
Characteristics of Macrophage Activation Syndrome in Systemic JIA Patients Receiving Anakinra as First-line Treatment
-
Abstract Number: 0379
Clinical Evolution of Patients Diagnosed of Juvenile Idiopathic Arthritis After the Transitional Care Consultation
-
Abstract Number: 0380
Use of Digital Health Tools to Evaluate Change in Clinical and Patient-Reported Outcomes Among Patients with Rheumatoid Arthritis Initiating Treatment with a JAKi or TNFi
-
Abstract Number: 0381
Disease Burden, Patient Experiences, and Unmet Needs in Refractory Rheumatoid Arthritis: Insights from 20 Years of Real-World Data
-
Abstract Number: 0382
Heterogeneity Within a “difficult to Treat” Rheumatoid Arthritis Patients Cohort: 36% May Have a More Benign Course and Have Distinct Characteristics at bDMARD or tsDMARD Initiation
-
Abstract Number: 0383
Identification of Contributing Factors to Difficult-to-Treat Rheumatoid Arthritis (D2T RA) in a Cohort of 972 Patients Using a Natural Language Processing (NLP) Approach
-
Abstract Number: 0384
Targeting NET Formation in Early RA Patients; A Spin-off Study from the NORD-STAR
-
Abstract Number: 0385
Heterogeneity of the Joint Location Supports the Importance of Local Factors in Early RA Synovitis : Analysis of the ERA UCLouvain Brussels Cohort
-
Abstract Number: 0386
Functional Disability and Disease Activity Are Affected by Social Determinants of Health in Patients with Rheumatoid Arthritis
-
Abstract Number: 0387
The Association Between Inflammation, High-Sensitivity Cardiac Troponin T, and Cardiovascular Events in Rheumatoid Arthritis
-
Abstract Number: 0388
Left Ventricular Geometry Abnormalities Are Related to Higher Clinical Activity in Rheumatoid Arthritis Patients
-
Abstract Number: 0389
The Role of anti-CCP3 Antibodies in anti-CCP2 Antibody Negative Patients with Musculoskeletal Symptoms
-
Abstract Number: 0390
Statins Influence the Relationship Between ATP-binding Cassette Transporter A1 (ABCA1)-mediated Cholesterol Efflux and Coronary Atherosclerosis in Rheumatoid Arthritis
-
Abstract Number: 0391
Biologic Use Regulates the Impact of Inflammation on Ischemic Cardiovascular Risk in Rheumatoid Arthritis
-
Abstract Number: 0393
Pulmonary Involvement in Patients with Seropositive and ACPA Positive Rheumatoid Arthritis (RA-ILD) – Novel Screening Protocol for Early Detection of Pulmonary Involvement
-
Abstract Number: 0394
Higher Intakes of Red Meat Are Associated with an Increased Risk of Developing Seropositive but Not Seronegative Rheumatoid Arthritis – Results from a Nested Case-Control Study
-
Abstract Number: 0395
Prevalence of Objectively Measured Sleep Disturbance in Rheumatoid Arthritis (RA)
-
Abstract Number: 0396
Hydroxychloroquine Is Associated with a Decreased Risk of Non-alcoholic Fatty Liver Disease in Patients with Rheumatoid Arthritis: A Population-based, Cohort Study
-
Abstract Number: 0397
Obesity Is Associated with Worse Flare Symptoms and Quality of Life in Early Rheumatoid Arthritis: Insights from the RA Flare Questionnaire
-
Abstract Number: 0398
Identification of Disease Activity-related miRNAs Through Artificial Neural Network Analysis in Rheumatoid Arthritis
-
Abstract Number: 0399
Differential Synovial Tissue Enrichment of Oxylipins and Their Mediators Across Rheumatoid Arthritis Trajectory
-
Abstract Number: 0400
Thresholds of Presenteeism Measurement Instruments for Unacceptable Work Participation and Future Adverse Work Outcomes in Rheumatoid Arthritis
-
Abstract Number: 0401
Resolution of Swollen Joint Count Is an Important Clinical Objective in Early Rheumatoid Arthritis : Analysis of the UCLouvain Brussels ERA Cohort and Comparison with the Remission Composite Index
-
Abstract Number: 0402
Automated Detection and Quantification of Hand Joint Swelling in Rheumatoid Arthritis: Computer Vision, Deep Neural Network Models, and a Potential Biomarker for Disease Activity Monitoring
-
Abstract Number: 0403
Disease Activity Is Associated with Frailty in Veterans with Rheumatoid Arthritis
-
Abstract Number: 0404
Persistent Pain and Its Predictors After Start of Anti-TNF Therapy in Rheumatoid Arthritis – Is Line of Treatment Linked to Different Pain Patterns?
-
Abstract Number: 0405
Clinical Features of Anti-Th/To Antibodies-positive Systemic Sclerosis Patients: A Single-center Retrospective Study
-
Abstract Number: 0406
Obesity Is a Risk Factor for Poor Response to Treatment in Early Rheumatoid Arthritis – a NORD-STAR Spin-Off Study
-
Abstract Number: 0407
Meteorological Conditions Contribute to the Joint Ultrasound Findings in Patients with Rheumatoid Arthritis: Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study
-
Abstract Number: 0408
The Role of Synovial Biopsy in Evaluating Rheumatoid Arthritis Acitivity in Patients: Findings from a Study of 30 Patients Treated with Adalimumab
-
Abstract Number: 0409
Prevalence of Pulmonary Manifestations in Patients with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, and Peripheral Spondyloarthritis
-
Abstract Number: 0410
Usefulness of RAPID3 in Assessing Unmet Needs of Patients with Rheumatoid Arthritis in Remission or with Low Disease Activity -a Multicenter Observational Study: T-FLAG Study-
-
Abstract Number: 0411
The Impact of Patient-reported Outcomes on Boolean 2.0 Remission Criteria in Rheumatoid Arthritis Patients in Real Clinical Practice -a Multicenter Observational Study: T-FLAG Study-
-
Abstract Number: 0412
COVID Antibody Response to Third Dose Anti-SARS-COV2 mRNA Vaccine in Patients with Seropositive Rheumatoid Arthritis on Immunosuppressive Therapy
-
Abstract Number: 0413
Transcriptomic Analysis of Peripheral Blood Mononuclear Cells Reveals Pain and Inflammation Specific Alterations in Difficult-to-treat Rheumatoid Arthritis
-
Abstract Number: 0414
Association of a Treat-to-Target Management Approach with Physician and Patient Reported Outcomes Among Real – World Patients with Rheumatoid Arthritis Receiving Advanced Therapy in Europe
-
Abstract Number: 0415
Serious Infections Hospital Admissions and Mortality in Patients with Early Inflammatory Arthritis: Results from a Large UK Cohort
-
Abstract Number: 0416
Association Between Sleep Disorders and Rheumatoid Arthritis: A Population-based Cohort Study
-
Abstract Number: 0417
The Role of Rheumatoid Arthritis Flare in the Risk of Alzheimer’s Disease and Related Dementias: A Population-based Cohort Study
-
Abstract Number: 0418
Synovial Fluid Cell Counts Associated with Joint Histopathology in Rheumatoid Arthritis
-
Abstract Number: 0419
No Clinically Relevant Changes in Coagulation Activation Between Patients Initiating TNF-blockers versus JAK-inhibitors
-
Abstract Number: 0421
Bioinformatics Platform to Study the Genetics of Biologic DMARD Non-responders: Design and Protocol of the RA Non-responders to Treatment (RANT) Study
-
Abstract Number: 0422
Electronic Health Record-Based Machine Learning Model for Predicting Disease Activity in Patients with Rheumatoid Arthritis
-
Abstract Number: 0423
Detection of Citrullinated Proteins Recognized by a Novel Chimeric Antigen Receptor TregTherapy in Both Synovial Fluid and Serum from Patients with Rheumatoid Arthritis
-
Abstract Number: 0424
Real-World Effectiveness of Upadacitinib in Patients with Moderate/Severe Rheumatoid Arthritis: 6-Month Data from the Observational UPHOLD Study
-
Abstract Number: 0425
Long-term Safety of Rituximab in Rheumatoid Arthritis: A Systematic Review and Meta-analysis
-
Abstract Number: 0426
The Clinical Efficacy of Switching Therapy Between Biological Agents and JAK Inhibitors in the Patients with Rheumatoid Arthritis
-
Abstract Number: 0427
Molecular Characterization of Biologic and Targeted Synthetic DMARDs Effects Through Ex- vivo Studies in Rheumatoid Arthritis Immune Cells
-
Abstract Number: 0428
Real World Patterns of Advanced Therapy Tapering in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort
-
Abstract Number: 0429
Direct and Indirect Effects of Upadacitinib or Adalimumab on Pain in Rheumatoid Arthritis: Results from a Randomized Phase 3 Study
-
Abstract Number: 0430
A Multicenter, Real-world Clinical Data Study of the Use of JAK Kinase Inhibitors in a Large Cohort of Patients with Rheumatoid Arthritis
-
Abstract Number: 0431
Senescence and Cell Exhaustion in CD4+ and CD8+ Lymphocytes in Rheumatoid Arthritis Patients in Remission Without Treatment
-
Abstract Number: 0432
Predictors of Use, Survival and Safety of Tofacitinib Monotherapy vs. in Combination with CsDMARDs in Daily Clinical Practice
-
Abstract Number: 0433
DMARD Initiation in Older Adults with New Diagnosis of Late-Onset Rheumatoid Arthritis
-
Abstract Number: 0434
Effects of B/tsDMARDs on Non-inflammatory Pain in Patients with Rheumatoid Arthritis -ANSWER Longitudinal Cohort Study-
-
Abstract Number: 0435
Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following Release of Safety Data
-
Abstract Number: 0436
Patients with Difficult-to-treat Rheumatoid Arthritis Have Higher Levels of Inflammation on Ultrasound
-
Abstract Number: 0437
Comparative Safety of Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for Cardiovascular Outcomes in Rheumatoid Arthritis
-
Abstract Number: 0438
Association Between Methotrexate Use and Lymphoma in Rheumatoid Arthritis: A Systematic Literature Review
-
Abstract Number: 0440
Baseline T Cell and B Cell-related Markers and HLA-DRB1 Shared Epitope Alleles Predict the Therapeutic Efficacy of Abatacept in Patients with Moderate to Severe Rheumatoid Arthritis
-
Abstract Number: 0441
Outcomes in Patients with Rheumatoid Arthritis Initiating Therapy with Etanercept, Adalimumab, or Janus Kinase Inhibitors
-
Abstract Number: 0442
Infliximab Clearance a Predictive Factor of Pharmacokinetic Origin in Relation to Suboptimal Pharmacokinetics and Immunogenicity in United States Based Rheumatology Practices
-
Abstract Number: 0443
The Potential of an Oral TNFα Inhibitor with TNFR1 Specificity: Results of a Phase 1b Proof-of-mechanism Trial in Psoriasis
-
Abstract Number: 0446
Review of Rheumatoid Arthritis Treatment Landscape During the COVID-19 Pandemic
-
Abstract Number: 0447
Glucocorticoid Use in Rheumatoid Arthritis Patients Initiating Biological or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs (b/tsDMARDs) in Real Life: Data from BIOBADASER
-
Abstract Number: 0448
Cardioprotective Impact of JAKi, Tofacitinib, on CV Risk in Rheumatoid Arthritis: JAKi CV Risk Impact Study
-
Abstract Number: 0449
Parsing Pathophysiology of Rheumatoid Arthritis-associated Lymphoproliferative Disorders via Whole RNA Transcriptome Analysis: Multi-center Study in Japan
-
Abstract Number: 0450
Baricitinib versus TNF-inhibitors in Patients with Active Rheumatoid Arthritis After Failure of CsDMARDs: A Pragmatic, Multicenter, Real-Life Study in a Treat-to-Target Setting
-
Abstract Number: 0451
Long-term Clinical Profile of Filgotinib in Patients with Rheumatoid Arthritis by Cardiovascular Risk Factors: A Post Hoc Subgroup Analysis
-
Abstract Number: 0452
Real Life Safety and Survival of Targeted Therapies in Arthritis Patients over Age of 65
-
Abstract Number: 0453
Risk of Lung Cancer in Veterans with Rheumatoid Arthritis in Relation to Use of Conventional versus Biologic or Targeted Synthetic DMARDs
-
Abstract Number: 0456
The “Topics” in the Electronic Health Record of Rheumatoid Arthritis Patients Before Initiating Targeted Therapies and Association with Future Treatment Course
-
Abstract Number: 0457
Biologic Disease Modifying Antirheumatic Drug Use in Immune Checkpoint Inhibitor-Treated Cancer Patients with Rheumatoid Arthritis: Utilization and Overall Survival
-
Abstract Number: 0458
Drug Switching Due to Inefficacy in Rheumatoid Arthritis Patients Treated with Biological and Targeted Therapies. Daily Clinical Experience
-
Abstract Number: 0459
Upadacitinib Monotherapy versus Methotrexate in Patients with Rheumatoid Arthritis: Efficacy and Safety Through 5 Years in the SELECT-EARLY Randomized Controlled Trial
-
Abstract Number: 0460
Knowledge Related to Fertility and Infertility Treatments Among Women with Systemic Rheumatic Disease
-
Abstract Number: 0461
Self-esteem as a Determinant of Sexual Function in SLE Patients
-
Abstract Number: 0462
Breastfeeding Intention in Systemic Lupus Erythematosus Patients
-
Abstract Number: 0463
Appropriate Preconception Care Improves Pregnancy Outcomes in SLE Patients
-
Abstract Number: 0464
Adverse Pregnancy Outcomes in Sjogren’s Disease Compared to Controls: An Interdisciplinary Approach with Maternal Fetal Medicine
-
Abstract Number: 0465
The Effects of Post-Dobbs Abortion Policy on Rheumatology Clinical Practice: A Survey of Rheumatologists
-
Abstract Number: 0466
Impact of Postpartum on Patients with Inflammatory Rheumatic Diseases: The P2Rheum Study
-
Abstract Number: 0467
Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals with Autoimmune Rheumatic Diseases and Antiphospholipid Syndrome
-
Abstract Number: 0468
Patients with Autoimmune Skin Diseases Are at Increased Risk of Adverse Pregnancy Outcomes
-
Abstract Number: 0469
Hydroxychloroquine and Preeclampsia Risk in Lupus Pregnancy: Results from a Large Regional Integrated Health Network
-
Abstract Number: 0470
Educational Intervention to Increase Contraception Screening and Documentation for Reproductive-Aged Women Seen in an Academic Rheumatology Clinic
-
Abstract Number: 0471
Knowledge and Misconceptions About Contraception Among Individuals with Inflammatory Arthritis and Lupus-like Diseases
-
Abstract Number: 0472
Contraception Choices in Individuals with Inflammatory Arthritis and Lupus-like Disease Differ Based on Diagnosis and Teratogen Use
-
Abstract Number: 0473
The Number of Rheumatoid Arthritis Patients Who Give up Pregnancy Due to the Disease Is Decreasing
-
Abstract Number: 0474
Acute Cardiovascular Events During Pregnancy and Delivery in Patients with Autoimmune Rheumatic Diseases (ARDs): An Analysis of National Inpatient Sample
-
Abstract Number: 0475
Prevalence of Endometriosis and Polycystic Ovarian Syndrome in Patients with Rheumatic Diseases in the United States
-
Abstract Number: 0476
Factors Associated with the Need for Assisted Reproductive Therapies in a Spanish Cohort of Patients with Rheumatic Diseases
-
Abstract Number: 0479
Exploring Reproductive Experiences with Women Enrolled in the Vasculitis Pregnancy Registry
-
Abstract Number: 0480
Non-random Sampling in Rheumatology Randomized Controlled Trials: Evidence of Concerning Trial Conduct?
-
Abstract Number: 0481
Automatically Detect Finger Joint Center and Angle on Hand X-ray: A Deep Learning Model
-
Abstract Number: 0482
Preference and Relative Sensitivity of Indicators Reporting Response Rate in Pharmaceutical Trials of Psoriasis and Psoriatic Arthritis
-
Abstract Number: 0483
The Influence of “Fibromyalgia-ness” on Treatment Response Amongst Patients with Psoriatic Arthritis (PsA). Results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR‐PsA)
-
Abstract Number: 0484
Higher Levels of High-sensitivity CRP Are Associated with Future Risk of Developing Psoriatic Arthritis Among Patients with Psoriasis: A Prospective Cohort Study
-
Abstract Number: 0485
Sex and Treatment-associated Outcomes in Patients with Active Psoriatic Arthritis Treated with Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial
-
Abstract Number: 0486
Identifying Serum Metabolomic Markers Associated with Psoriasis Skin Disease Activity
-
Abstract Number: 0487
A Comparative Study of Serositis Between Inpatients with Psoriatic Arthritis and Rheumatoid Arthritis
-
Abstract Number: 0488
Factors Associated with Work Productivity Among Individuals with Psoriatic Arthritis (PsA) and Psoriasis (PsO): The Role of Patient Reported Outcomes and Disease Severity
-
Abstract Number: 0489
Prediction of Low Disease Activity in Patients with Psoriatic Arthritis Treated with Secukinumab in Real World – Data from a German Observational Study
-
Abstract Number: 0490
Racial/Ethnic Differences in Psoriatic Arthritis Patient Responses Regarding Disease Burden, Treatment, and Communication with Care Team
-
Abstract Number: 0491
Arthralgia with Risk of Progression to Psoriatic Arthritis in a Large Cohort of Patients: Role of Ultrasound
-
Abstract Number: 0492
Axial Spondyloarthritis in Patients with Late-Onset Chronic Low Back Pain (Older Than 45 Years). Axial Spa or Psoriatic Disease with Axial Involvement?
-
Abstract Number: 0493
Axial Disease Activity in Psoriatic Arthritis Is Higher in Patients with Carotid Plaque
-
Abstract Number: 0494
Levels of Atherosclerotic Index of Plasma and Triglyceride Glucose Index in Patients with Psoriatic Arthritis and Carotid Plaque
-
Abstract Number: 0495
Prevalence of Undiagnosed Inflammatory Bowel Disease in Patients with Spondyloarthritis: EISER Study
-
Abstract Number: 0496
Higher Values of Atherogenic Index of Plasma Are Correlated with Increased Cardiovascular Risk in Patients with Psoriatic Arthritis
-
Abstract Number: 0497
Effects and Tolerability of Low to Moderate Biomechanical Stress During Leisure Sport Activity in Patients with Psoriasis and Psoriatic Arthritis
-
Abstract Number: 0498
Biological Therapies for Psoriasis and Psoriatic Arthritis- effects on Future Risk Development of Major Adverse Cardiovascular Events (MACE)
-
Abstract Number: 0499
Durability of Response Among Patients with Psoriatic Arthritis (PsA) Using Biological or Targeted Synthetic Disease-Modifying Antirheumatic Drugs in the CorEvitas PsA/Spondyloarthritis Registry
-
Abstract Number: 0501
Multicentre Study of Uveitis in Spondyloarthritis: Prevalence, Characteristics, and Prognosis
-
Abstract Number: 0502
Developing Electronic Health Record Algorithms to Accurately Identify Psoriatic Arthritis Patients
-
Abstract Number: 0503
Spinal Inflammation a Dominant Pathology in Psoriatic Arthritis: Characterization and Quantification by In-Vivo 18F-FDG Total-Body PET/CT Imaging
-
Abstract Number: 0504
Burden of Disease of Psoriatic Arthritis in Latin America: A Systemic Review of Literature
-
Abstract Number: 0505
Factors Associated with Minimal Disease Activity in Psoriatic Arthritis: Insights from a Registry-Based Study
-
Abstract Number: 0506
Patient and Physician Global Assessment of Psoriatic Arthritis Disease Activity: High Concordance in an ArLAR Multinational Study
-
Abstract Number: 0507
The Use of PSAID-12 in Remote Monitoring Correlates with In-person Clinical Examination Findings in Psoratic Arthritis
-
Abstract Number: 0508
Assessment of Pain Outcomes in a Phase 2 Trial of a Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, in Patients with Active PsA
-
Abstract Number: 0510
Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies
-
Abstract Number: 0511
Long-term Safety and Tolerability of Bimekizumab in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: Results from Pooled Phase 2b/3 Studies
-
Abstract Number: 0512
Factors Associated with Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-year Follow-up of the DESIR Cohort
-
Abstract Number: 0513
Impact of Pregnancy on Sacroiliac Imaging in Women with Axial Spondyloarthritis: Results of the Analysis of the DESIR Cohort
-
Abstract Number: 0514
Difficult-to-treat Axial Spondyloarthritis Is Associated with Psoriasis and Comorbidities: Results from a Nationwide Study
-
Abstract Number: 0515
Dose Adjustment of Tumor Necrosis Factor Inhibitors Does Not Correlated with Radiographic Progression in Patients with Ankylosing Spondylitis
-
Abstract Number: 0516
Drivers of Treatment Intensification in Patients with Axial Spondyloarthritis and High Disease Activity: Results from a Clinical Practice Registry
-
Abstract Number: 0517
Which ASDAS Cut-Off Corresponds Best to Treatment Intensification in Patients with Axial Spondyloarthritis in Daily Practice?
-
Abstract Number: 0518
Tofacitinib Efficacy and Safety in Patients with Ankylosing Spondylitis by Baseline C-Reactive Protein Levels: A Post Hoc Analysis
-
Abstract Number: 0519
Long-Term Safety and Efficacy of Bimekizumab in Patients with Active Ankylosing Spondylitis: 5-Year Results from a Phase 2b Study and Its Open-Label Extension
-
Abstract Number: 0520
How Do Early Disease Activity and Early Clinical Response Associate with Long-Term Outcomes with Ixekizumab in Radiographic Axial Spondyloarthritis?
-
Abstract Number: 0521
Work Productivity Improved in Patients with Axial Spondyloarthritis Receiving Bimekizumab Treatment over 52 Weeks: Results from Two Phase 3 Studies
-
Abstract Number: 0523
Bimekizumab Maintained Stringent Clinical Responses Through Week 52 in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies
-
Abstract Number: 0524
Efficacy of Certolizumab Pegol in Preventing Anterior Uveitis Flares Compared with Standard Non-Biologic Treatment: A Matched Control Study in High-Risk Patients with Axial Spondyloarthritis
-
Abstract Number: 0526
Bimekizumab Improved Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 52-Week Results from Two Phase 3 Studies
-
Abstract Number: 0528
Risk of Cardiovascular Disease Associated with Long-term Use of NSAIDs in Ankylosing Spondylitis
-
Abstract Number: 0529
Sex-dependent Differences in Disease Characteristics Do Not Influence Effectiveness of Secukinumab Therapy in Patients with Active Axial Spondyloarthritis in a Non-Interventional Trial (AQUILA)
-
Abstract Number: 0530
Impact of Upadacitinib on Wearable Device-Measured Physical Activity in Patients with Ankylosing Spondylitis from the SELECT-AXIS 2 Trial
-
Abstract Number: 0531
Effects of Anti-tumor Necrosis Factor Treatment on Lipid Profiles in Patients with Ankylosing Spondylitis
-
Abstract Number: 0532
Factors Associated with Cause-specific Discontinuation of Long-term Anti-tumor Necrosis Factor Agent Use in Patients with Ankylosing Spondylitis
-
Abstract Number: 0533
Remission in Axial Spondyloarthritis: Is There a Difference Between NSAIDs and b/tsDMARDs in Daily Practice?
-
Abstract Number: 0534
Tapering Tofacitinib for Axial Spondyloarthritis in Remission or Low-disease Activity State
-
Abstract Number: 0535
Pharmacologic Treatment of Ankylosing Spondylitis in a Large Urban Medical Center: Effects of Socioeconomic Status, Race/Ethnicity and Sex
-
Abstract Number: 0536
Asynchronous Tele Consultation by WhatsApp Chatbot in Controlled Axial Spondyloartrhitis Patients Under Biological Therapy: Patients Perspective
-
Abstract Number: 0537
Asynchronous Teleconsultation by WhatsApp Chatbot in Controlled Axial Spondyloartrhitis Patients Under Biological Therapy as a More Sustainable Model Than Face-to-face Classical Consultation
-
Abstract Number: 0538
The Challenge of Identifying Difficult-To-Treat Axial Spondyloarthritis in Clinical Practice: Results from La Paz-SpA Cohort
-
Abstract Number: 0539
Impact of Extreme Baseline BASDAI and/or Maastricht AS Enthesitis Score on Treatment Response to Upadacitinib in Patients with Axial Spondyloarthritis
-
Abstract Number: 0540
The Impact of Baseline BMI and Physical Activity on Upadacitinib Treatment Response: A Post Hoc Analysis of Patients with Ankylosing Spondylitis from the SELECT-AXIS 2 Study
-
Abstract Number: 0541
Treat-to-Target Strategy Implementation in Spondyloarthritis Patients of Real-World Clinical Practice: A Cross-Sectional Single-Center Study
-
Abstract Number: 0542
Two-Year Treatment Adherence and Clinical Response to Secukinumab Compared to TNF Inhibitors in Axial and Peripheral Spondyloarthritis Patients: A Single-Center Prospective Observational Study
-
Abstract Number: 0544
Autoantibodies to dsDNA and Associated Proteins: Association with Proteinuria and Lupus Nephritis
-
Abstract Number: 0545
Referral Pattern and Factors Associated with Time to Diagnosis for Lupus in India- multicentric Data from the SLE Special Interest Group (SIG) of the Indian Rheumatology Association (IRA)
-
Abstract Number: 0546
Markers of Oxidative Stress in Systemic Lupus Erythematosus Patients with Nephritis
-
Abstract Number: 0547
A Spatially-resolved Single Cell Resolution Atlas of Pediatric Lupus Nephritis Uncovers Complex Interactions Between Stromal and Infiltrating Immune Cells
-
Abstract Number: 0548
Clinical and Interferon Biomarkers to Exclude Imminent Autoimmune Disease in ANA Positive Individuals
-
Abstract Number: 0549
Development of Customized Digital Cognitive Assessment Battery: A Pilot Use Case in SLE Patients
-
Abstract Number: 0550
Harnessing Machine Learning to Predict Neuropsychiatric Events in Systemic Lupus Erythematosus
-
Abstract Number: 0551
Monogenic Lupus: Clinical Phenotypes and Genetic Mutations in a Cohort of Pediatric Patients
-
Abstract Number: 0552
The Impact of Antiphospholipid Antibodies on Future Atherosclerotic Cardiovascular Disease Risk in Systemic Lupus Erythematosus
-
Abstract Number: 0553
Serum Isolevuglandin IgG Antibody Concentrations Are Increased in Patients with Systemic Lupus Erythematosus versus Control Subjects and Associated with Lower 24-hour Blood Pressure
-
Abstract Number: 0554
A Refined Disease Activity Immune Index Informed by Select Immune Mediators That Characterizes Clinical Disease Activity in Systemic Lupus Erythematosus
-
Abstract Number: 0555
Evaluation and Management of the “False Positive” ANA and Undifferentiated Connective Tissue Disease Amongst Rheumatologists
-
Abstract Number: 0556
Classical Complement Activation in Lupus Nephritis Correlates with Disease Biomarkers: Results from Two Observational Studies
-
Abstract Number: 0557
Longitudinal Evaluation of Cell-bound Complement Activation Products in Patients with SLE
-
Abstract Number: 0558
Elevated Serum Levels of S100A8/A9 Discriminate Systemic Lupus Erythematosus Patients with Cognitive Impairment from Patients Without Impairment
-
Abstract Number: 0559
Development of Charlson Comorbidity Index (CCI) Comorbidities and CCI Score in Danish Nationwide Cohort of 3,178 Patients with Newly Diagnosed Systemic Lupus Erythematosus
-
Abstract Number: 0560
Genetic Determinants of Lupus Nephritis and Kidney Function in Systemic Lupus Erythematosus
-
Abstract Number: 0561
Frequency of Anti-Ro Antibodies in Systemic Lupus Erythematosus Patients: Insights from Multicenter and National Registry
-
Abstract Number: 0562
HDL-Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
-
Abstract Number: 0563
Urinary Neutrophil Gelatinase-associated Lipocalin (NGAL) as a Mediator of the Association Between Particulate Matter Exposure and Disease Activity in Systemic Lupus Erythematosus
-
Abstract Number: 0564
Risk Factors for Immune Thrombocytopenia in Systemic Lupus Erythematosus and Generation of a Predictive Model to Assess Its Risk of Development
-
Abstract Number: 0565
Insulin Resistance and the Complement System Are Linked in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0566
Characterization of Disease Activity Using a Novel Physiologic Biomarker in Pediatric SLE
-
Abstract Number: 0567
N-Terminal Pro-Brain Natriuretic Peptide Correlates Strongly with Cardiovascular Damage in Systemic Lupus Erythematous (SLE): A Cross-sectional Study
-
Abstract Number: 0568
Comparison of Plasma Protein Profiles and Endothelial Function in Patients with Pediatric-Onset Systemic Lupus Erythematosus and Healthy Controls
-
Abstract Number: 0569
Serum S100A8 and S100A9 Are Useful Biomarker Indicated IFN Associated Organ Involvements in Systemic Lupus Erythematosus
-
Abstract Number: 0570
BLyS Levels Are Elevated in Systemic Lupus Erythematosus Patients with Neuropsychiatric Manifestations
-
Abstract Number: 0571
A Polygenic Risk Score for Systemic Lupus Erythematosus (SLE) Discriminates Between Patients with Lupus and Individuals Without Lupus and a Positive Antinuclear Antibody Test
-
Abstract Number: 0572
Serum/ Urine Levels and Expression of CD163 in Lupus Nephritis
-
Abstract Number: 0573
Presence of Mediterranean Fever Gene Variants Provides Protection from the Development of Lupus Nephritis in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0574
Type I IFN-associated Regulation of Immune Checkpoint Genes in Patients with SLE
-
Abstract Number: 0575
The Real-World Utility of a Lupus Activity Monitoring Panel in the United States Community Rheumatologist Practice
-
Abstract Number: 0576
Enhancing Systemic Lupus Erythematosus Diagnosis: Comparative Performance Characteristics of TC4d and Anti-T-Cell Antibodies with Conventional Biomarkers
-
Abstract Number: 0577
Analysis of Intracytoplasmic Toll – Like Receptors (TLRs) and MyD88 Expression in B Cell Subsets in Patients with Lupus Nephritis
-
Abstract Number: 0578
Prospective Observational Study of Microvascular C5b-9 Deposition in Non-lesional Skin in Systemic Lupus Erythematosus Patients and Its Correlation with Active Lupus Nephritis
-
Abstract Number: 0579
Sub-types of Ischemic Stroke in Systemic Lupus Erythematosus,-associations with STAT4 and HLA-DRB1 Risk Genotypes
-
Abstract Number: 0580
Performance of Conventional Cardiovascular Risk Scores in Identifying Subclinical Atherosclerosis in Systemic Lupus Erythematosus
-
Abstract Number: 0582
Evaluation of Anifrolumab Treatment Responses by the Short Form 36 Health Survey Version 2 in SLE: A Post Hoc Analysis of the Placebo-Controlled Phase 3 Long-Term Extension Trial
-
Abstract Number: 0583
Therapeutic Potential of Imvotamab, a CD20-Targeted Bispecific IgM T Cell Engager, for the Treatment of Refractory Autoimmune Disease Patients
-
Abstract Number: 0584
Targeting Key Components of SLE Pathogenesis with the Multifaceted Immunomodulatory Properties of Cenerimod, a Selective S1P1 Receptor Modulator
-
Abstract Number: 0585
The Impact of Impaired Vagus Nerve Activity and Transcutaneous Vagus Nerve Stimulation (tVNS) on Arterial Stiffness in Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 0586
Therapeutic Drug Monitoring of Azathioprine and Tacrolimus in SLE Pregnancies: Preliminary Results from the LEGACY Cohort
-
Abstract Number: 0588
Long Term Safety and Predictors of Serious Infections Among Patients with Systemic Lupus Erythematosus Treated with Rituximab: Audit from a Single Center Biologic Registry
-
Abstract Number: 0589
A Comparative Evaluation of IgA2 Anti-dsDNA Antibodies and Clinical Outcome in Two Clinical Trials of Belimumab After Rituximab in SLE
-
Abstract Number: 0591
Despite Dramatic Expansion of Approved Biologics in SLE, Unmet Needs Remain
-
Abstract Number: 0592
Real-World Treatment Patterns in Patients with Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
-
Abstract Number: 0593
Lupus Nephritis of the Spanish National Registry of Belimumab in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0595
Renal Involvement in Patients with Systemic Lupus Erythematosus Treated with Anifrolumab Compared with Placebo over a 4-Year Period
-
Abstract Number: 0597
Efficacy of Anifrolumab in Systemic Lupus Erythematosus by Overall and Organ-Specific SLEDAI-2K Improvements: Results from the Randomized, Placebo-Controlled Phase 3 Long-Term Extension Study
-
Abstract Number: 0598
Litifilimab Modulates Type I IFN Biomarkers in Patients with SLE or CLE in the Phase 2 LILAC Study
-
Abstract Number: 0599
Targeted Inhibition of Cathepsins Limits the Intracellular Complement Activation in Lupus Nephritis Podocytes
-
Abstract Number: 0600
Identification of Subsets of SLE Patients Responsive to Baricitinib by Transcriptomic Analysis at Baseline
-
Abstract Number: 0601
Selective Disposition of Voclosporin, Cyclosporine, and Tacrolimus in Renal Tissue
-
Abstract Number: 0602
Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN-101) Reveals Non-Redundant Roles of T Cell Co-Stimulation Pathways in Systemic Lupus Erythematosus
-
Abstract Number: 0603
Antiphospholipid Antibodies as Potential Predictors of Disease Severity and Poor Prognosis in Systemic Lupus Erythematosus Associated Thrombocytopeinia
-
Abstract Number: 0605
Determining the ECG Cut-off Point in Systemic Lupus Erythematosus Patients Undergoing Hydroxychloroquine Therapy
-
Abstract Number: 0606
Risk of Damage Progression with Belimumab versus Oral Immunosuppressant Use in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0607
CAR T Cell Therapy Leads to Long-term Abrogation of Autoimmunity in SLE Patients While Vaccination Responses Are Maintained
-
Abstract Number: 0608
Efficacy of Cenerimod in Patients with High IFN-1 Gene Expression Signature and High Anti-dsDNA Antibody Levels: Post-hoc Analysis from a Phase 2 Study
-
Abstract Number: 0609
Mortality After Autologous Hematopoietic Stem Cell Transplant for Autoimmune Disease: Do Scleroderma Patients Fare Worse?
-
Abstract Number: 0610
Nailfold Capillaroscopy for Prediction of Novel Severe Organ Involvement in Systemic Sclerosis
-
Abstract Number: 0611
Demographics and Clinical Features Associated with Small Bowel Hypomotility in Systemic Sclerosis
-
Abstract Number: 0612
COVID Vaccinations and Infections Among Individuals with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study
-
Abstract Number: 0613
Quantification of Skin Hardness of Patients with Systemic Sclerosis Using SOFTGRAM
-
Abstract Number: 0614
Self-Reported Sexual Dysfunction and Perceptions of Rheumatologist Engagement on This Issue in Patients with Systemic Sclerosis
-
Abstract Number: 0615
Prevalence of Barrett’s Esophagus in Patients with Systemic Sclerosis
-
Abstract Number: 0616
Does Systemic Sclerosis Affect the Interpretation of Mammograms? A Retrospective Cohort Study
-
Abstract Number: 0617
Pulmonary Rehabilitation in Connective Tissue Disease-Related Interstitial Lung Diseases
-
Abstract Number: 0618
Incident versus Prevalent Interstitial Lung Disease in Systemic Sclerosis in the EUSTAR Database: Different Disease Phenotypes and Prognosis
-
Abstract Number: 0619
Different Definitions of Disease Severity, Progression and Outcomes in Systemic Sclerosis Associated Interstitial Lung Disease: A Systematic Literature Review
-
Abstract Number: 0620
Physical and Mental Health in Early Systemic Sclerosis: Baseline Results for Patient-Reported Outcomes Measurement Information System-29 from the Collaborative National Quality and Efficacy Registry
-
Abstract Number: 0621
Scleroderma Renal Crisis: A Large Single-center Experience
-
Abstract Number: 0622
The Effectiveness of Breath-holding Test to Predict Pulmonary Function in Systemic Sclerosis Patients Using Machine Learning Model
-
Abstract Number: 0623
Nailfold Capillaroscopy in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib
-
Abstract Number: 0624
Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Based on Serological Profiles: Focus on Anti-Centromere Antibody (ACA) and Anti-RNA Polymerase III (ARA) Antibodies
-
Abstract Number: 0625
Use of Heated Gloves for Raynaud’s Phenomenon in Systemic Sclerosis
-
Abstract Number: 0626
Clinical Features of Anti-hUBF Antibodies-positive Patients: A Single-center Retrospective Study
-
Abstract Number: 0627
Clinical Significance of Anti-Ro/SSA Antibodies in Patients with Systemic Sclerosis: A Study from the EUSTAR Database
-
Abstract Number: 0628
Interstitial Lung Disease in Very Early Systemic Sclerosis
-
Abstract Number: 0629
Negative Affect, Anxiety and Fatigue Moderate the Association Between Pain Intensity and Physical Function in People with Systemic Sclerosis
-
Abstract Number: 0630
Prevalence and Risk Factors for Systemic Sclerosis Digital Ischemic Complications in the Collaborative National Quality and Efficacy Registry
-
Abstract Number: 0631
Safety of Radiotherapy for Malignancy in Systemic Sclerosis. a Systematic Review
-
Abstract Number: 0632
A Longitudinal Analysis of Mouth Opening in 1101 Systemic Sclerosis Patients from the French National Cohort Study
-
Abstract Number: 0633
Prediction of Progressive Fibrosing Interstitial Lung Disease in Systemic Sclerosis Patients: Insight from the CRDC Cohort Study
-
Abstract Number: 0634
Prevalence and Associations of Anaemia in Systemic Sclerosis Patients in a National Observational Cohort; Results from the Australian Scleroderma Cohort Study
-
Abstract Number: 0635
Clinical Characteristics and Longitudinal Outcomes of Patients with Childhood-Onset Systemic Sclerosis at a Tertiary Center
-
Abstract Number: 0636
Chasing Pain: Investigating Somatosensory Profiles in Patients with Rheumatological Diseases Using Quantitative Sensory Testing
-
Abstract Number: 0637
Comparison of Four Risk Stratification Models for Prediction of Mortality in Systemic Sclerosis-associated Pulmonary Arterial Hypertension in the EUSTAR Cohort
-
Abstract Number: 0639
Evaluating Esophageal Dysmotility by Scintigraphy in Systemic Sclerosis: Subsets and Phenotypes
-
Abstract Number: 0640
Multidisciplinary and Multiparametric Evaluation of Sarcopenia in Patients with Systemic Sclerosis
-
Abstract Number: 0643
Progression of Interstitial Lung Disease in Systemic Sclerosis Does Not Predict Further Progression
-
Abstract Number: 0644
Prediction of Stable SSc-ILD Depends on Definition of ILD Progression
-
Abstract Number: 0645
Continuous Progressive ILD in Systemic Sclerosis Is Associated with Mortality
-
Abstract Number: 0646
Racial Variability in Immune Responses Only Partially Explains Differential Systemic Sclerosis Disease Severity
-
Abstract Number: 0647
Prevalence and Risk Factors of Left Ventricular Diastolic Dysfunction in Systemic Sclerosis: Insights from New Echocardiographic Parameters
-
Abstract Number: 0648
Incidence and Prevalence of Malnutrition and Its Impact on Mortality in the Multicentre Singapore Systemic Sclerosis Cohort
-
Abstract Number: 0649
Early Systemic Sclerosis Definitions: Time to Rethink ‘Early’ in SSc Disease?
-
Abstract Number: 0650
Understanding the Employment Landscape in People with Systemic Sclerosis
-
Abstract Number: 0651
Abnormal Nailfold Video-capillaroscopy Is Independently Associated with non-UIP Radiographic Patterns in Autoimmune ILD: A Multicenter Study from the NEREA Registry
-
Abstract Number: 0652
Ethnic Variations in Systemic Sclerosis Associated Interstitial Lung Disease
-
Abstract Number: 0653
Association Between Systemic Sclerosis and Increased Risk of Ischemic Stroke: A Meta-Analysis
-
Abstract Number: 0654
Comparison of Cardiovascular Risk in Patients with Systemic Sclerosis and the General Population
-
Abstract Number: 0655
A Novel Association Between Lipodermatosclerosis and Key Vascular Outcomes in Systemic Sclerosis
-
Abstract Number: 0656
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression
-
Abstract Number: 0657
The Value of the Six-Minute Walk Test in Detecting Cardiopulmonary Involvement in Patients with Systemic Sclerosis
-
Abstract Number: 0658
Evaluating the Associations Between Autonomic Dysfunction, Clinical Phenotype and Gastrointestinal Transit in Patients with Systemic Sclerosis
-
Abstract Number: 0659
Cigarette Exposure in Systemic Sclerosis: Impact on Autoantibody Expression and Disease Manifestations: Analysis of the EUSTAR Cohort
-
Abstract Number: 0660
Cigarette Smoking Increases the Risk of All-Cause Mortality in Male Patients with Systemic Sclerosis: An Analysis of the EUSTAR Cohort
-
Abstract Number: 0661
Assessment of Systemic Sclerosis-Associated Myocarditis: A Single Center Case Series Study
-
Abstract Number: 0662
Changes in Treatment Patterns and Their Influence on the Outcome of Systemic Sclerosis-interstitial Lung Disease (SSc-ILD) Patients: An EUSTAR Analysis
-
Abstract Number: 0663
Vaccine-Preventable Diseases in Hospitalized Patients with Systemic Sclerosis: A Nationwide Cohort Analysis
-
Abstract Number: 0664
Quantitative Hand Held Dynamometry to Assess Muscle Strength in Scleroderma Associated Myopathy
-
Abstract Number: 0665
A Descriptive Study of Disease Characterisics of SSc Patients with the U2RNP Autoantibody
-
Abstract Number: 0666
Troponin I Levels in Systemic Sclerosis Patients with Myocardial Involvement
-
Abstract Number: 0667
The Risk of Stroke and Myocardial Infarction in Systemic Sclerosis: A Population-based Study
-
Abstract Number: 0668
Increased Risk of Cancer in Patients with Systemic Sclerosis: A Population-based Study
-
Abstract Number: 0669
Optical Coherence Tomography Angiography in Systemic Sclerosis: Correlations with Morphological and Functional Peripheral Microvascular Status
-
Abstract Number: 0670
Title: Patient Characteristics and Outcomes of Scleroderma Renal Crisis versus Hypertensive Emergencies: A Nationwide Comparative Study
-
Abstract Number: 0671
Decreased Odds of Malignancy with Mycophenolate Use in a Single-Center Scleroderma Cohort
-
Abstract Number: 0672
Risk of New-onset Depression in Patients with Systemic Sclerosis : A Nationwide Population-based Study
-
Abstract Number: 0673
Reporting of Race, Ethnicity, Sex, Gender, Socioeconomic Status and Representativeness of Race and Ethnicity in ANCA-associated Vasculitis Randomized Trials
-
Abstract Number: 0674
Efficacy and Safety of Mepolizumab During Maintenance Therapy in Patients with Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 0675
Investigating the Impact of anti-IL5 Therapy in the Management of Relapsing and Refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA); A Three Year Longitudinal Perspective and Beyond
-
Abstract Number: 0676
Mepolizumab Can Achieve Glucocorticoid Discontinuation in Eosinophilic Granulomatosis with Polyangiitis Patients Regardless of IgE Levels: A Retrospective Study at a Single Center
-
Abstract Number: 0678
Benralizumab in Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 0679
Long-term Safety of Rituximab (Mabthera) in Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA): Rituximab Surveillance Study in VASculitis (RIVAS)
-
Abstract Number: 0680
Risk Factors for Hypogammaglobulinemia and Association with Relapse and Severe Infections in ANCA-Associated Vasculitis: A Retrospective Single-Centre Cohort Study
-
Abstract Number: 0681
Real-World Outcomes for Remission Induction in Working-Age Adults with Severe Anti-Neutrophil Cytoplasmic Antibody-associated Vasculitis
-
Abstract Number: 0682
Avacopan in ANCA-associated Vasculitis Received Intensified Induction Therapy with Cyclophosphamide Plus Rituximab – Retrospective Case Serial of 12 Patients
-
Abstract Number: 0684
Report on Twelve Patients with Diffuse Alveolar Hemorrhage in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
-
Abstract Number: 0685
Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial
-
Abstract Number: 0686
Safety and Efficacy of Avacopan in Patients 65 Years and Older with ANCA-Associated Vasculitis
-
Abstract Number: 0687
Avacopan for the Treatment of ANCA-associated Vasculitis. Real World Experience in Spain
-
Abstract Number: 0688
Efficacy and Safety Experience with Avacopan Beyond 52 Weeks in the Early Access Program (EAP)
-
Abstract Number: 0689
Use of Avacopan in Patients with ANCA-associated Vasculitis and Estimated Glomerular Filtration Rate < 15 mL/min/1.73m2
-
Abstract Number: 0690
Treating Patients with ANCA-Associated Vasculitis and Very Severe Renal Injury with an Intensified B Cell Depletion Therapy: Comparison with a Control Cohort Receiving a Conventional Therapy
-
Abstract Number: 0691
Recognizing the New Disorder “Idiopathic Hypocryoglobulinaemia” in Patients with Previously Unidentified Clinical Conditions
-
Abstract Number: 0692
Behçet’s Disease-Associated TCR in the Eye Points to HLA Class I-Restricted Autoimmunity
-
Abstract Number: 0693
Comparison of the Cardiovascular Risk in Patients with Vasculitis and Diabetes Mellitus
-
Abstract Number: 0694
Off-label Use of Biologics in Urticarial Vasculitis: A European Cohort Study
-
Abstract Number: 0695
Impact and Cardiovascular Outcomes of Large Vessel Vasculitis in Atrial Fibrillation Hospitalization: A Nationwide Inpatient Database Study
-
Abstract Number: 0696
Association of Large-vessel Vasculitis with Inflammatory Bowel Diseases: A European Case-control Study
-
Abstract Number: 0697
Alterations in Composition and Function of Gut Microbiota in Patients with Large-Vessel Vasculitis
-
Abstract Number: 0698
Differentiating Large Vessel Vasculitis from Vasculitis Mimickers in a Real World Setting: Clinical Presentation, Laboratory Tests and Radiographic Findings
-
Abstract Number: 0699
T Cell Subset Analysis in Patients with Large-Vessel Vasculitis
-
Abstract Number: 0700
A Population-Based Study of Vasculitis Among Farmers and Urban Residents in Alberta
-
Abstract Number: 0701
Incidence of Neurobehçet Disease in Northern Spain 1999-2019. a Population-based Study
-
Abstract Number: 0702
Large Vessel Vasculitis Increases Risk of Acute Myocardial Infarction in Patients Admitted for Congestive Heart Failure : A Nationwide Inpatient Database Study
-
Abstract Number: 0703
Cardiovascular Disease-Related Mortality in Primary Systemic Vasculitis
-
Abstract Number: 0704
Clinical Characteristics and Outcomes in Patients Found to Have Clinically Isolated Aortitis After Aortic Aneurysm Repair: A Single-Center Experience
-
Abstract Number: 0705
Sleep Disturbances in Patients with Vasculitis: Results of the Vasculitis Patient-Powered Research Network Sleep Study (SleepVasc)
-
Abstract Number: 0706
Aortitis and Periaortitis Spectrum in 135 Patients from a Single Referral Centre
-
Abstract Number: 0707
Prevalence and Distribution of Vascular Calcifications at CT Scan in Patients with Large Vessel Vasculitis and Patients with Lymphoma: A Matched Cross-sectional Study
-
Abstract Number: 0708
NFKB1 and NFKBIA: Relevant Players in the Pathogenesis of IgA Vasculitis?
-
Abstract Number: 0709
Survival of Adults with IgA Vasculitis
-
Abstract Number: 0710
The Association of IgA Vasculitis and Malignancy in Adults: A Systematic Review
-
Abstract Number: 0711
IgA Vasculitis in a Diverse Adult Patient Population
-
Abstract Number: 0712
Clinical and Histologic Prognostic Factors of Renal Progression in Adults with IgA Vasculitis
-
Abstract Number: 0713
IgG4-Related Disease as a Potencial Etiology of Idiopathic Constrictive Pericarditis
-
Abstract Number: 0714
Single Center Experience of Rituximab Treatment for IgG4-RD Disease in a Large Multi-ethnic Cohort
-
Abstract Number: 0715
Glucocorticoid Toxicity in Patients with IgG4-Related Disease Within the First Year of Treatment
-
Abstract Number: 0716
Efficacy of Immunosuppressants for Disease Relapse in Patients with IgG4-related Disease at Our Institution
-
Abstract Number: 0717
Mitochondria-mediated Platelet Activation in Polymyalgia Rheumatica
-
Abstract Number: 0718
Clinical and Economic Burden of Polymyalgia Rheumatica in Patients with an Inadequate Response to Glucocorticoids in a Real-World Setting
-
Abstract Number: 0719
Polymyalgia Rheumatica Following SarsCOV-2 Vaccination: A Single Center Cohort Study
-
Abstract Number: 0720
Cognitive Function and Its Associated Factors in Polymyalgia Rheumatica
-
Abstract Number: 0721
Characterization of Numeric Rating Scales for Symptom Assessment in Polymyalgia Rheumatica
-
Abstract Number: 0722
Acute Cardiovascular Events in Autoimmune Rheumatic Disease Pregnancies
-
Abstract Number: 0723
Investigating the Effects and Molecular Mechanisms of TRAF5 on the Pathogenesis of SLE Associated Pulmonary Arterial Hypertension
-
Abstract Number: 0724
Synovial Macrophage Subsets Defined by ScRNAseq Demonstrate Sexually Dimorphic Gene Expression in RA and a Mouse Inflammatory Arthritis Model
-
Abstract Number: 0725
Real-life Use of the PEXIVAS Reduced-dose Glucocorticoid Regimen in Granulomatosis with Polyangiitis and Microscopic Polyangiitis
-
Abstract Number: 0726
Expert Consensus Recommendations for Musculoskeletal Ultrasound Education in Canadian Rheumatology Residency Training Programs
-
Abstract Number: 0727
A Novel Active Pemphigus Vulgaris Mouse Model Induced by Immunization with TLR Ligand Adjuvanted Recombinant Desmoglein 3 Protein Vaccine
-
Abstract Number: 0728
Systemic Lupus Erythematosus B Lymphocyte Responsiveness to Type I and Type III Interferon Is Determined by Donor IFN Status and B Cell Phenotype
-
Abstract Number: 0729
ROCK1 Orchestrates B-cell Differentiation Under Stress
-
Abstract Number: 0730
NF-κB Signaling Is Critically Important for Functional Responses of ACPA-producing B Cell Clones from Patients with Rheumatoid Arthritis
-
Abstract Number: 0731
ZEB2 Acts as a Crucial Transcriptional Regulator Governing Age-Associated B Cell Formation and Pathogenicity in Systemic Lupus Erythematosus
-
Abstract Number: 0732
Should Complete B-cell Depletion Be Maintained in Patients Treated Long-term with Rituximab for Rheumatoid Arthritis?
-
Abstract Number: 0733
Global Identification of Lupus Genetic Risk Variants Facilitating the Type I Interferon Pathway Through CRISPR-based Genomic Screening
-
Abstract Number: 0734
Immune Isoform Atlas: Landscape of Alternative Splicing in Human Immune Cells and Involvement of Dysregulated Alternative Splicing in Autoimmune Diseases
-
Abstract Number: 0735
Deep Immunophenotyping Reveals Circulating Activated Lymphocytes in Individuals at Risk for Rheumatoid Arthritis
-
Abstract Number: 0736
Deciphering Complement System-dependent Cellular Pathways in Human Rheumatoid Arthritis Synovial Tissue Using Large Single-cell Computational Omics
-
Abstract Number: 0737
Unraveling Pathophysiology and Hematopoiesis of VEXAS Syndrome by Multi-omics Analysis and Targeted Gene Editing
-
Abstract Number: 0738
A Genome-wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome
-
Abstract Number: 0739
Major Adverse Cardiovascular Event and Venous Thromboembolism Risk Comparing Advanced Therapies Among Individuals with Axial Spondylarthritis and Psoriatic Arthritis
-
Abstract Number: 0740
Renal Arteriosclerosis in Index Lupus Nephritis Biopsies Predicts Future Cardiovascular Disease
-
Abstract Number: 0741
Adverse Events Among Patients with and Without Autoimmune Rheumatic Disease Prescribed SGLT2 Inhibitors
-
Abstract Number: 0742
Risk of Incident Gout Associated with Initiation of Sodium-glucose cotransporter-2 Inhibitors versus Other Second-line Agents Among Metformin Users with Type 2 Diabetes
-
Abstract Number: 0743
Risk and Temporal Trends of Heart Failure Subtypes in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study
-
Abstract Number: 0744
Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0745
Artificial Intelligence Models for Computer-Assisted Joint Detection and Sharp-van Der Heijde Score Prediction in Hand Radiographs from Patients with Rheumatoid Arthritis
-
Abstract Number: 0746
The Association Between Sonographic Imaging Phenotype and Response to Treatment in Patients with Psoriatic Arthritis
-
Abstract Number: 0747
Clinical Phenotype of Patients with Subclinical Giant Cell Arteritis in Polymyalgia Rheumatica
-
Abstract Number: 0748
Assessment of Myositis-related Interstitial Lung Disease by ⁶⁸ Ga-DATA.SA.FAPi PET/CT
-
Abstract Number: 0749
Impact of Sprifermin on Denuded Areas of Subchondral Bone (dABs): A Post Hoc Analysis of the FORWARD Study
-
Abstract Number: 0750
Multispectral Optoacoustic Tomography of the Entheses Reveals Common Metabolic and Architectural Tissue Patterns in Psoriasis and Psoriatic Arthritis Independent of Inflammation
-
Abstract Number: 0751
Recombinant Zoster Vaccination Among U.S. Veterans Receiving Immunosuppressive Medications 2017-2023
-
Abstract Number: 0752
Tuberculosis Screening Among New Users of a Biologic or Targeted Synthetic DMARD: Gaps in Coverage Overall and Among JAKi Initiators
-
Abstract Number: 0753
Facility Variation in HLA-B*58:01 Allele Testing for Asian and Black Patients Receiving Allopurinol in the Veterans Affairs Healthcare System
-
Abstract Number: 0754
Towards a Guide for Evidence-based Remote Monitoring: Sensitivity of Patient Reported Outcomes to Change in Disease Activity Status in Early and Established Rheumatoid Arthritis
-
Abstract Number: 0755
Changes in Rheumatology Providers’ Perceptions of Telehealth Appropriateness from 2021 to 2022
-
Abstract Number: 0756
Validation of Quantitative Effusion-synovitis Volume Measured by Deep-learning: Data from the Osteoarthritis Initiative
-
Abstract Number: 0757
Identification of 23 Novel COPA Rare Exonic Non-Synonymous Variants and Their Associated Autoimmune and Inflammatory Clinical Phenotypes Among 53,364 Individuals
-
Abstract Number: 0759
Derivation and Validation of Four Patient Clusters in Still’s Disease, Results from GIRRCS AOSD-study Group and AIDA Network Still Disease Registry
-
Abstract Number: 0760
Treatment Patterns and Outcomes in Patients with Macrophage Activation Syndrome Secondary to Still’s Disease Treated with Emapalumab: The REAL-HLH Study
-
Abstract Number: 0761
EULAR / PreS Recommendations for the Diagnosis and Management of Systemic Juvenile Idiopathic Arthritis (sJIA) and Adult Onset Still’s Disease (AOSD)
-
Abstract Number: 0762
Liver Disease Is a Common Feature of HA20 That Causes Significant Morbidity Associated with Interferon Induction
-
Abstract Number: 0763
Sticking the Landing: A 3-Year Qualitative Longitudinal Study on Navigating Transitions in Pediatric Rheumatology Fellowship
-
Abstract Number: 0764
An Atypical ClassRheum: RheumMadness, a Collaborative Rheumatology Competition Building Knowledge and Community
-
Abstract Number: 0765
RheumMadness and TheMednet: The Impact of a Collaboration Between Independent Educational Initiatives
-
Abstract Number: 0766
The OMERACT GCA Phantom Project: Validation of 3D Printed Ultrasound Training Models for Giant Cell Arteritis
-
Abstract Number: 0767
Current Musculoskeletal Ultrasound Practices of 12 Years of past Participants of a 10-Months Rheumatology Ultrasound Training Program (Ultrasound School of North American Rheumatologists)
-
Abstract Number: 0768
Using Participatory Design-Thinking Process to Create a More Applicant-Centered Rheumatology Fellowship Interview Experience
-
Abstract Number: 0769
Development and Validation of a Combined Clinical and Genetic Risk Score for Interstitial Lung Disease in a Large, Multicenter, Prospective Rheumatoid Arthritis Cohort
-
Abstract Number: 0770
Plasma Matrix Metalloproteinases in Rheumatoid Arthritis-Interstitial Lung Disease: Associations with Disease Presence, Severity, and Subtypes
-
Abstract Number: 0771
A Modified Idiopathic Pulmonary Fibrosis-Derived Composite Biomarker Score Is Associated with Interstitial Lung Disease Among U.S. Veterans with Rheumatoid Arthritis
-
Abstract Number: 0772
MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung Disease
-
Abstract Number: 0773
Sputum Lautropia Abundance Is Decreased in Rheumatoid Arthritis-Associated Pulmonary Fibrosis and Correlates with Lung Disease Severity
-
Abstract Number: 0774
Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Phenotypes Using Unsupervised Hierarchical Clustering Analysis: Results from a Large Collaborative International Study
-
Abstract Number: 0775
Effectiveness of Dose Reduction and Withdrawal Strategies of TNF Inhibitors in Psoriatic Arthritis and Axial Spondyloarthritis: Long Term Extension of the DRESS-PS Study
-
Abstract Number: 0776
Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: 16- and 52-Week Results from a Randomized, Double-Blind, Phase 3 Study
-
Abstract Number: 0777
Characteristics of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis
-
Abstract Number: 0778
The Effect of Probiotic Modulation of Enteral Dysbiosis on Disease Activity in Patients with Psoriatic Arthritis – A Randomized Controlled Trial
-
Abstract Number: 0779
Influence of Sex on the Persistence of Different Classes of Targeted Therapies for Psoriatic Arthritis: A Cohort Study of 14,778 Patients from the French Health Insurance Database (SNDS)
-
Abstract Number: 0781
Low vs. High Initial Oral Glucocorticoid Dose for Lupus Nephritis Induction Treatment: A Pooled Analysis of Randomized Controlled Clinical Trials
-
Abstract Number: 0782
Comparison of Dual-immunosuppressive Therapy with a Voclosporin-based, Triple-immunosuppressive Regimen for Lupus Nephritis in the ALMS and AURORA 1 Studies
-
Abstract Number: 0783
Tolerability of CAR T Cell Therapy in Autoimmune Disease
-
Abstract Number: 0784
Kidney-Related Outcomes and Steroid-Sparing Effects in Patients with Active Lupus Nephritis Treated with Obinutuzumab: A Post Hoc Analysis of a Phase 2 Trial
-
Abstract Number: 0785
Therapeutic Range of Hydroxychloroquine Blood Levels May Reduce Odds of High Lupus Disease Activity
-
Abstract Number: 0786
A Retrospective Analysis of the Efficacy of the Euro-Lupus Nephritis Cyclophosphamide Regimen versus NIH Regimen in a South Carolina Lupus Nephritis Cohort
-
Abstract Number: 0787
Understanding Distinct Resident and Migratory Fibroblast Populations in Systemic Sclerosis Skin Through Single-cell RNAseq and Immunohistochemistry
-
Abstract Number: 0788
Whole Exome Sequencing and Evolutionary Action Missense Mutation Analysis Identifies MICB as a New SSc Susceptibility Locus and the Interferon Pathway as Contributors to SSc Pathogenesis
-
Abstract Number: 0789
Telomere Length of Peripheral Blood Cells Predicts More Severe Pulmonary Disease and Worse Survival in Systemic Sclerosis
-
Abstract Number: 0790
Transcriptomic Analyses of Lung Tissues Reveals Potential Key Genes Associated with Progression of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD)
-
Abstract Number: 0791
Expression of TL1A, Inflammatory, and Fibrotic Pathways in Patients with Diffuse Systemic Sclerosis
-
Abstract Number: 0792
Single Cell RNA-seq of Myeloid Cells from Systemic Sclerosis Patients Identifies Circulating Monocyte Population with Interferon Signature Associated with Interstitial Lung Disease
-
Abstract Number: 0793
The Dual Specificity Phosphatase 6 (DUSP6) Regulates Arthritis Severity and IL10 Production
-
Abstract Number: 0794
Microbiota-dependent Indole Production Is Required for the Development of Collagen-induced Arthritis
-
Abstract Number: 0795
The Focal Adhesion Protein Lasp1 Links the Arp2/3 Complex to Cell-to-cell Contact Formation in Arthritic Fibroblast-like Synoviocytes
-
Abstract Number: 0796
Role of Group 2 Innate Lymphoid Cells in the Pathogenesis of Rheumatoid Arthritis
-
Abstract Number: 0797
Innate Lymphoid Cells Enhance Development of CD4+ T-cell Driven Autoimmune Arthritis
-
Abstract Number: 0798
A Novel 3D Model of Rheumatoid Arthritis Synovial Tissue Incorporating Fibroblasts, Endothelial Cells and Macrophages
-
Abstract Number: 0799
Human Chimeric Antigen Receptor (CAR)-Tregs Targeting OX40L for Treatment of Systemic Lupus Erythematosus
-
Abstract Number: 0800
CD4+ CD96+ T Cells Are Pathogenic Effector Cells in Giant Cell Arteritis
-
Abstract Number: 0801
LncRNA PIGL-217 Regulates Th17 Differentiation by Targeting miR-5008-5p and Suppressing FoxO1 in Behçet’s Disease
-
Abstract Number: 0802
Targeting Fibroblasts in Inflammatory Disease Using Engineered T Cells
-
Abstract Number: 0803
IL10 Inhibits Toll-like Receptor-9-induced T Cell Receptor-mediated T Cell Activation in Macrophage Activation Syndrome
-
Abstract Number: 0804
Mutated NOD2 Controls IL-2 Production in Blau Syndrome Patients and Mice
-
Abstract Number: 0805
De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis
-
Abstract Number: 0807
Inferring Disease Activity Scores and Low Disease Activity at Registry Visits Based on Structured and Narrative Data from Electronic Health Records
-
Abstract Number: 0808
Real-World Disease Monitoring Patterns in Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Veterans Affairs Health Care System
-
Abstract Number: 0809
Underserved by Rehabilitation: Characteristics Among Adults with Rheumatoid Arthritis
-
Abstract Number: 0810
Telehealth Utilization and Satisfaction Among Patients with Rheumatic Diseases: Trends Since the Onset of the COVID-19 Pandemic
-
Abstract Number: 0811
Comparative Effectiveness of Sodium-glucose cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-primary Emergency Department Visits and Hospitalizations: A General Population Cohort Study
-
Abstract Number: 0812
Length of Synovial Fluid Monosodium Urate Crystals According to Sonographic Articular Deposits: Advancing in the Crystallization Process
-
Abstract Number: 0813
Sonographic Crystal Deposits and Power-Doppler Signal in Patients with Gout Fulfilling Remission Criteria: A Multicenter Study Enrolling 115 Participants
-
Abstract Number: 0814
Treat-to-target Urate-lowering Therapy Reduces Gout Flare Burden: Post-hoc Analysis of a Multicenter, Randomized, Double-blind, Non-inferiority Trial
-
Abstract Number: 0815
Intermittent Fasting Reduces Crystal-induced Inflammation
-
Abstract Number: 0816
Additive Association of ABCG2 rs4148155 and SLC22A12 rs75786299 Polymorphisms with Hyperuricemia, Gout and Nephrolithiasis, a Hospital-Based, Case-Control Study
-
Abstract Number: 0817
Comparative Effectiveness of Yoga and Strengthening Exercise for Treating Knee OsteoArthritis: A Randomised Controlled Trial (YOGA Trial)
-
Abstract Number: 0818
Efficacy of XT-150, a Novel Non-Viral Gene Therapy Delivering IL-10v, on Moderate to Severe Pain Due to Osteoarthritis of the Knee: Results of a Phase 2 Trial
-
Abstract Number: 0819
Regression to the Mean for Physical Function and Quality of Life in Trials for Symptomatic Knee Osteoarthritis
-
Abstract Number: 0821
Effects of Sprifermin on a Novel Outcome of Osteoarthritis Symptom Progression: Post Hoc Analysis of the FORWARD Study
-
Abstract Number: 0822
From Biomarkers to Endotypes: Data-driven Identification of Knee Osteoarthritis Patients Subtypes
-
Abstract Number: 0823
Sleep Disturbance Predicts Pain Interference in Patients with Early Rheumatoid Arthritis in a Prospective Real-World Cohort
-
Abstract Number: 0825
A Revised Outcome Measure for Dermatomyositis Clinical Trials: The Dermatomyositis Outcomes for Muscle and Skin (DMOMS)
-
Abstract Number: 0826
Development of a Decision Aid for Clinical Trial Participation in Systemic Lupus Erythematosus
-
Abstract Number: 0827
Development and Initial Validation of a Brief Measure of Uncertainty in Rheumatic Disease
-
Abstract Number: 0828
Item Reduction and Validation of the Cutaneous Lupus Erythematosus Quality of Life Questionnaire
-
Abstract Number: 0829
Decreased History of Breastfeeding During Infancy in Juvenile Spondyloarthritis: A Case-Control Study
-
Abstract Number: 0830
The Upregulation of MAP Kinase Pathway Genes Is Associated with Poor Treatment Response to Tofacitinib in Polyarticular Course Juvenile Idiopathic Arthritis
-
Abstract Number: 0831
Two- and Three-Year Outcomes from the Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA (STOP-JIA) Study
-
Abstract Number: 0832
Cumulative Social Disadvantage Is Associated with Disease Activity and Functional Disability in Juvenile Idiopathic Arthritis: An Analysis of the CARRA Registry
-
Abstract Number: 0833
Machine Learning Detected Healthcare Encounter Patterns Leading to Diagnosis of Juvenile Arthritis in a Population-Based Canadian Cohort
-
Abstract Number: 0835
Abatacept in Individuals at Risk of Developing Rheumatoid Arthritis: Results from the Arthritis Prevention in the Pre-clinical Phase of RA with Abatacept (APIPPRA) Trial
-
Abstract Number: 0836
Vagotomy and Subsequent Risk of Rheumatoid Arthritis and Osteoarthritis: A Danish Register-Based Cohort Study
-
Abstract Number: 0837
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis
-
Abstract Number: 0838
Infusion of Etanercept into the Peripheral Lymphatics Significantly Reduces Disease Activity in Rheumatoid Arthritis Patients with Inadequate Response to Subcutaneous Injections
-
Abstract Number: 0839
Efficacy and Safety of Nipocalimab in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA): The Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2a IRIS-RA Study
-
Abstract Number: 0840
Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Final Results from a Phase IIa Study
-
Abstract Number: 0841
Spondyloarthritis Research and Treatment Network (SPARTAN) Draft Referral Recommendations for Axial Spondyloarthritis
-
Abstract Number: 0842
Low Rate of Switching from Nr-axSpA to r-axSpA After 10 Years of Follow up in Early Axialspondyloarthritis. Data from DESIR Cohort
-
Abstract Number: 0843
Predictive Validity of Data-driven Definitions for Active and Structural Lesions in the SI Joints Typical for Axial SpA: A 2-year Follow-up in the SPondyloArthritis Caught Early Cohort
-
Abstract Number: 0844
Facet Joint Inflammation Is Rare, but When Present It Is Associated with Facet Joint Ankylosis in Radiographic Axial Spondyloarthritis Patients from the SIAS Cohort
-
Abstract Number: 0845
The Yield of Repeated Assessments in Chronic Back Pain Patients Suspected of Early Axial Spondyloarthritis: Two-year Data from the SPondyloArthritis Caught Early (SPACE) Cohort
-
Abstract Number: 0846
Preosteoclast Plays a Pathogenic Role in Syndesmophyte Formation of Ankylosing Spondylitis Through the Secreted PDGFB – GRB2/ERK/RUNX2 Pathway
-
Abstract Number: 0848
Performance of Serum MRP8/14, sCD14, IL-6 and Neutrophil CD64 in Isolation and in Combination for Differentiating Flare from Bacterial Infection in Febrile SLE Patients
-
Abstract Number: 0849
Multiplex Profiling and Machine Learning Reveal Distinct Signatures of Circulating Cytokines Associated with Autoantibody Profiles and Disease Severity in Systemic Lupus Erythematosus
-
Abstract Number: 0850
Persistence of Urinary Biomarkers of Intrarenal Inflammation Precedes Loss of Kidney Function in Lupus Nephritis
-
Abstract Number: 0851
Lupus Nephritis Flares Linked to Platelet Activation During Gut Pathobiont Blooms
-
Abstract Number: 0852
Screening for Specific Antinuclear Antibodies Using an Artificial Intelligence-enabled Antinuclear Antibody HEp-2 Substrate by Indirect Immunofluorescence Assay
-
Abstract Number: 0853
Early Experience with Avacopan for ANCA-Associated Vasculitis in a Large Integrated Healthcare System
-
Abstract Number: 0854
Long-term Efficacy of Remission-induction Regimens for Eosinophilic Granulomatosis with Polyangiitis
-
Abstract Number: 0855
Real-world Experience with Avacopan in ANCA Vasculitis: A Multi-center Retrospective Cohort Analysis
-
Abstract Number: 0856
Dupilumab for Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis: A European Retrospective Study
-
Abstract Number: 0857
Change in Albuminuria in Patients with ANCA-Associated Vasculitis Treated with Avacopan
-
Abstract Number: 0858
Randomized, Controlled, Double-Blind Trial on the Impact of Rosuvastatin on Sublinical Markers of Atherosclerosis in Patients with ANCA-Associated Vasculitis
-
Abstract Number: 0859
Single Injection AAV2-hFGF18 Demonstrates Superior Safety and Efficacy over Repeat rhFGF18 Protein Injections in a Model of Induced Osteoarthritis
-
Abstract Number: 0860
Vagus Nerve Stimulation Enhances Bone Morphology in a Rodent Model of Central Nervous System Inflammation
-
Abstract Number: 0861
The Analgesic Effect of RC-0165, a TRPV1 Antagonist, for Osteoarthritis Pain
-
Abstract Number: 0862
Role of CRTAC1 as a Biomarker of Osteoarthritis
-
Abstract Number: 0863
Phenotype and Energy Metabolism Differ Between Osteoarthritic Chondrocytes from Male Compared to Female Patients
-
Abstract Number: 0864
Proteomic Analysis of Circulating Neutrophils from Osteoarthritis Patients Shows Metabolic Dysregulation That Is Associated with Decreased Physiologic Apoptosis
-
Abstract Number: 0865
Reactive Oxygen Species-scavenging Nanoparticles Target Macrophage Polarization for Osteoarthritis Therapy
-
Abstract Number: 0866
A Novel 3D-Synovium-Immune Microenvironment Mimics Macrophage-Synovial Fibroblast Interactions in Inflammatory Arthropathies
-
Abstract Number: 0867
Pentosan Polysulfate Sodium, a Glycosaminoglycan Mimetic Demonstrates Durable Effects on Pain, Function and Joint Structure in Canine Naturally Occurring Osteoarthritis
-
Abstract Number: 0868
Enhancing Oxidative Phosphorylation Through PDK2 Depletion Alleviates Cartilage Degradation in Surgically Induced Osteoarthritis
-
Abstract Number: 0869
Clinical Impact of PTEN as a Marker for Diabetes-Associated Osteoarthritis
-
Abstract Number: 0870
Targeting Peroxisome Proliferator-Activated Receptor α Is a Disease-Modifying Therapy for Osteoarthritis
-
Abstract Number: 0871
Mitochondrial Transfer Functionally Restores the Human Osteoarthritis (OA) Chondrocyte, Is Protective Against Oxidative Stress and Improves OA in a Clinical Model of Disease
-
Abstract Number: 0872
Synovial 5-LOX-Derived Oxylipins Define a B Cell-Enriched Synovium
-
Abstract Number: 0873
FOXO Activators as Drugs for Osteoarthritis
-
Abstract Number: 0874
RNA-Binding Proteins That Are Highly Expressed and Enriched in Healthy Cartilage but Suppressed in Osteoarthritis
-
Abstract Number: 0875
INV-1498, a Promising Caspase Inhibitor, Exhibits Dose-dependent Therapeutic Efficacy in a Canine Model of Osteoarthritis
-
Abstract Number: 0876
Metabolomic Analysis Reveals Associations Between Calcium Crystals and Metabolites in Osteoarthritic Synovial Tissue
-
Abstract Number: 0877
Loss of Transient Receptor Potential Channel 1 (TRPC1) Links Regulation of Intracellular Calcium to Cellular Senescence and Leads to Development of Osteoarthritis
-
Abstract Number: 0878
Synovial Fibroblasts Undergo a Phenotypic Shift from Early- to Late-stage Knee Osteoarthritis
-
Abstract Number: 0879
Recommendations for a Standardized Approach to Histopathologic Evaluation of Synovial Membrane in Murine Models of Experimental Osteoarthritis
-
Abstract Number: 0880
CD14 Inhibition as a Potential Therapeutic in Post Traumatic OA
-
Abstract Number: 0881
Deficiency of the Pattern-recognition Receptor CD14 Protects Against LPS-induced Inhibition of Osteoclastogenesis in Vitro
-
Abstract Number: 0882
Activation of Ovarian Cancer G-Protein Coupled Receptor (OGR1) Attenuates Chondrocytes Inflammation via ERK1/2 Signaling Pathways in an in Vitro Model of Osteoarthritis
-
Abstract Number: 0883
The Role of Plasmin and Fibrinolysis Pathways in Osteoarthritis
-
Abstract Number: 0884
Identification of a Mast Cell-high Synovial Pathotype of Osteoarthritis
-
Abstract Number: 0885
Mice Fed a Well-formulated Ketogenic Diet After OA Induction Develop Worse OA Outcomes and Increased Pain Sensitivity
-
Abstract Number: 0886
Neonatal Roseolovirus Infection Predisposes to Development of Lupus-like Disease After TLR7 Stimulation
-
Abstract Number: 0887
Dapagliflozin Modulates Inflammation and Germinal Centers in Lupus by Increasing Regulatory T Cells
-
Abstract Number: 0888
Functionally Selective Immunomodulator Shows Robust Efficacy in Spontaneous Lupus Mouse Model
-
Abstract Number: 0889
Axl Receptor Tyrosine Kinase Ameliorates Pristane Induced Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization
-
Abstract Number: 0890
Specificity of Brain-Intrinsic and Hematopoietic-Derived Mechanisms in Mediating Neuropsychiatric Symptoms of Systemic Lupus Erythematosus
-
Abstract Number: 0891
Selective and Potent Inhibition of Cyclic GMP-AMP Synthase (cGAS) Fully Normalizes Autoinflammation Across Tissues in a Trex1-/- Mouse Model for Type I Interferonopathies
-
Abstract Number: 0892
Single-Cell RNA Sequencing Reveals Keratinocytes and Fibroblasts Drive Hippo and TGFb Dysregulation and Fibrosis in Epidermal Overexpression of VGLL3 in Cutaneous Lupus
-
Abstract Number: 0893
Involvement of Type I Interferon-responsive Myeloid Cells in Renal Inflammation in a Lupus Mouse Model
-
Abstract Number: 0894
The Cellular and Spatial Type I Interferon Response Following Skin Exposure to Ultraviolet Light
-
Abstract Number: 0895
Lipocalin-2 Promotes Cutaneous and Neuropsychiatric Disease in Murine Lupus
-
Abstract Number: 0896
Targeting Toll-Like Receptor 7 with DS-7011a, a Promising Novel Antagonistic Antibody for the Treatment of Systemic Lupus Erythematosus
-
Abstract Number: 0897
Steroid-sparing Effects of Afimetoran (BMS-986256), an Equipotent Toll-like Receptor (TLR)7 and TLR8 Antagonist, in a Lupus Mouse Model
-
Abstract Number: 0898
The Role of the Endothelin System in the Development of TLR7-accelerated Lupus-Associated Cardiac Dysfunction
-
Abstract Number: 0899
Complement Factor I (CFI) Gene Expression by Kidney Tubular Cells Is Increased in Lupus Nephritis Patients with Interstitial Fibrosis and Tubular Atrophy
-
Abstract Number: 0900
Complement Deposition on Extracellular Mitochondria Induces Platelet Activation in Vitro
-
Abstract Number: 0901
Scavenging of Isolevuglandins Attenuates Neutrophil Expansion and Aortic NETosis in Systemic Lupus Erythematosus
-
Abstract Number: 0902
Neutrophils in Systemic Lupus Erythematosus Demonstrate Heterogeneity Based on Sex
-
Abstract Number: 0903
Effects of Hydroxychloroquine on Maternal Outcomes in Pregnant Patients with Systemic Lupus Erythematous
-
Abstract Number: 0904
KYV-101, a Fully Human Anti-CD19 CAR T Cell Therapy, Demonstrates CAR-Mediated and CD19-Dependent Activity Against Autologous B Cells from Patients with Autoimmune Disease
-
Abstract Number: 0905
Low-Density Granulocytes and Neutrophil Extracellular Traps in Incomplete Systemic Lupus Erythematosus
-
Abstract Number: 0906
Paired Autoantibody Specificities from Serum and Immune Complexes Do Not Fully Explain the Circulating Immune Complex Load in Systemic Lupus Erythematosus: A Study on 530 Patients
-
Abstract Number: 0907
Epstein Barr Virus Reactivation May Associate with Transition from Incomplete to Systemic Lupus Erythematosus
-
Abstract Number: 0908
Association of Biologic Sex with Glycosphingolipids and the N-glycome in Lupus Nephritis and Renal Mesangial Cell Function
-
Abstract Number: 0909
Rab4A Controls the Depletion of IL-2 in CD4+ T Cells via Enhanced CD38 Expression: Potential Involvement in Proinflammatory Lineage Development in Systemic Lupus Erythematosus
-
Abstract Number: 0910
17β-estradiol and B-cell Intrinsic Type I Interferon Amplify Toll-like Receptor 7 Signaling Loop in B Cells of Female Lupus Prone BXD2 Mice
-
Abstract Number: 0912
Inadequate Screening for Antiphospholipid Syndrome with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0913
Neutrophils in Patients with Systemic Lupus Erythematosus Show Pronounced Inflammatory Signals
-
Abstract Number: 0914
Transcription Factor RFX1 Promotes M1 Macrophage Polarization in Systemic Lupus Erythematosus via Regulating APOBEC3A
-
Abstract Number: 0915
IL-16+ Is Abundantly Expressed by Kidney-infiltrating Myeloid and Lymphoid Cells in Lupus Nephritis: A Spatially Resolved Multiplexed Approach
-
Abstract Number: 0916
Upregulation of the M-CSF Receptor on Non-Classical Monocytes from SLE Patients as an Indicator for Premature Monocyte Aging
-
Abstract Number: 0917
Role of Immunoglobulin Polygenic Risk in Systemic Lupus Erythematosus
-
Abstract Number: 0918
Network Analysis of Genome Sequences Identifies Important Pathways in the Pathogenesis of Childhood-onset Systemic Lupus Erythematosus
-
Abstract Number: 0919
Investigating the Role of Interferon in Promoting Flares of SLE at a Single Cell Level
-
Abstract Number: 0920
Proinflammatory Neutrophils and NETs Mediate Skin and Kidney Inflammation During Lupus Flare in Asymptomatic Lupus-prone Mice Triggered by UVB
-
Abstract Number: 0921
SAPhigh T Peripheral Helper Cells Are a Novel Subset Associated with Lupus Nephritis
-
Abstract Number: 0922
The Multi-Omic Landscape of Systemic Lupus Erythematosus Patients Highlights Metabolic and Immune Pathways Associated with Distinctive Clinical Profiles
-
Abstract Number: 0923
Identification of Lupus Nephritis Kidney Immune Populations via Hi-Resolution 20-Plex Immunohistochemistry Single-Cell Spatial Analyses
-
Abstract Number: 0924
Distinct Cell-Bound Complement Activation Products Associate with Disease Activity and Immune Transcriptional Signatures in SLE
-
Abstract Number: 0925
IL-4 Acts Through Aryl Hydrocarbon Receptor to Antagonize TLR7-induced Double Negative 2 B Cells in Lupus
-
Abstract Number: 0926
Single-cell Multi-Omic Evaluation of Differences in Immune Cell Populations in Progression Toward Systemic Lupus Erythematosus
-
Abstract Number: 0928
Skewing of B Cell Receptor Repertoire in Unswitched Memory B Cells Is Associated with Disease Activity of Systemic Lupus Erythematosus and Targeted by Belimumab
-
Abstract Number: 0929
Persistent Up- or Down-regulation of SOCS1 Exacerbates the Pathogenesis of Systemic Lupus Erythematosus Through Several Mechanisms
-
Abstract Number: 0930
Genetic Risk Profiles of Patients with Lupus Nephritis to Identify Those at Risk for Kidney Deterioration and Eventual Damage
-
Abstract Number: 0931
Down-Regulation of Human NADH-Ubiquinone Oxidoreductase Chain 6 by N6-Methyladenosine Methylation Is Associated with Lupus CD4+ T Cell Activation
-
Abstract Number: 0932
The Landscape of Immune Cells in Systematic Lupus Erythematosus Patients with Epstein-Barr Virus Infection by Single-cell Sequencing
-
Abstract Number: 0933
The ‘Sweet’ in Lupus – IgG Glycosylation in Lupus Nephritis
-
Abstract Number: 0935
Sodium Pyruvate Improves Mitochondrial Fitness in SSc Fibroblasts to Prevent Fibroblast-to-myofibroblast Transition and Fibrotic Remodeling
-
Abstract Number: 0936
Impaired DNA Repair Responses Activate a Novel FOXO1-dependent Metabolic Remodelling in Patients with Progressive Systemic Sclerosis to Promote Fibrosis
-
Abstract Number: 0937
IL-4+ and IFN-α+ Profibrotic T Cells Aggravate Systemic Sclerosis via STIM1/STING Signaling in SKG Mice
-
Abstract Number: 0938
Deconvolution of the Molecular Signature of Very Early Diagnosis of Systemic Sclerosis (VEDOSS) and Established Disease: A Biomarker Blueprint of Scleroderma Disease Continuum
-
Abstract Number: 0939
HRCT-derived Delta Radiomic Features Classify Response to Anti-Fibrotic Treatment in Experimental and Human Fibrosing Interstitial Lung Disease
-
Abstract Number: 0940
A Novel Therapeutic Opportunity in Systemic Sclerosis: The Fibrolytic Activities of a Specialized Macrophage Secretome
-
Abstract Number: 0941
RUNX1 Expression and Binding Site Accessibility Is Associated with Increased Disease Severity in Systemic Sclerosis
-
Abstract Number: 0942
G Protein-coupled Receptor Kinase 5 in Fibrotic Tissue Remodeling
-
Abstract Number: 0943
Attenuation of Fibroblast Activation and Fibrosis by Adropin in a Hedgehog-Dependent Manner
-
Abstract Number: 0944
Macrophages Regulate Adipocyte Differentiation and Proliferation in Skin Fibrosis
-
Abstract Number: 0945
The Nuclear Receptor TR4 Orchestrates Cytoskeletal Organization in a Gα12/ROCK-dependent Manner to Promote Myofibroblast Differentiation and Tissue Fibrosis in Systemic Sclerosis
-
Abstract Number: 0946
Immunoglobulins G Purified from Systemic Sclerosis Patients Influence Cytoplasmic and Nuclear Proteins Profile in Dermal Fibroblasts
-
Abstract Number: 0947
Fcγ Receptors Define Pro-Phagocytic Macrophages and Trigger Pro-Inflammatory Responses in Patients with Systemic Sclerosis
-
Abstract Number: 0948
Nintedanib Alters Fibroblast and Macrophage Diversity in a 3D Skin Model of Systemic Sclerosis (SSc)
-
Abstract Number: 0949
Development of Interstitial Pneumonia with Autoimmune Features in Conditional Tgfb3 Deletion
-
Abstract Number: 0950
KL-6 and IL-18 Levels Are Negatively Correlated with Respiratory Function Tests and ILD Extent Assessed on HRCT in Patients with Systemic Sclerosis-related Interstitial Lung Disease (SSc-ILD)
-
Abstract Number: 0951
Single Cell Analysis of Transitional B Cells in Systemic Sclerosis Highlights Defective Peripheral Tolerance
-
Abstract Number: 0952
Unraveling the Role of MiR-181 in Skin Fibrosis Pathogenesis by Targeting NUDT21
-
Abstract Number: 0953
Flavin-containing Monooxygenase (FMO3) Links the Gut and Fibrosis in Systemic Sclerosis
-
Abstract Number: 0954
Non-canonical WNTA Promotes Cytoskeletal Rearrangement and Integrin Alpha V Clustering via JNK and ROCK to Control the Activation of Latent TGFβ
-
Abstract Number: 0955
GRB2 Serves as a Viable Target Against Skin Fibrosis in Systemic Sclerosis by Regulating Endothelial Cell Apoptosis
-
Abstract Number: 0956
Effects of B Cell Depletion by CD19-targeted CAR-T Cells in a Murine Model of Systemic Sclerosis
-
Abstract Number: 0957
Rationale for Targeting Insulin-like Growth Factor Signalling in Systemic Sclerosis
-
Abstract Number: 0958
Shared Genetic Susceptibility Between Systemic Sclerosis and Primary Biliary Cholangitis: Analyses from Genome-Wide Association Studies
-
Abstract Number: 0959
Redirecting Macrophage Immunophenotype Attenuates Inflammation and Fibrotic Activation in Systemic Sclerosis
-
Abstract Number: 0960
MiR-3606-3p Alleviates Skin Fibrosis by Suppressing Fibroblast Inflammation and Migration via Inhibiting GAB1 and ITGAV
-
Abstract Number: 0961
Transcriptomic Analysis of Scleroderma Monocytes Identifies Distinct Clinically Relevant Clusters and Novel Genes Associated with Disease Complications
-
Abstract Number: 0962
Topological Proteomic Differences in Fibrotic and Unaffected Skin in Scleroderma
-
Abstract Number: 0963
Anti-Topoisomerase Antibody in dcSSc: Unravelling Its Intracellular Effects in Systemic Sclerosis
-
Abstract Number: 0964
Systemic Sclerosis (SSc) Dermal Fibroblasts Show Shortened Primary Cilia Due to Aberrant Aurora a Kinase Activation Independently of Transforming Growth Factor β Signalling
-
Abstract Number: 0966
The Burden of Oligoarticular Psoriatic Arthritis in the United States
-
Abstract Number: 0967
Overall Survival in Patients with versus Without Rheumatoid Arthritis Initiating Immune Checkpoint Inhibitors for Metastatic Non Small Cell Lung Cancer
-
Abstract Number: 0968
Risk of Incident Heart Failure and Heart Failure Subtypes in Patients with Rheumatoid Arthritis
-
Abstract Number: 0969
Tumor Necrosis Factor-α Inhibitors Reduces Obstructive Sleep Apnea in Patients with Juvenile Idiopathic Arthritis: A Population-based Cohort Study
-
Abstract Number: 0971
Network Meta Analyses of the Effectiveness and Safety Profiles of Janus Kinase Inhibitors and Biologic Agents in Treating Children with Non-systemic Juvenile Idiopathic Arthritis (nsJIA)
-
Abstract Number: 0972
Increased Incidence of Inflammatory Arthritis After COVID-19 in a Colombian Population
-
Abstract Number: 0973
Real-World Comparative Effectiveness Study of Janus Kinase Inhibitors Compared to Biologic Disease Modifying Antirheumatic Drugs in Korean Patients with Rheumatoid Arthritis
-
Abstract Number: 0974
Validation of Boolean 2.0 Criteria for Assessing Remission and Predicting Quality of Life in Korean Patients with Rheumatoid Arthritis Undergoing Targeted Therapy
-
Abstract Number: 0975
Association of HLA-DRB1 Alleles with Ischemic Events and Mortality in a Multi-ethnic Community-living Population
-
Abstract Number: 0976
Sarcopenia and All-Cause Mortality in US Adults with and Without Rheumatoid Arthritis
-
Abstract Number: 0977
Prevalence of Arthritis in the United States: National Estimates from a Population-based Study
-
Abstract Number: 0978
Identifying Important Clinical Features for Predicting Remission in Patients with Rheumatoid Arthritis Treated with Biologics Using Machine Learning Model
-
Abstract Number: 0979
Use and Discontinuation of Tumour Necrosis Factor Inhibitors Among Pregnant Women with Chronic Inflammatory Diseases
-
Abstract Number: 0980
Temporal Trends in Incidence Rates of Seropositive and Seronegative Rheumatoid Arthritis: A Danish Nationwide Population-based Study
-
Abstract Number: 0981
Time Trends in Overall Infection Risk in Patients with Inflammatory Arthritides Treated with Tumor Necrosis Factor Inhibitors
-
Abstract Number: 0982
Systemic Autoimmune Rheumatic Diseases (SARD) in the Agricultural Health Study Cohort: Rates of Rheumatoid Arthritis (RA) and Other SARD Among Medicare-linked Participants
-
Abstract Number: 0983
Association Between Disease-modifying Anti-rheumatic Drugs and Short-term Outcomes of Dengue: A Population-based, Cohort Study
-
Abstract Number: 0985
Assessing the Value of Comorbidity Clusters in Predicting Clinical Outcomes in Rheumatoid Arthritis: A Machine Learning Approach Using a Very Large US Registry
-
Abstract Number: 0986
Medication Use Patterns and Factors Associated with Abnormal Pregnancy Outcomes in Patients with Rheumatoid Arthritis in Korea
-
Abstract Number: 0987
Risk Factors and Predictors of Disease Activity in Rheumatoid Arthritis and Psoriatic Arthritis: Data from the Mexican Adverse Events Registry (BIOBADAMEX)
-
Abstract Number: 0988
Elderly Patients’ Discontinuation of Biologic DMARDs in Patients with Rheumatic Diseases: Data from the Mexican Adverse Events Registry (BIOBADAMEX)
-
Abstract Number: 0989
Rheumatoid Arthritis and Risk of Migraine: A Population-based Nationally Representative Cohort
-
Abstract Number: 0991
Trends in Arthroplasty Utilization for Inflammatory Arthritis Including Rheumatoid Arthritis and Spondyloarthritis in China: Analysis of a Large National Database
-
Abstract Number: 0992
Association Between Metabolic Syndrome and the Presence of Enthesophytes on Musculoskeletal Ultrasound Compared to Joint X-ray
-
Abstract Number: 0993
Successful Implementation of a New Patient Video Triage Program
-
Abstract Number: 0994
Narrative Medicine and Pediatric Rheumatology: Addressing Burnout and Bias
-
Abstract Number: 0995
Rheumatoid Arthritis Early Diagnostic Clinic: A Web-based Referral Tool Serving Ethnic Minority Patients
-
Abstract Number: 0996
Will Patients Engage with Digital Technologies as Part of Routine Healthcare?
-
Abstract Number: 0997
Impact of Depression on Healthcare Utilization in Members with Underlying Rheumatoid Arthritis, Psoriatic Arthritis and Systemic Lupus Erythematosus
-
Abstract Number: 0998
Barriers and Facilitators for Osteoporosis and Sarcopenia Care for Persons Living with HIV in Peru: HIV Physician and Coordinator Perspectives
-
Abstract Number: 0999
Race, Payer, and Hospital Factors Are Associated with Post-primary Total Hip Arthroplasty Healthcare Utilization
-
Abstract Number: 1000
Incorporation of Social Drivers of Health Screening into a Structured Healthcare Transition Program for Adolescents and Young Adults with Chronic Rheumatic Disease
-
Abstract Number: 1002
Optimizing Rural Rheumatology Access: Collaborative Tele-Health Clinic Between University of North Carolina and Piedmont Health 1 Year Extension and Opportunities for Improvement
-
Abstract Number: 1003
A Multidisciplinary Obstetric-Medicine/Rheumatology Specialty Clinic in the United States: A Five Year Analysis
-
Abstract Number: 1004
Telerheumatology Shared-Care Model: Leveraging the Expertise of an ACPAC-Trained Extended Role Practitioner (ERP) in Rural-Remote Ontario
-
Abstract Number: 1005
Telemedicine for Rheumatology Care: A Randomized, Single-Blind, Parallel Group, Noninferiority Trial
-
Abstract Number: 1006
Use of Implementation Strategies to Promote Adherence of Knee Osteoarthritis Guidelines and Improve Patient Outcomes: A Systematic Review
-
Abstract Number: 1007
Telehealth Conversion: A Strategy for Optimizing Ambulatory Access
-
Abstract Number: 1008
Identifying Inflammatory Arthritis Ambulatory Care Service Model Enhancements Needed to Reduce Avoidable Emergency Department Use
-
Abstract Number: 1009
More Implementation Strategies Are Not Associated with Better Implementation Outcomes: Implementing the Lupus Patient Decision Aid
-
Abstract Number: 1010
Advanced Clinician Practitioners in Arthritis Care: A Workforce Profile
-
Abstract Number: 1011
A Rheumatology Model of Care Re-design: Integrating the Advanced Practice Provider
-
Abstract Number: 1012
Leveraging Cues and Rewards to Form Habits to Improve Medication Adherence in Gout: An Adaptive Behavioral Pilot Trial
-
Abstract Number: 1013
Implementation of a Rheumatology-Based Social Determinants of Health Screening Program to Uncover and Address Needs in a Multihospital Health Care System
-
Abstract Number: 1015
Health Care Access in an Indigenous North American Population of Rheumatoid Arthritis Patients and Their At-risk First-Degree Relatives
-
Abstract Number: 1016
Cost-related Medication Burden for Patients with and Without Systemic Autoimmune Rheumatic Diseases
-
Abstract Number: 1017
Cross Country Differences in b/tsDMARD Prescription Behavior: Associations Between Socioeconomics, Real World b/tsDMARD Use and Disease Outcomes
-
Abstract Number: 1018
Recognizing Rural Healthcare Disparities in Pain Assessment for Autoimmune Rheumatologic Diseases
-
Abstract Number: 1019
Association of Historical Redlining and Present-Day Neighborhood Inequities with Missed Outpatient Appointments Among Individuals with Rheumatic Conditions
-
Abstract Number: 1020
An Increase in Safety Outcome Trials and the Issue of Informed Consent
-
Abstract Number: 1021
Racial Disparities Between Black and White Patients in Joint Replacement Surgery: A Systematic Review
-
Abstract Number: 1022
Lower Rates of Statin Therapy Initiation in Dermatomyositis/Polymyositis vs. Rheumatoid Arthritis Patients with Hyperlipidemia: A Multicenter USA-Based Study (2018-2023)
-
Abstract Number: 1023
Characterization of Phenotypic Differences in IgG4-Related Disease Across the Sexes
-
Abstract Number: 1024
Relationship Between Race and Ethnicity, Time to Diagnosis, and Disease Activity for Children with Juvenile Idiopathic Arthritis in the CARRA Registry
-
Abstract Number: 1025
Embedding Treat to Target Principles in Rheumatoid Arthritis Patient Education in Routine Care of Ethnic Minority Patients
-
Abstract Number: 1026
Patients’ Barriers to Total Joint Arthroplasty: Associations with the Orthopedic Consultation
-
Abstract Number: 1027
Single-Payer Health Insurance May Not Mitigate Income-Based Differences in Total Hip Arthroplasty Utilization: A Transnational Analysis
-
Abstract Number: 1028
Barriers to Total Joint Arthroplasty for Patients Residing in High-Poverty Communities
-
Abstract Number: 1029
Social Determinants of Health in Children with Rheumatic Disease: A Single Center Cohort
-
Abstract Number: 1030
Patterns in the Prescription, the Denials of Coverage, and the Delays in Dispensation of Janus Kinase Inhibitors
-
Abstract Number: 1031
Geographic Socioeconomic Influences on Disease Activity in Rheumatoid Arthritis in an Academic and Safety-Net Hospital System
-
Abstract Number: 1032
“Not of Your Ethnicity”: A Qualitative Study Exploring Diverse Patient Experiences in Axial Spondyloarthritis (axSpA)
-
Abstract Number: 1033
The Detection of Subclinical Joint Inflammation by Thermal and Ultrasound Imaging at the Metacarpophalangeal Joints in Patients with Rheumatoid Arthritis
-
Abstract Number: 1034
The Relationship Between the Extent of Ground Glass to Fibrosis Ratio and Treatment Response to Immunomodulatory Therapy in Three Separate Autoimmune Interstitial Lung Disease Cohorts
-
Abstract Number: 1035
Diagnostic and Educational Utility of an Ultrasound Protocol for Evaluation of Hand Pain in Systemic Sclerosis
-
Abstract Number: 1036
The Prevalence of Shoulder and Hip Joints Ultrasound Findings in Polymyalgia Rheumatica: A Multicenter International Study
-
Abstract Number: 1037
Dual Energy Computed Tomography (DECT) Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Intensive Urate-Lowering Therapy
-
Abstract Number: 1038
Improved Assessment of Structural Damage in the Spine in Patients with Axial Spondyloarthritis by MRI-based Synthetic CT: A Comparison with Low-dose CT and X-ray
-
Abstract Number: 1039
Cross-Sectional Associations of Ultrasound Features with Symptom Outcomes at the Knee: A Community-based Study
-
Abstract Number: 1040
Impact of Ultrasound Limitation to Assess Aortitis in Patients with Giant Cell Arteritis: Comparative Study with FDG-PET/CT
-
Abstract Number: 1041
Efficacy of Apremilast on Peripheral and Axial Inflammation in Patients with Psoriatic Arthritis Based on Whole-Body Magnetic Resonance Imaging
-
Abstract Number: 1042
B-line of Lung Ultrasound Reflects Different Morphological Features on Chest HRCT Between Interstitial Lung Disease Associated with Systemic Sclerosis and Myositis
-
Abstract Number: 1043
Comparison of Optical and Ultrasound Imaging in Lupus Arthritis
-
Abstract Number: 1044
Prevalence and Distribution of Sonographic Elementary Lesions in PsA – Results of 2 Cohorts
-
Abstract Number: 1045
Ultrasound Findings in Patients with Difficult to Treat Rheumatoid Arthritis
-
Abstract Number: 1046
The Level of RF or Anti-CCP Antibody Affect Ultrasound Synovial Findings in Patients with Rheumatoid Arthritis?
-
Abstract Number: 1047
Infrared Thermography Imaging Discriminates Between Inflamed and Non-inflamed Joints
-
Abstract Number: 1048
The Prediction of Response to Advanced Therapies on a Joint Level in Rheumatoid Arthritis: The Interpretation of Tenderness and Doppler Ultrasound
-
Abstract Number: 1049
Enhanced Diagnostic Confidence with High Frequency Temporal Artery Ultrasound in Diagnosis of Cranial Giant Cell Arteritis (GCA)
-
Abstract Number: 1050
Diagnostic Accuracy of Lung Ultrasound for Detecting Interstitial Lung Disease Among Patients with Systemic Sclerosis: A Comparative Study of Two Scanning Protocols
-
Abstract Number: 1051
Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology: Interim Analysis
-
Abstract Number: 1052
Unique Cellular and Autoantibody Signatures in Patients with irAEs Revealed by Longitudinal Immune Tracking
-
Abstract Number: 1053
Outcomes of Immune Check Point Inhibitor Use in US Veterans with Pre-Existing Inflammatory Muscle Disease
-
Abstract Number: 1054
Immune Checkpoint Inhibitor Induced Polymyalgia Rheumatica Demonstrates a Similar Scintigraphic Appearance to Classical Polymyalgia Rheumatica on 18F-Fluorodeoxyglucose PET/CT
-
Abstract Number: 1055
Cancer Outcomes in Cancer Patients with Immune Checkpoint Inhibitor-induced Inflammatory Arthritis Treated with Glucocorticoids: Data from the CanRIO Retrospective Cohort
-
Abstract Number: 1056
Immune Checkpoint Inhibitor Rechallenge in Patients Who Previously Experienced Immune-Related Inflammatory Arthritis: A Multicenter Observational Study
-
Abstract Number: 1058
Resolution of Immune Checkpoint Inhibitors-Induced Inflammatory Arthritis While Maintaining Active Treatment with Checkpoint Inhibitors
-
Abstract Number: 1059
Identification of Patients with Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis Using Medicare Claims Data
-
Abstract Number: 1060
Impact of Troponin Monitoring on Cardiac Outcomes in Patients Receiving Immune Checkpoint Inhibitors
-
Abstract Number: 1061
Vasculitis as an Immune-Related Adverse Event: Unraveling the Complexities at the Intersection of Immunology and Vascular Pathology
-
Abstract Number: 1062
Antiretinal Autoantibodies in Hydroxychloroquine Eye Toxicity
-
Abstract Number: 1063
Impact of Aging on Rheumatic Immune-related Adverse Events Secondary to Immune Checkpoint Inhibitors: Experience from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
-
Abstract Number: 1064
Seroconversion Rates in Rituximab-Treated Rheumatic Patients Receiving COVID-19 Vaccination
-
Abstract Number: 1065
Association Between COVID-19 and Disease-Modifying Antirheumatic Drugs
-
Abstract Number: 1066
Biologic Drug and Anti-Drug Antibody Monitoring: All 5 TNF-Inhibitors, Infliximab, Adalimumab, Golimumab, Etanercept, Certolizumab Pegol, in 63,930 Patient Samples
-
Abstract Number: 1067
A Comparison of Joint Involvement Patterns in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Rheumatoid Arthritis
-
Abstract Number: 1068
Multidisciplinary Prospective Study of Patients Treated with Immune Checkpoint Inhibitors Who Developed Rheumatic Immune-related Adverse Events
-
Abstract Number: 1069
Exploring the Risk of Demyelination Associated with TNF Alpha Inhibitors: Analysis of the FDA Adverse Event Reporting System (FAERS)
-
Abstract Number: 1070
Safety of DMARDs in Rheumatologic Immune-related Adverse Events Associated with Immune Checkpoint Inhibitors: Data from a Monocentric Cohort in Hospices Civils De Lyon
-
Abstract Number: 1071
No Increase in Mortality in US Veterans with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors (ICIs)
-
Abstract Number: 1072
Increase in Major Osteoporotic Fractures After Therapy with Immune Checkpoint Inhibitors
-
Abstract Number: 1073
Risk of Inflammatory Central Nervous System Diseases Among New Users of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
-
Abstract Number: 1074
Baseline Clinical Features, but Not Shared Epitope or HLA B27, Predict Severe Outcomes for Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
-
Abstract Number: 1076
Rituximab-Associated Hypogammaglobulinemia in Patients with Rheumatic Diseases: A Multicenter Retrospective Observational Study
-
Abstract Number: 1077
Anti-drug Antibodies Formation During Tapering and Stopping of Methotrexate in Rheumatoid Arthritis Patients with Longstanding Use of Adalimumab
-
Abstract Number: 1078
Outcomes of COVID-19 Infection in Hospitalized Autoimmune Patients and Transplant Patients on Immunosuppression
-
Abstract Number: 1079
Identification of Immune Checkpoint Inhibitor-Induced Myositis Patients Using Electronic Health Records Is Most Successful When Employing Multiple Data Elements
-
Abstract Number: 1080
Prevalence and Incidence of Paradoxical Side-effects of TNF-α Inhibitors: A Cross-sectional Study
-
Abstract Number: 1081
Clinical Consequences of Infliximab Immunogenicity and the Impact of Proactive Therapeutic Drug Monitoring: Secondary Analyses of a Randomised Clinical Trial
-
Abstract Number: 1082
Reducing No-shows and Late Cancellations at an Academic Medical Center Subspecialty Clinic
-
Abstract Number: 1083
A Patient-Centered Approach to Increase Herpes Zoster Vaccination in Patients on Janus Kinase Inhibitors: A Fellowship Quality Improvement Initiative
-
Abstract Number: 1084
Identifying and Addressing Disparities in Health Literacy in Patients with Rheumatic Diseases Through Point of Care Distribution of Patient Education Materials
-
Abstract Number: 1085
Utilizing a Maintenance of Certification (MOC) Part 4 Quality Improvement Project to Improve Data Completeness in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
-
Abstract Number: 1086
Increase Shingrix Vaccination Rate in Patients on JAK Inhibitors: A Quality Improvement Project at the Rheumatology Practice of an Urban Institution
-
Abstract Number: 1087
Characterizing Herpes Zoster Vaccination Patterns in Rheumatoid Arthritis Patients in a Tertiary Care Clinic: A Quality Improvement Approach
-
Abstract Number: 1088
Improving JIA Outcomes Assessments in a Large Pediatric Rheumatology Practice: A Fellow Quality Improvement Project
-
Abstract Number: 1089
Improving Recombinant Zoster Vaccination Rates Among Immunosuppressed Veterans in an Academic Rheumatology Clinic
-
Abstract Number: 1090
Improved Patient and Team Satisfaction and Pharmacy Outcomes After Implementing a Rheumatology Clinical Pharmacist in a Large Academic Medical Center
-
Abstract Number: 1091
Prevalence of Loss to Follow up of Systemic Lupus Erythematosus Patients and Its Effect on Quality of Care
-
Abstract Number: 1092
Improving Screening of Lupus Nephritis in Patients with Systemic Lupus Erythematous
-
Abstract Number: 1093
Development of Adaptive Immunity Against Different SARS-CoV-2 Variants over the Course of Three COVID-19 Vaccinations in Patients with Inflammatory Rheumatic Diseases
-
Abstract Number: 1094
“Lupus Doesn’t Have Me, I Have Lupus” a Patient Centered Quality Improvement Project to Increase Medication Adherence for Patients with Lupus Nephritis
-
Abstract Number: 1095
Engagement with the RISE Registry Clinician Dashboard Is Associated with Higher Performance on Rheumatology Quality Measures
-
Abstract Number: 1096
A Quality Improvement Project About Medication Adherence to Understand What Questions Rheumatology Patients Have About Their Medications, and How They Answer Them
-
Abstract Number: 1097
Improving Vaccine Uptake of the Pneumococcal 20-valent Conjugate Vaccine (PCV20) in Young Rheumatic Disease Patients Using a Brief Intense Partnership Program
-
Abstract Number: 1098
Improving Osteoporosis Screening in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis
-
Abstract Number: 1099
Improving Hydroxychloroquine Dosing and Eye Screening Compliance in Patients with Connective Tissue Disorder
-
Abstract Number: 1100
A Comparison of Characteristics of Patients with Crystalline and Septic Arthritis Confirmed by Synovial Fluid Analysis: Towards the Development of a Diagnostic Rule
-
Abstract Number: 1101
Systemic Inflammation Associated with Silent Deposition of Monosodium Urate Crystals in Asymptomatic Hyperuricemia
-
Abstract Number: 1102
Finding Lost-to-Care Gout Patients in a Large Community Rheumatology Network: Patient Re-engagement Initiative with Metrics (PRIME)
-
Abstract Number: 1103
Evaluation of Outcomes Following Discontinuation of Pegloticase Therapy
-
Abstract Number: 1105
Effects of Uric Acid Lowering Treatment on Vascular Stiffness in Gout Patients
-
Abstract Number: 1106
Monosodium Urate and Calcium Pyrophosphate Crystal-induced Inflammation Relies on Cell Volume Regulation and LRRC8/VRAC Channel Activation
-
Abstract Number: 1107
Predictors of Pegloticase Urate-lowering Response in the Presence and Absence of Methotrexate Co-therapy
-
Abstract Number: 1108
Minimal Clinically Important Difference (MCID) of Quality of Life Assessments in Patients with Uncontrolled Gout
-
Abstract Number: 1109
Genetic Risk Variants in Hyperuricemia and Gout: Common Disease, Multiple Common and Rare Variant Hypothesis
-
Abstract Number: 1110
Pharmacokinetics and Pharmacodynamics of AR882 Following 12-Week Treatment in Patients with Gout
-
Abstract Number: 1111
Urate-Lowering Therapy Is Associated with a Reduced Risk of Arrhythmias: A Systematic Review and Meta-analysis
-
Abstract Number: 1112
AR882, a Potent Uricosuric Agent, Shows Favorable Uric Acid Excretion Profile Following Multiple Doses
-
Abstract Number: 1113
Comparing a Capillary Urate Point-Of-Care Device to Standard Laboratory-based Serum Urate Test for Dose Titration in Gout Patients
-
Abstract Number: 1114
Role of Dual-energy Computed Tomography (DECT) in Detection of Carotid Artery Monosodium Urate Deposition in Patients with Gout
-
Abstract Number: 1115
EULAR Recommendations for the Use of Imaging in the Diagnosis and Management of Crystal-induced Arthropathies in Clinical Practice
-
Abstract Number: 1116
The Current State of Sodium-Glucose Cotransporter Type 2 Inhibitor Use Among Patients with Gout at a Tertiary Academic Healthcare System
-
Abstract Number: 1117
Serum Urate Change Among Gout Patients Initiating Sodium-Glucose Cotransporter Type 2 Inhibitors (SGLT2i) vs. Sulfonylureas: A Comparative Effectiveness Analysis
-
Abstract Number: 1119
Preliminary Descriptive Analysis of the RADIAL Cohort Study About the Prevalence and the Clinical Characteristics of Patients with CPPD in Daily Clinical Practice
-
Abstract Number: 1120
Target Serum Urate Levels, Recurrent Gout Flare Rates, and Gout-Primary Hospitalizations: Nationwide Prospective Cohort Study of 3,613 Gout Patients
-
Abstract Number: 1121
Cardiovascular Safety of Febuxostat in Patients with Gout or Hyperuricemia: A Systematic Review of Randomized Controlled Trials
-
Abstract Number: 1122
The Tophus Impact Questionnaire (TIQ-20): Responsiveness to Change During Urate-Lowering Therapy
-
Abstract Number: 1123
Real-world Trends in the Use of Immunomodulation as Co-therapy to Pegloticase: Claims-based Findings Since 2016
-
Abstract Number: 1124
A Double-blind, Placebo-parallel Controlled Phase III Clinical Study of the Efficacy and Safety of Hemay005 Tablets in Patients with Moderate to Severe Chronic Plaque Psoriasis in China
-
Abstract Number: 1125
A Rheumatologic Clinical Profile of the VEXAS Syndrome: Results from a Survey Conducted Among Rheumatologic Units of 126 Hospitals Across Spain
-
Abstract Number: 1126
Identification of Clinical Phenotypes in Behçet’s Disease Using a Cluster Analysis
-
Abstract Number: 1127
Factors Associated with Vision-Related Quality of Life in Patients with Non-infectious Uveitis: A Longitudinal Analysis
-
Abstract Number: 1128
Refractory Inflammatory Ocular Pathology and Treatment with Janus Kinase Inhibitors. Multicenter Study and Literature Review
-
Abstract Number: 1129
Accuracy and Performance Characteristics of Administrative Codes for the Diagnosis of Autoinflammatory Syndromes: A Discovery and Validation Study
-
Abstract Number: 1130
Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI
-
Abstract Number: 1131
Clinical Phenotypes of IgG4-related Disease in a Multi-ethnic Singapore Cohort
-
Abstract Number: 1132
Preclinical Profiles of FZ007-119, a Highly Potent and Selective Tyk2 Inhibitor, for the Treatment of Immune Mediated Inflammatory Diseases
-
Abstract Number: 1133
Exploring the Clinical Characteristics and Correlation with Corticosteroid Dependence in Polymyalgia Rheumatica (PMR) Patients: Insights from an Academic Center
-
Abstract Number: 1134
Pilot Study Investigating Adenosine Deaminase-2 as a Disease Activity Biomarker for Cardiac Sarcoidosis
-
Abstract Number: 1135
The Prescribing Patterns and Role of TNF-α Inhibitors in Treatment of Cardiac Sarcoidosis Patients
-
Abstract Number: 1136
Challenges in Diagnosing VEXAS Syndrome: Delayed Diagnosis, Misdiagnosis, and Associations with Specific Gene Mutations
-
Abstract Number: 1137
Association Between Nailfold Videocapillaroscopy Findings and sKL-6 Levels in Patients with Idiopathic Inflammatory Myopathies–Related Interstitial Lung Disease
-
Abstract Number: 1138
Nailfold Capillaroscopy Findings in Patients with Idiopathic Inflammatory Myopathies and Its Association to Autoantibodies
-
Abstract Number: 1139
From Skin to Bone Lesions: A Pioneer Study Unraveling the Underdiagnosis of SAPHO Syndrome in the Dominican Republic
-
Abstract Number: 1141
COVID-19 Vaccination Status and Adverse Events Following SARS-CoV-2 Vaccine in Autoimmune Inflammatory Rheumatic Disease (AIRD) Patients: A Single Center Experience
-
Abstract Number: 1142
A Retrospective Analysis of Radiographic and Serologic Findings in Patients with Scleroderma and Interstitial Lung Disease
-
Abstract Number: 1143
Nationwide Analysis of Adult-Onset Still’s Disease with and Without Hemophagocytic Lymphohistiocytosis
-
Abstract Number: 1144
Deucravacitinib in Plaque Psoriasis: Maintenance of Response over 3 Years
-
Abstract Number: 1145
Human Cardiovascular Disease Model Provides Transcriptomic Evidence of Cardiovascular Risk Associated with Febuxostat
-
Abstract Number: 1146
Gene X Environment Paradigm: Exemplified by Selected Cases of Autoinflammatory Diseases
-
Abstract Number: 1147
Blood-Based Biomarkers of Inflammation and Tissue Remodeling Can Discriminate Between Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis and Are Associated with Hand Function
-
Abstract Number: 1148
A Comparative Study of Clinical Phenotype in Relation to NOD2 Sub-genotypes in Yao Syndrome
-
Abstract Number: 1149
Tumor Necrosis Factor Inhibitors as First Line Steroid-Sparing Therapy for Neurosarcoidosis: A Case Series
-
Abstract Number: 1150
A Comparative Study of Cryofibrinogenemia Before and After COVID-19 Era
-
Abstract Number: 1151
Revised IWOS Criteria for Ocular Sarcoidosis: A 2019 Review of the 2009 Criteria in a Study of 384 Patients from a Single University Hospital
-
Abstract Number: 1152
Relation Between Positive MPO-ANCA Antibodies And: Associated Diseases, Anca-associated Vasculitis Specificty, Severity and Prognosis. Study from a Single University Hospital
-
Abstract Number: 1153
Unmasking SAPHO: A Case Series Revealing the Clinical Spectrum and Treatment Approaches
-
Abstract Number: 1154
Clinical Presentation of IgG4-Related Disease. Single Referral Hospital Experience and Literature Review
-
Abstract Number: 1155
Identification of Serum Biomarkers Associated with Muscle Damage Detected on MRI in Polymyositis/dermatomyositis
-
Abstract Number: 1156
Presentations and Outcomes of Idiopathic Inflammatory Myopathies in Hong Kong
-
Abstract Number: 1157
Experience of Pain in Adults with Idiopathic Inflammatory Myopathies, Myositis
-
Abstract Number: 1158
Dermatomyositis Flares After COVID-19 Vaccination and/or SARS-CoV-2 Infection
-
Abstract Number: 1159
Expanded Cytotoxic CD8+ T Cell Clones Characterize the Blood of Inclusion Body Myositis Patients
-
Abstract Number: 1160
Antibody Predictors of Prognosis in a Large Multi-centre Cohort of Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease
-
Abstract Number: 1161
Proteasome Inhibitor Repurposed for Dermatomyositis: Results of a Drug Repurposing Analysis Based on the Transcriptomic Signature of Patients’ Perifascicular Fibers Validated in Pre-clinical Models
-
Abstract Number: 1162
Serial Imaging Changes in Skeletal Muscle Composition and Their Association with Clinical Outcomes in Idiopathic Inflammatory Myopathies
-
Abstract Number: 1163
Anti-melanoma Differentiation Associated Gene 5 (Anti-MDA5) Antibody Dermatomyositis: Clinical Features and Outcome in a Racially Diverse Patient Cohort
-
Abstract Number: 1164
Can We Differentiate Patients with Dysferlinopathies and Inflammatory Myopathies by Muscle Ultrasound? A Discriminant Analysis Study
-
Abstract Number: 1166
Patients with COVID-19 and Polymyositis Inpatient Outcomes and Hospital Cost: Nationwide Inpatient Sample 2020
-
Abstract Number: 1168
Evaluation of Agreement Between Functional and Radiological Changes in Idiopathic Inflammatory Myositis (IIM) Associated Interstitial Lung Disease (ILD)
-
Abstract Number: 1169
All-cause Mortality and Risk Factors for Death in a Large Multi-center Prospective Registry Cohort of Idiopathic Inflammatory Myositis in China
-
Abstract Number: 1170
Damage Accrual in Idiopathic Inflammatory Myopathies: Data from a Monocentric Cohort and Impact on Patients’ Quality of Life
-
Abstract Number: 1171
Cardiac Biomarkers Are a Useful Initial Screening Tool for Myocarditis in Patients with Idiopathic Inflammatory Myopathies
-
Abstract Number: 1173
Prognostic Biomarkers and Radiological Features of Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease
-
Abstract Number: 1174
Anti-HMGCR Immune-mediated Necrotising Myopathy: Calculation of Incidence and Confirmation of Low Malignancy Risk in Two Independent Cohorts. a Retrospective Case Review
-
Abstract Number: 1175
Inclusion of All Myositis Specific Autoantibodies or Other Rashes Leads to Better Sensitivity but Lower Specificity of 2017 EULAR/ACR Myositis Classification Criteria for Dermatomyositis
-
Abstract Number: 1176
Brepocitinib Prevents Type-I Interferon Induced Damage in Cultured Myocytes and Endothelial Cells Indicating a Potential Role in the Treatment of Dermatomyositis
-
Abstract Number: 1177
Anti-HMGCR Autoantibody Levels in the Follow-up of Statin-induced Immune-mediated Necrotizing Myopathy: Multicentric Study of 24 Patients
-
Abstract Number: 1178
Self-Perceived Knowledge of Myositis Among Social Media Respondents- a Pilot Study on Twitter
-
Abstract Number: 1179
Rituximab in the Treatment of Interstitial Lung Disease Associated with the Antisynthetase Syndrome
-
Abstract Number: 1180
Machine Learning Approach for the Prediction of anti-MDA5 Positive Dermatomyositis Mortality
-
Abstract Number: 1181
Real-World Myositis Antibody Frequency and Patient Awareness
-
Abstract Number: 1182
Treatment Trajectories and Patient Outcomes in Idiopathic Inflammatory Myopathies
-
Abstract Number: 1183
CoLchicine for Treatment of OsteoArthritis of the Knee—Updated Data from a Double-blind, Placebo-controlled Trial
-
Abstract Number: 1184
A Wearable-Sensor for Assessment of Gait and Chair Stand Patterns in People with Knee Osteoarthritis: Validation and Responsiveness to Treatment of a Potential Digital Biomarker
-
Abstract Number: 1185
Soluble Buffered Alendronate After Denosumab Discontinuation in Erosive Hand OA Patients
-
Abstract Number: 1186
Presence of Erosions Is Not a Risk Factor for the Development of Knee OA in a Hand OA Population: The Framingham OA Study
-
Abstract Number: 1187
Post-hoc Analysis of Individual Questions from the Australian/Canadian Osteoarthritis Hand Index from a Randomized, Double-blind, Placebo-controlled Trial of Patients with Hand OA
-
Abstract Number: 1188
Development of a Method to Isolate Functional Mitochondria and Assess Their Functionality and Integration in Joint Tissues: In Vitro and in Vivo Models
-
Abstract Number: 1189
Evaluating Neuropathic and Nociplastic Pain in Patients with Hip and Knee Osteoarthritis
-
Abstract Number: 1190
Worsening of Pain as Perceived by Patients Is Not Reflected by an Annual Standardized Questionnaire
-
Abstract Number: 1192
Autoimmune Thyroid Disease Associates with Symptomatic Hand Osteoarthritis in Older Persons in the Third National Health and Nutrition Examination Survey
-
Abstract Number: 1193
The Association of Peak Forces and Loading Rates During Walking with MRI-Based Structural Worsening of the Knee: The Multicenter Osteoarthritis Study
-
Abstract Number: 1194
Extent of Subregional Involvement of Subchondral Bone Marrow Lesions in Incident Knee OA Is Associated with Weight-Bearing Knee Pain
-
Abstract Number: 1195
Relationship of Depth-Specific Subchondral Bone Mineral Density to MRI Cartilage Worsening: The Multicenter Osteoarthritis Study
-
Abstract Number: 1198
Bicycling Is Not Associated with New Knee Pain or Disease Progression over 48 Months in Those with Knee Osteoarthritis: Data from the Osteoarthritis Initiative
-
Abstract Number: 1199
Association of Dipeptidyl Peptidase-4 Inhibitor Use for Type 2 Diabetes and Incidence of OA in Taiwan
-
Abstract Number: 1200
Self-Reported Effectiveness of Cannabis for Arthritis-Related Pain
-
Abstract Number: 1201
Frailty and Its Impact on Patient Reported Outcomes in Polymyalgia Rheumatica
-
Abstract Number: 1202
Goal Concordant Patient-clinician Dyads Have Higher Odds of Communication Around Rheumatoid Arthritis Goals
-
Abstract Number: 1203
Vaccination Against SARS-CoV-2 in Inflammatory Arthritis and Factors Determining Its Decision
-
Abstract Number: 1204
Understanding Community Perspectives on Disease Management: A Social Media Analysis of Gout Care Strategies
-
Abstract Number: 1205
Universal Social Determinants of Health Screening in a Pediatric Rheumatology Specialty Clinic: A Feasibility Study
-
Abstract Number: 1206
Self-Perceptions of Aging and Physical Activity in Older Adults with Arthritis: Does General Health Matter?
-
Abstract Number: 1207
Cardiovascular Mortality of Acute Myocardial Infraction and Acute Heart Failure Hospitalization in Rheumatic Diseases Patients Evaluation from the 2016-2020 National Inpatient Sample (NIS) Database
-
Abstract Number: 1208
Investigating the Experiences of Patients Living with Antiphospholipid Antibodies: A Qualitative Study
-
Abstract Number: 1209
The Role of Kinesiophobia on Ankylosing Spondylitis Disease Activity, Exercise Habits, and Quality of Life
-
Abstract Number: 1210
Assessing Patient-Reported Drug Efficacy and Adherence Among IL-23 Inhibitors for Psoriasis and Psoriatic Arthritis
-
Abstract Number: 1211
Description of Self-Efficacy for Managing Symptoms and Emotions in a Large Rheumatology Clinic Population
-
Abstract Number: 1212
Racial Disparities in Comorbidities and Perception of Physical Health in Systemic Lupus Erythematosus
-
Abstract Number: 1213
Using Patient-Reported Disease Activity in a Population-Based Cohort to Predict Systemic Lupus Erythematous Hospitalization and Emergency Room Visits
-
Abstract Number: 1214
Using Patient Self-Reported Measures to Predict All-Cause Hospitalization in a Population-Based Lupus Cohort
-
Abstract Number: 1217
Sex Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey
-
Abstract Number: 1218
Discovering the Potential Application of Digital Biomarkers for Inflammatory Arthritis Patients, a Design Thinking Approach; Preliminary Results of the Patients’ Perspective
-
Abstract Number: 1219
Patient Experience of Brain Fog to Inform the Development of a De Novo Patient Reported Outcome (PRO) in Patients with Sjögren’s Disease
-
Abstract Number: 1220
Sjögren’s Patients’ Experiences and Content Validity of the Dry Eye Disease Symptom Questionnaire (DED-SQ)
-
Abstract Number: 1221
Familial Clustering of Dysbiotic Oral and Fecal Microbiomes in Juvenile Dermatomyositis (JDM)
-
Abstract Number: 1222
The Association Between Gingival Inflammation and Clinical Signs of Active Juvenile Dermatomyositis (JDM)
-
Abstract Number: 1223
Extracorporeal Life Support for Childhood-Onset Systemic Lupus Erythematosus: An ELSO Registry Analysis
-
Abstract Number: 1224
Mental Health Screening Follow-Up in the Childhood-Onset Systemic Lupus Clinic
-
Abstract Number: 1225
Nailfold Video Capillaroscopy and Its Association with Autoantibodies and Rheumatic Diseases in Pediatric Patients
-
Abstract Number: 1226
Examining the Relationship Between Socioenvironmental Factors and Cognitive Functioning in Youth with Childhood-Onset Systemic Lupus Erythematosus
-
Abstract Number: 1227
Serious Infections Following Rituximab Administration in Children with Systemic Lupus Erythematosus
-
Abstract Number: 1228
Validation of the PEDiatric Behçet’s Disease Classification Criteria (PEDBD): An International Consensus-based Approach
-
Abstract Number: 1229
Longitudinal Assessment of Self-reported Executive Function in Youth with Childhood-Onset Lupus
-
Abstract Number: 1230
Differences in Nailfold Capillary Morphology Distinguish Juvenile Dermatomyositis Patients That Are Myositis-Specific Autoantibody Positive
-
Abstract Number: 1231
Successful Implementation of a Mental Health Screening Program for Youth with Juvenile Dermatomyositis
-
Abstract Number: 1232
Improvement Across Organ System, Physician and Patient Reported Outcome Measures over a 36-time Period in the Juvenile Systemic Scleroderma Inception Cohort
-
Abstract Number: 1233
The Pattern of Medication Use Significantly Changed over 36 Months Observation Period. Result from the Juvenile Scleroderma Inception Cohort
-
Abstract Number: 1234
Cognitive Performance Score of the Pediatric Automated Neuropsychological Assessment Metrics Software in a Brazilian Cohort and Its Association with Disease Activity
-
Abstract Number: 1236
Melanoma Differentiation-Associated Protein-5 in Juvenile Dermatomyositis: A Single Center Cohort
-
Abstract Number: 1237
The Associations Between Depressive Symptoms and Executive Function and Academic Outcomes in Children with SLE
-
Abstract Number: 1238
Prevalence of Celiac Disease Among Children and Adolescents with Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 1239
Clinical Manifestations and Management of Takayasu Arteritis: A Multicenter Pediatric Cohort
-
Abstract Number: 1240
Obvious Only in Retrospect: A Cohort of STING Associated Vasculopathy in Infancy (SAVI) Without Typical Rash
-
Abstract Number: 1241
Adverse Childhood Experiences in a Paediatric Systemic Lupus Erythematosus Cohort
-
Abstract Number: 1242
Agreement Between Parent- and Self-Report of Executive Function in Adolescents with Childhood-Onset Systemic Lupus Erythematosus
-
Abstract Number: 1243
Tubulointerstitial Inflammation Is Associated with End-Stage Renal Disease in Pediatric Lupus Nephritis: A Single Center Retrospective Cohort Study
-
Abstract Number: 1244
Characterizing Lupus in African American Children in Southern United States
-
Abstract Number: 1245
Evaluating a Diagnostic Algorithm for Childhood Sjögren’s Disease
-
Abstract Number: 1246
Assessment and Outcomes of 63 Cases of Juvenile Dermatomyositis-Associated Calcinosis
-
Abstract Number: 1247
Pharmacokinetic, Pharmacodynamic, and Safety Profile of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: Analysis of Data from a Multicenter, Open-Label Trial
-
Abstract Number: 1248
Thrombotic Manifestations in Pediatric Behçet Disease Patients: A Multicentre Comparative Study from EUROFEVER Registry
-
Abstract Number: 1249
Cross-Sectional Associations of Emotional Distress and Cardiovascular Health in Juvenile Lupus and Dermatomyositis
-
Abstract Number: 1250
Local Inflammatory Response Mediated by the Homing of Tfh17 Cells Is Involved in Tissue Injury of Immunoglobulin a Vasculitis
-
Abstract Number: 1251
Neurologic Manifestations of Pediatric Sjogren’s Disease Patients: Case Series from an Academic Children’s Hospital
-
Abstract Number: 1252
Physician Global Assessment of Disease Activity in Childhood-Onset Systemic Lupus Erythematosus – Does the Approach Matter?
-
Abstract Number: 1253
The Novel Florida Scoring System: A Machine Learning-Based Stratification of Clinical and Laboratory Features in Children with Suspected Sjögren’s Disease
-
Abstract Number: 1254
Outcome of Pediatric Lupus in South Asia: Data from Indian SLE Inception Cohort for Research (INSPIRE)
-
Abstract Number: 1255
Clinical Characteristics and Disease Outcomes of anti-NXP2 Positive Juvenile Dermatomyositis: A Single Center Cohort
-
Abstract Number: 1256
Self-esteem and Body Image of Young People with Rheumatic Diseases: A Systematic Review
-
Abstract Number: 1257
The Psychological Experience of Work for People with Inflammatory Arthritis (IA)
-
Abstract Number: 1258
“What Is My Risk Really?”: A Qualitative Exploration and Ideal-Type Analysis of Preventive Interventions Among Individuals at Risk of Rheumatoid Arthritis
-
Abstract Number: 1259
Voices Unheard: Unmasking the Hidden Challenges of Youth with Rheumatic Diseases
-
Abstract Number: 1260
Optimal Approaches for Reducing Depressive Symptoms in Rheumatoid Arthritis Patients Based on Psychological Interventions: A Systematic Review and Network Meta-analysis
-
Abstract Number: 1261
Network Analysis of Depression and Anxiety Symptoms in Chinese Rheumatoid Arthritis Patients
-
Abstract Number: 1263
Depression and Anxiety Risk Assessment in Patients with Rheumatic Diseases
-
Abstract Number: 1264
Nomination of Biomarkers for Self-testing Disease Activity in Rheumatoid Arthritis Using Patient Similarity Networks: A Pilot Study
-
Abstract Number: 1265
Changes in the Endocannabinoid Tone in Rheumatoid Arthritis and Osteoarthritis – Discovery of a Novel Target for the Treatment of Pain and Inflammation?
-
Abstract Number: 1266
The Anti-inflammatory Effect of High-density Lipoprotein Is Blunted by Delivery of Altered MicroRNA Cargo to Macrophages in Patients with Rheumatoid Arthritis
-
Abstract Number: 1267
Lower Herpes Zoster Rate of Tocilizumab and Tofacitinib in Patients Undergoing Treatment for Rheumatoid Arthritis
-
Abstract Number: 1269
The Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-associated Interstitial Lung Disease Subtypes
-
Abstract Number: 1270
Identification of Subclinical Atherosclerosis by Six Cardiovascular Risk Calculators in Rheumatoid Arthritis Patients
-
Abstract Number: 1271
Upregulation of IFNγ-Response Genes in Monocytes and T Cells Identified by Single-Cell Transcriptomics in Patients with Anti-CCP Antibody-Positive Rheumatoid Arthritis (RA)
-
Abstract Number: 1272
Immunomodulators and Risk for Breakthrough COVID-19 After a Third SARS-CoV-2 mRNA Vaccine Among Patients with Rheumatoid Arthritis: A Cohort Study
-
Abstract Number: 1273
Long-term Follow-up of Treated-to-target RA and UA: Results of the BeSt and IMPROVED Studies
-
Abstract Number: 1275
Prevalence of Frailty Among Individuals Living with Rheumatoid Arthritis: A Population-based Cohort Study
-
Abstract Number: 1276
Multimorbidity Burden Predicts Lower Likelihood of Remission in Patients with Rheumatoid Arthritis
-
Abstract Number: 1277
Relationship Between Quality of Life and the Region of the Affected Joints in Japanese Patients with Rheumatoid Arthritis: A Cross-sectional Study
-
Abstract Number: 1278
Nature and Severity of Activity Limitations According to the Health Assessment Questionnaire Disability Index in Patients with Rheumatoid Arthritis and Functional Disability
-
Abstract Number: 1280
Systemic Inflammation Is Associated with Incident Valvular Heart Disease in Patients with Rheumatoid Arthritis: A Multicenter, Prospective Cohort Study
-
Abstract Number: 1281
Risk of Cancer in Patients with Rheumatoid Arthritis Under Tocilizumab: Data from the French National Registry REGATE
-
Abstract Number: 1282
Proteomic Signature in Peripheral Blood and Sputum in Rheumatoid Arthritis Patients with and Without Lung Involvement
-
Abstract Number: 1283
Atherogenic Index of Plasma Identifies Patients with Rheumatoid Arthritis and Increased Carotid Intima-Media Thickness
-
Abstract Number: 1284
Baseline Data’s Role in Predicting All-cause Mortality in Chinese Rheumatoid Arthritis Patients: Findings from the China Registry of Rheumatoid Arthritis (CREDIT) Study
-
Abstract Number: 1285
PROMIS Symptom Clusters Predict Disease Activity in the First 6 Months in Newly Diagnosed RA Patients Starting MTX Therapy: Data from the Canadian Early Arthritis Cohort
-
Abstract Number: 1286
Impact of Body Mass Index (BMI) on Upper versus Lower Extremity Joints Assessed Using Clinical and Musculoskeletal Ultrasound Measures in Rheumatoid Arthritis Patients
-
Abstract Number: 1287
Impact of Body Mass Index (BMI) on Rheumatoid Arthritis Disease Activity and Musculoskeletal Ultrasound Measures
-
Abstract Number: 1288
Frailty Is Associated with Higher Risk of Readmission in Patients with Rheumatoid Arthritis
-
Abstract Number: 1289
Increases in Serum Levels of Tartrate-Resistant Acid Phosphatase 5b Reflected Radiographic Progression of Joint Damage in Treated Rheumatoid Arthritis
-
Abstract Number: 1290
Development of a Genetic Risk Score for Pain in Rheumatoid Arthritis
-
Abstract Number: 1291
Risk Factors for Major Adverse Cardiovascular Events and Malignancies in Patients with Rheumatoid Arthritis in a Real-World Setting in Japan
-
Abstract Number: 1292
Active Rheumatoid Arthritis Patients Exhibit an Altered Serum Lipidomic Profile Directly Linked to Disease Activity, Which Is Reversed by Biologic and Targeted Synthetic DMARD
-
Abstract Number: 1293
Single Camera Hand Motion Capturing as a Digital Biomarker for Disease Activity in Rheumatoid Arthritis Using Computer Vision: The Proof-of-Concept MeFisto Study
-
Abstract Number: 1294
Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: Using Rasch Measurement Theory and Cognitive Interviewing to Achieve More Meaningful Measurement
-
Abstract Number: 1295
Having More Tender Than Swollen Joints Is Associated with Worse Functional Outcomes in Patients with Early RA in a Prospective Real-World Cohort
-
Abstract Number: 1296
Decline in Incidence of Extraarticular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study
-
Abstract Number: 1297
COVID-19 Vaccination-related Delayed Adverse Events Among Patients with Rheumatoid Arthritis: Results from the COVAD Study
-
Abstract Number: 1298
Risk Factors Associated with Venous Thromboembolism in Rheumatoid Arthritis in Clinical Practice
-
Abstract Number: 1299
Rheumatoid Arthritis Patients Who Never Use a Biological During Their Disease Course Represent a Subgroup of Patients Likely to Achieve Sustained DMARD-free Remission
-
Abstract Number: 1300
Bone Marrow Edema in MRI Is More Associated with Rapid Radiographic Progression Than Clinically Relevant Radiographic Progression
-
Abstract Number: 1301
The Relationship Between Socioeconomic Factors and Persistent Active Rheumatoid Arthritis: Results from (NEIAA) a Large UK Cohort of Early Inflammatory Arthritis
-
Abstract Number: 1302
Biomarkers of Cardiovascular Risk in Patients with Rheumatoid Arthritis: Results from the TARGET Trial Biomarker Study
-
Abstract Number: 1303
Patient’s and Physician’s Evaluation of Global Assessment of Disease Activity over Follow up and Across Disease Activity Levels in Recent-Onset Rheumatoid Arthritis
-
Abstract Number: 1304
Window of Opportunity to Achieve Better Functional Outcomes in Patients with RA: Effectiveness of an Early Treatment Strategy
-
Abstract Number: 1305
Variations in Macrophage Cholesterol Loading over Time Are Linked to Dynamic Changes in Coronary Atherosclerotic Plaque in Rheumatoid Arthritis
-
Abstract Number: 1306
Statin Use Attenuates the Impact of Systemic Inflammation on Ischemic Cardiovascular Risk in Patients with Rheumatoid Arthritis
-
Abstract Number: 1307
Impact of Comorbidities on the First bDMARD Effectiveness and Retention Rate After 2 Years of Follow-up in Patients with Rheumatoid Arthritis. Data from the Spanish Registry BIOBADASER
-
Abstract Number: 1309
Refractory RA Patients for Targeted Therapies in Real Life
-
Abstract Number: 1310
Comparison of Two Methotrexate Initiation Strategies in Rheumatoid Arthritis in Current Practice
-
Abstract Number: 1311
T Cell Subset Signatures Predicted Clinical Response to Etanercept-biosimilar Yisaipu in Patients with Rheumatoid Arthritis
-
Abstract Number: 1313
Remotely Supervised Weight Loss and Exercise Training Improves Disease Activity and Patient Reported Outcomes in Older Patients with Rheumatoid Arthritis
-
Abstract Number: 1314
Safety Results from a Phase 1 Double-blind Randomized Clinical Trial of Allogeneic Mesenchymal Stem Cells in Early RA
-
Abstract Number: 1316
Influence of Rheumatoid Factor on Serum Drug Levels of TNF Inhibitors with Different Structures in Rheumatoid Arthritis
-
Abstract Number: 1317
Discontinuation of Biological Disease Modifying Drugs Due to Adverse Drug Reactions in an Inception Rheumatoid Arthritis Cohort
-
Abstract Number: 1318
Abatacept Modulates Both Global and Citrulline Specific T Cell Signatures: Results from Inhibition of Co-Simulation in Rheumatoid Arthritis Phase IV Trial
-
Abstract Number: 1319
Real World Data on Antifibrotics in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 73 Patients
-
Abstract Number: 1320
Evaluation of Circulating Levels of Helper T and Innate Lymphoid Cells Subsets in a Cohort of bDMARDs-naïve Patients with Rheumatoid Arthritis Treated with Abatacept
-
Abstract Number: 1321
Effect of Subcutaneous Local Anaesthesia Prior to Intra-Articular Injection: An Open Label, Paired-group, Randomized Controlled Trial
-
Abstract Number: 1322
Efzofitimod, a First-in Class NRP2-targeting Immunomodulator, Ameliorates Rheumatoid Arthritis and Associated Lung Fibrosis in Preclinical Models
-
Abstract Number: 1323
Distinct Treatment Responses in Patients with Rheumatoid Arthritis Receiving Filgotinib 200 Mg over 12 Months: A Post Hoc Analysis of FINCH 1
-
Abstract Number: 1324
Previous History of Serious Infection Is Associated with the Use of IL-6 Inhibitors in Rheumatoid Arthritis in Wales, UK
-
Abstract Number: 1325
Integrated Safety Analysis of Filgotinib in Patients with Moderate to Severe Active Rheumatoid Arthritis with a Maximum Exposure of 8.3 Years
-
Abstract Number: 1326
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 204 from the SELECT-CHOICE Study
-
Abstract Number: 1327
Effects of Long-Term Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis on Body Weight and Blood Pressure: A Pooled Analysis of Individual Patient Data from Five Randomised Trials
-
Abstract Number: 1328
Switching Biologics or Janus Kinase Inhibitors Is Effective in Difficult-to-treat Rheumatoid Arthritis, Regardless of Inflammation
-
Abstract Number: 1329
R851, a Potent Second Generation IRAK1 and IRAK4 Inhibitor Suppresses IL-6 in Vitro and in Vivo for the Treatment of Rheumatoid Arthritis
-
Abstract Number: 1330
Certolizumab-pegol, Abatacept, Tocilizumab or Active Conventional Therapy in Early Rheumatoid Arthritis: 48 Week Patient-reported Outcomes of the NORD-STAR Trial
-
Abstract Number: 1331
Long-term Effectiveness of a Lifestyle Program for Rheumatoid Arthritis: One-year Follow-up of the “Plants for Joints” Randomized Clinical Trial
-
Abstract Number: 1332
Patient-Reported Outcomes, Disease Activity and Safety in 798 Patients with RA Treated with Filgotinib: Up to 1-Year Interim Results from a Prospective Observational Study (FILOSOPHY)
-
Abstract Number: 1333
Rheumatoid Arthritis-associated Lymphoproliferative Disorders: A Multi-center Analysis of Clinical Outcomes and Evaluation of Anti-rheumatic Drugs After LPD Onset
-
Abstract Number: 1334
Comparison of Malignancies and Serious Infections Between Etanercept Biosimilar and Bio-Originator Initiators: Population-Based Analyses
-
Abstract Number: 1335
Effectiveness of Longstanding Exercise Therapy versus Usual Care in People with Rheumatoid Arthritis and Severe Functional Limitations: A Randomized Controlled Trial (L-EXTRA)
-
Abstract Number: 1336
Adalimumab and Etanercept Serum Levels in Rheumatoid Arthritis Patients with and Without a Disease Flare During Tapering
-
Abstract Number: 1337
Effect of Tofacitinib Therapy on Angiotensin Converting Enzyme Activity in Rheumatoid Arthritis
-
Abstract Number: 1338
The Advantage of Tight Control and Treat-to-Target in New-onset Rheumatoid Arthritis Patients in Daily Rheumatology Practice: Results from a Contemporary University Clinic Inception Cohort
-
Abstract Number: 1339
Neutrophil Activation and Formation of Neutrophil Extracellular Traps Are Associated with Response to Abatacept in Patients with Moderate to Severe Rheumatoid Arthritis
-
Abstract Number: 1340
Recent Trends in Treatment Patterns for Rheumatoid Arthritis in Response to Emerging Data
-
Abstract Number: 1341
Impact of Ultrasound on Physician Assessments of Patients with RA with Elevated Clinical Disease Activity Scores
-
Abstract Number: 1342
The Delivery of the Super-repressor IκBα by Exosomes Has the Potential to Alleviate Inflammation Associated with Rheumatoid Arthritis
-
Abstract Number: 1343
Cardiovascular (CV) and Malignancy Events in the Filgotinib Rheumatoid Arthritis (RA) Clinical Development Program up to 8.3 Years
-
Abstract Number: 1344
Efficacy and Safety of JAK Inhibitors in Difficult to Treat Rheumatoid Arthritis in Clinical Practice
-
Abstract Number: 1345
Maternal and Infant Outcomes Following Abatacept Exposure During Pregnancy
-
Abstract Number: 1346
Semen Analysis of Patients with Psoriatic Arthritis, Axial Spondyloarthritis and Healthy Controls
-
Abstract Number: 1347
Continuing Biologic DMARDs During Pregnancy in Women with Rheumatic Disease Was Not Associated with Increased Unfavorable Pregnancy Outcomes, Serious Infections, and Adverse Effects of Vaccination
-
Abstract Number: 1348
Reproductive Outcomes for Women with Vasculitis
-
Abstract Number: 1349
Paternal Effects of Anti-TNFs in Inflammatory Arthritis
-
Abstract Number: 1350
Identification of ACR Guidelines for SLE Pregnancy Care in the Electronic Health Record
-
Abstract Number: 1351
HPV Vaccination in Adolescent and Young Adult Patients Seen in an Academic Rheumatology Center
-
Abstract Number: 1352
Similar Delivery Outcomes in Pregnant Patients with and Without Takayasu Arteritis – A Nationwide Inpatient Database Study
-
Abstract Number: 1353
Sexual Dysfunction in Women with Systemic Lupus Erythematosus: A Cross-Sectional Multicentre Study
-
Abstract Number: 1354
The Impact of Pregnancy Intention on Depression and Quality of Life in Women with Lupus
-
Abstract Number: 1355
Delivering Care for Pregnant Women with Rheumatic and Musculoskeletal Diseases in Ireland: Current Challenges and Practices
-
Abstract Number: 1356
Reproductive History and HPV Vaccination Awareness Among Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis
-
Abstract Number: 1357
Systemic Lupus Erythematosus and Assisted Reproductive Technology: A Case Series and Systematic Literature Review
-
Abstract Number: 1358
Experiences and Attitudes Related to Assisted Reproductive Technologies Among Women with Systemic Rheumatic Disease
-
Abstract Number: 1359
Association of Menstrual Cycles and Disease Flare Activity in Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis
-
Abstract Number: 1360
Factors Associated with Medication-related Concerns in Women with Inflammatory Rheumatic Diseases – an Analysis of a Nationwide Pregnancy Cohort
-
Abstract Number: 1361
Effect of Zen/Doria Remission and Glucocorticoid Dosage on the Pregnancy Outcome of SLE: Retrospective Study in Two Japanese Tertiary Referral Centers
-
Abstract Number: 1362
Improving Reproductive Health Counseling for Pediatric Adolescent Females Prescribed Teratogenic DMARDs
-
Abstract Number: 1363
Plasma Neutrophil Extracellular Trap Remnant Levels Are Lower in Premenopausal Healthy Women Using Oral Contraceptive Pills
-
Abstract Number: 1364
Both Low and High 25(OH)-Vitamin D Levels Increase Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus
-
Abstract Number: 1365
Extraglandular Involvement and Autoantibody Status as Risk Factors for Cardiovascular Disease in Primary Sjogren’s Syndrome (pSS): A 20 Year-follow up Study
-
Abstract Number: 1366
A Unique Cluster of Inflammatory Monocytes and Functionally Intact Regulatory T Cells in Rare Childhood Sjögren’s Disease
-
Abstract Number: 1367
Novel Autoantibodies Might Circumvent the Need for Labial Biopsy in a Subset of Seronegative Sjögren’s Disease Patients
-
Abstract Number: 1368
Development of the Sjögren’s-related Quality of Life (SRQoL) to Assess Health-related Quality of Life (HRQoL) in Sjögren’s
-
Abstract Number: 1369
Treatment Patterns and Drivers of Biologic Prescriptions in Patients with Primary Sjögren’s Disease: Results from a Multinational, Real-World Survey
-
Abstract Number: 1370
Synthetic Glabridin Derivatives Improves Sjogren’s Syndrome by Inducing Salivary Secretion and Salivary Gland Regeneration
-
Abstract Number: 1371
Are Ultrasound Salivary Parenchymal Abnormalities More Severe in Primary Sjögren Patients with a Higher Disease Duration ? A Cross-sectional International Study
-
Abstract Number: 1372
Obinutuzumab Efficacy and Tolerance in Patients with Auto-Immune Diseases Immunized Against Rituximab
-
Abstract Number: 1373
Deltex1 May Involve the Function of T Regulatory Cells and Regulate the Disease Activity of Sjögren’s Syndrome
-
Abstract Number: 1374
Interstitial Lung Disease Is Frequent in Primary Sjögren’s Syndrome and Is Associated with Reduced Survival
-
Abstract Number: 1375
The Relative Burden of Fatigue Is Associated with High TSH/fT4 Ratio in Korean Patients with Primary Sjogren’s Syndrome
-
Abstract Number: 1376
SJOGRENSER Registry: Prospective Evaluation of a Cohort of Patients with Primary Sjögren’s Syndrome After 8 Years of Follow-up
-
Abstract Number: 1377
Characterization of Pulmonary Manifestations of Sjögren Syndrome: A Multicenter Retrospective Study
-
Abstract Number: 1378
The UCSD Shortness of Breath Questionnaire Is a Useful Tool for the Assessment of Dyspnea in Primary Sjögren’s Syndrome Patients with Interstitial Lung Disease: A Monocentric Cross-Sectional Study
-
Abstract Number: 1379
Population Pharmacokinetic/Pharmacodynamic Modeling of Dazodalibep, a CD40L Antagonist, in Healthy Volunteers and Patients with Rheumatoid Arthritis and Sjogren’s Syndrome
-
Abstract Number: 1380
Synergistic Dose Effects of Extra X Chromosome in Development of Sjogren’s Syndrome in Klinefelter and Triple X Syndromes
-
Abstract Number: 1381
Fatigue and Associated Factors in Patients with Primary Sjogren’s Syndrome Compared to Secondary Sjogren’s Syndrome
-
Abstract Number: 1382
Efficacy of Tofacitinib Immunotherapy Suppresses Tfh and Tph Cells in Patients with Primary Sjögren’s Syndrome
-
Abstract Number: 1383
Long-term Association Between Physical Activity and Global Functioning in Patients with axSpA: Results of a 2 Year Prospective Study
-
Abstract Number: 1384
Functional Status by Sex and Socioeconomic Status in Axial Spondyloarthritis
-
Abstract Number: 1386
Opioid Prescription Rates in Patients with Ankylosing Spondylitis in the UK Between 2001-2020: An Electronic Health Records (EHR) Analysis
-
Abstract Number: 1387
Power Doppler Musculoskeletal Abnormalities in Patients with Psoriasis at High Risk of Progression to Psoriatic Arthritis
-
Abstract Number: 1388
Pain Mechanisms in Psoriatic Arthritis: Differentiating Inflammation Related Pain in Enthesitis Using Ultrasound, in Comparison to Functional MRI
-
Abstract Number: 1389
Low Spinal Radiographic Progression After a Mean of 15 Years of Follow-up in a Cohort of Patients with Axial Spondyloarthritis
-
Abstract Number: 1390
Prediction of Low Disease Activity in Patients with Ankylosing Spondylitis Treated with Secukinumab in Real World – Data from a German Observational Study
-
Abstract Number: 1391
Rates of Remission in Patients with Axial Spondyloarthritis Treated in Tertiary Care
-
Abstract Number: 1392
Improving the Diagnostic Accuracy in Axial Spondyloarthritis: Interim Results of a Nationwide Telemedicine Project
-
Abstract Number: 1393
Fully Automated Detection of Active Sacroiliitis in Patients with Axial Spondyloarthritis: A Machine Learning-Based Analysis Magnetic Resonance Image
-
Abstract Number: 1394
Comorbidities, Not Long-Term Use of Nonsteroidal Anti-Inflammatory Drugs, May Be Associated with Chronic Kidney Disease in Patients with Ankylosing Spondylitis: A Nationwide Population-Based Study
-
Abstract Number: 1395
Aerobic Capacity and Its Relation to Disease Characteristics and Lifestyle Habits in Patients with Axial Spondyloarthritis
-
Abstract Number: 1396
Comprehensive Evaluation of the Digital Annular Pulleys: From Ultrasonographical to Anatomical and Histological Evaluation with Special Focus on the Entheses
-
Abstract Number: 1397
Sustainability of Clinical Response at Week 52 to Upadacitinib Among Patients with Axial SpA: Data from the SELECT-AXIS 1 and SELECT-AXIS 2 Trials
-
Abstract Number: 1398
A Deep Learning Algorithm for MRI Spinal Inflammation in Axial Spondyloarthritis
-
Abstract Number: 1399
Trends in Proportionate Cardiovascular Mortality in Patients with Ankylosing Spondylitis in the Era of Biologic Therapies: Analysis of US Death Certificate Data
-
Abstract Number: 1400
Achieving ASDAS Inactive Disease Status in Axial Spondyloarthritis: A Systematic Review and Meta-analysis
-
Abstract Number: 1401
The Association of 3VAS/4VAS and DAPSA with Radiographic Progression in Early PsA
-
Abstract Number: 1402
Exceeding Activity Targets but Missing the Mark with Sleep: Mapping 24-Hour Movement Guidelines in Axial Spondyloarthritis
-
Abstract Number: 1403
MRI-defined Sacroiliitis in First Degree Relatives of Ankylosing Spondylitis Patients
-
Abstract Number: 1404
Factor H-related protein-5 Exacerbates Pathological Bone Formation of Ankylosing Spondylitis
-
Abstract Number: 1405
Diagnostic Delay of Axial Spondyloarthritis in African American Patients
-
Abstract Number: 1406
Temporal Trends in Cardiovascular Events in Axial Spondyloarthritis Patients with Medicare Insurance versus Commercial Insurance: An Analysis Using Claims Data
-
Abstract Number: 1407
Defining Thresholds of Presenteeism Measures for Unacceptable Work Participation in axSpA
-
Abstract Number: 1408
Impact of Disease Activity on Functional Impairment in Patients with Spondyloarthritis Is Different According to the Degree of Radiographic Progression: Result from SNUH-AS Cohort
-
Abstract Number: 1409
Analysis of Soluble Biomarkers in Axial Spondyloarthritis
-
Abstract Number: 1410
The Use of the ASAS Referral Criteria Together with Increased Education and Training of Its Use Improves Delay to Diagnosis of Axial Spondyloarthritis
-
Abstract Number: 1411
Prevalence of Early Axial Spondyloarthritis in the Be-GIANT Cohort Based on the ASAS Consensus Definition of Early Axial Spondyloarthritis
-
Abstract Number: 1413
Effect of Apremilast Treatment on the Domains of MDA-Joints in Patients with Early Oligoarticular Psoriatic Arthritis: 16-Week Results from FOREMOST
-
Abstract Number: 1414
Effects of Apremilast on Changes in Cardiometabolic Parameters by Diabetes and Obesity Status in Patients with Psoriatic Arthritis
-
Abstract Number: 1415
Bimekizumab Treatment Impact on Work Productivity in Biologic DMARD‑Naïve and TNFi-IR Patients with Active Psoriatic Arthritis: Results up to 1 Year from Two Phase 3 Studies
-
Abstract Number: 1416
Improvement of Work Absenteeism Following Start of Methotrexate Monotherapy in Newly-Diagnosed Psoriatic Arthritis
-
Abstract Number: 1417
Do Long-term Patient-reported Outcomes Improve Similarly in Psoriatic Arthritis and Axial Spondyloarthritis Patients Treated with Secukinumab? Results from the EuroSpA Collaboration
-
Abstract Number: 1418
Efficacy of the Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, Deucravacitinib, on Psoriasis in Patients with Active PsA: Results from a Phase 2 Trial
-
Abstract Number: 1419
Impact of Psoriatic Arthritis Manifestations on Perception of Pain Improvement: Pooled Analysis of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies with Guselkumab
-
Abstract Number: 1420
Changes in Serum Cytokines and Collagen Proteins Correlate with Durability of Guselkumab Efficacy and Continued Disease Improvement Through 2 Years in Patients with Active Psoriatic Arthritis
-
Abstract Number: 1421
Domains Impacting Minimal Disease Activity Non-Achievement in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors Receiving Guselkumab (COSMOS)
-
Abstract Number: 1422
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: Integrated Analysis of Psoriasis and Psoriatic Arthritis Clinical Trial Data
-
Abstract Number: 1423
Impact of Upadacitinib on Enthesitis and Dactylitis by Location in Patients with Psoriatic Arthritis and an Inadequate Response to Biologic DMARDs from the SELECT-PsA 2 Trial
-
Abstract Number: 1426
Distinct Treatment Response Trajectories in Patients with Psoriatic Arthritis Receiving Tofacitinib
-
Abstract Number: 1430
A Proof-of-concept Study Evaluating the Use of Functional Brain Magnetic Resonance Imaging in Assessing Treatment Response in Psoriatic Arthritis Patients
-
Abstract Number: 1431
Izokibep, a Unique IL-17A Inhibitor, Improves Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis up to Week 46 – Phase 2 RCT Results
-
Abstract Number: 1432
Experiences and Perspectives of Patients with Psoriatic Arthritis Participating in a Randomized Controlled Trial of Dietary Interventions
-
Abstract Number: 1433
Bimekizumab Impact on Core Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Domains for Patients with Psoriatic Arthritis: 52-Week Results from Four Phase 3 Studies
-
Abstract Number: 1434
Long-Term Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 148-Week Results from the KEEPsAKE 2 Trial
-
Abstract Number: 1435
Long-Term Efficacy and Safety of Risankizumab for CsDMARD-IR Patients with Active Psoriatic Arthritis: 148-Week Results from the KEEPsAKE 1 Trial
-
Abstract Number: 1436
Secukinumab Demonstrates a Consistent Safety Profile in Patients with Psoriasis, Psoriatic Arthritis and Axial Spondyloarthritis: Updated Pooled Safety Analysis from Clinical Trials
-
Abstract Number: 1438
Efficacy of Guselkumab in Early-Onset and Late-Onset Psoriatic Arthritis: Post Hoc Pooled Analyses of Two Phase 3 Randomized Controlled Trials in Patients with Active PsA
-
Abstract Number: 1440
Removal of Methotrexate in Patients with Active Psoriatic Arthritis with Newly Induced Ustekinumab Treatment Leads to a Delayed Response in DAPSA and DAS28 Within the First 16 Weeks
-
Abstract Number: 1441
Bimekizumab Maintenance of Response and Safety in Patients with Moderate to Severe Plaque Psoriasis: Results from the Open-label Extension Period (Weeks 48–144) of the BE RADIANT Phase 3b Trial
-
Abstract Number: 1442
Incident Vascular Events in Danish Nationwide Cohort of Patients with Newly Diagnosed Systemic Lupus Erythematosus
-
Abstract Number: 1443
Vasculitis Associations Among Patients with Systemic Lupus Erythematous
-
Abstract Number: 1444
Identifying Determinants of Favourable and Poor Physical Function in Systemic Lupus Erythematosus: Results from an International Collaborative Study
-
Abstract Number: 1445
SLESIS-R: An Improved Score for Prediction of Serious Infection in Patients with Systemic Lupus Erythematosus Based on the RELESSER Prospective Cohort
-
Abstract Number: 1446
Glucocorticoids Use Is a Major Driver of Self-perceived Depression in Systemic Lupus Erythematosus: Insights from a Large, Prospective and Multicenter Study Using RELESSERPROS Register’s Database
-
Abstract Number: 1447
Increased Left Ventricular Mass Index in Systemic Lupus Erythematosus Patients with Lupus Nephritis Compared to Those Without Nephritis
-
Abstract Number: 1448
Association of Disease Activity and Anti-Double Stranded DNA Antibodies Titers with Echocardiographic Parameters in Systemic Lupus Erythematosus Patients
-
Abstract Number: 1449
Evaluation of Progression from Preclinical to Systemic Autoimmune Rheumatic Disease
-
Abstract Number: 1452
Inflammatory Markers and Left Ventricular Dysfunction in Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 1453
Musculoskeletal Involvement in Systemic Lupus Erythematosus: Insights from a Survey of Lupus Experts
-
Abstract Number: 1454
Neuropsychiatric Systemic Lupus Erythematosus in Children: A Scoping Review
-
Abstract Number: 1455
Risk Factors of Cytomegalovirus Reactivation and Disease in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1456
Systematic Review of Effects of Systemic Lupus Erythematosus on Brain Structure and Structural Connectivity and Its Relationship with Cognitive Dysfunction Through an Advanced Neuroimaging Lens
-
Abstract Number: 1457
Obesity Is an Independent Poor Prognostic Factor in Lupus Nephritis
-
Abstract Number: 1458
Activated Naïve DNA-Reactive B Cells in Lupus Nephritis Patients Are Increased and Associated with Disease Activity
-
Abstract Number: 1459
Unveiling the Impact of Neuropsychiatric Involvement in Systemic Lupus Erythematosus on Damage Accrual
-
Abstract Number: 1460
Impact of Neuropsychiatric Involvement on Health-related Quality of Life in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1461
Association of Serum Analytes with SLE Cognitive Impairment Phenotypes Formed by Machine Learning: MMP-9, S100A8/A9, IL-6, IL-10, and NGAL
-
Abstract Number: 1463
Predictors of Cognitive Impairment in Individuals with Systemic Lupus Erythematosus
-
Abstract Number: 1464
Lupus Flares More Common in Patients on Dialysis Compared to After Renal Transplant: A Systematic Review and Meta-analysis
-
Abstract Number: 1465
Blood-dominant Disease in Older-onset Lupus: A Systematic Review and Meta-analysis
-
Abstract Number: 1466
Impact of Co-morbid Depression on Systemic Lupus Erythematosus Hospitalizations: Insights from National Readmission Database 2020
-
Abstract Number: 1467
Antiphospholipid Antibodies and the Risk of Diffuse Alveolar Hemorrhage in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
-
Abstract Number: 1468
Prediction of Cardiovascular Disease in Patients with Systemic Lupus Erythematosus Using a Machine Learning Algorithm for Time-to-Event Outcomes: Random Survival Forest
-
Abstract Number: 1469
Prevalence of Cardiovascular Disease in a Populations Based Registry of Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1470
SARS-CoV-2 Antibody Formation After COVID-19 Vaccination in SLE Patients Treated with Belimumab: Single-Center Prospective Observational Study
-
Abstract Number: 1471
A Comparative Study of Lupus Nephritis Class II and IgA Nephropathy: Renal Disease Other Than Lupus Nephritis in Systemic Lupus Erythematosus Patients
-
Abstract Number: 1472
Prevalence of Hepatic Injury in Patients with Systemic Lupus Erythematosus: A 28-Year Single Center Experience
-
Abstract Number: 1473
Mortality from Diseases of the Nervous System in Patients with Lupus in the past Two Decades
-
Abstract Number: 1474
Associations and Outcomes of Critical Peripheral Ischemia in Systemic Lupus Erythematosus (SLE): Data from Indian SLE Inception Cohort for Research (INSPIRE)
-
Abstract Number: 1475
Retrospective Study of Obesity on Clinical and Immunological Features in Systemic Lupus Erythematosus Using AI Software Deep 6 and EPIC Slicer Dicer
-
Abstract Number: 1476
Discriminating Disease Flare from Infection in Febrile Patients with Systemic Lupus Erythematosus Admitted to a Safety-Net Hospital System: A Retrospective, Multicenter Study
-
Abstract Number: 1477
Clinical and Economic Burden of Herpes Zoster in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study
-
Abstract Number: 1478
Presentation and Outcomes of Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus: A Multicenter Cohort and a Systematic Literature Review
-
Abstract Number: 1479
Risk Factors for Human Papillomavirus Cervical Infection and Clearance in Patients with Systemic Lupus Erythematosus: The PAPILUP Study
-
Abstract Number: 1480
Demographic and Clinical Characteristics of Patients with LN: A Multicenter Study from the Gulf Region
-
Abstract Number: 1481
Racial Disparities in Lupus Nephritis: A Nationwide Analysis
-
Abstract Number: 1482
Change in the SLE Mortality Rate and Prevalence of Lupus Nephritis Overtime: Single Center Retrospective Study in Japan
-
Abstract Number: 1484
Ruminococcus Implicated in the Clinical Development of Lupus Nephritis: A Systematic Review of the Literature
-
Abstract Number: 1485
Risk of Diabetes Mellitus in Systemic Lupus Erythematosus: Systematic Review and Meta-analysis
-
Abstract Number: 1486
Clinical Outcomes in Patients Admitted for ST-Elevation Myocardial Infarction with vs Without Systemic Lupus Erythematosus: An Analysis from National Inpatient Sample Database (2015-2018)
-
Abstract Number: 1487
Prevalence of Objectively Measured Sleep Disturbance in Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 1488
Association of Glucocorticoid Use with Patient-Reported Outcomes Among Persons with Systemic Lupus Erythematosus
-
Abstract Number: 1489
Treatment with Upadacitinib in Patients with Systemic Lupus Erythematosus Results in the Inhibition of B-Cell–related Biomarkers: Analysis of the M19-130 (SLEek) Phase 2 Study
-
Abstract Number: 1490
Early Experience with SGLT2i in Systemic Lupus Erythematosus
-
Abstract Number: 1491
Targeting the Mevalonate Pathway-dependent Protein Geranylgeranylation to Restrict Follicular Helper T Cell Differentiation for the Treatment of Systemic Lupus Erythematosus
-
Abstract Number: 1492
Pre-treatment Differentially Expressed Metagenes Characterize Systemic Lupus Patients Who Subsequently Achieve Clinical Response to Belimumab
-
Abstract Number: 1494
The Effect of Belimumab on Steroid Use in Patients with SLE: Results from a Retrospective Observational Study of Real-World Data from a US Rheumatology Provider Network
-
Abstract Number: 1495
Deep Serological Profiling of SLE Patients Treated with anti-CD19 CAR T Cells
-
Abstract Number: 1496
Clinical Safety and Efficacy Results from EQUALISE Type B: A Phase 1b Open-label Clinical Study of Itolizumab, a Novel anti-CD6 Therapy, in Subjects with Active Proliferative Lupus Nephritis
-
Abstract Number: 1497
Eltrombopag in SLE-Associated Thrombocytopenia: Treatment Response and Thrombotic Complications
-
Abstract Number: 1498
First-in-Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of DS-7011a, an Anti-TLR7 Antagonistic Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
-
Abstract Number: 1500
Cumulative Infections by Week 52 Among Patients with SLE: A Summary of Data from Placebo-Controlled Belimumab Studies
-
Abstract Number: 1501
Lupus Low Disease Activity State (LLDAS) Achievement with Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial in SLE
-
Abstract Number: 1502
Introduction of Belimumab Within Five Years of the Onset of Systemic Lupus Erythematosus (SLE) Contributes to the Better Therapeutic Response; A Multi-center Retrospective Cohort Study
-
Abstract Number: 1503
Disease Course and Complement as Predictors of Response to Standard of Care Plus Placebo in Patients with SLE: A Post Hoc Analysis of Dapirolizumab Pegol and Epratuzumab Clinical Trial Data
-
Abstract Number: 1504
Characteristics and Prior Treatment Journey of Systemic Lupus Erythematosus (SLE) Patients Who Were Prescribed Anifrolumab — Observations from the American Rheumatology Network (ARN) in the U.S
-
Abstract Number: 1505
Long-term Safety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis: Results from the AURORA 1 and AURORA 2 Studies
-
Abstract Number: 1506
Prescribing Patterns in Lupus Nephritis: Analyzing Time from Proteinuria to Prescription of ACE/ARB
-
Abstract Number: 1507
Pharmacodynamic Changes in SLE Relevant Gene Expression Induced by Deucravacitinib in Patients Enrolled in the Phase 2 PAISLEY Trial
-
Abstract Number: 1508
Predicting in Virtual Patients the Efficacy of an Anti IFNa Mab in Cutaneous Lupus Erythematosus
-
Abstract Number: 1509
Calcineurin Inhibitors for Treatment of Lupus Nephritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
-
Abstract Number: 1510
Efficacy of Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in Women with Systemic Lupus Erythematosus (SLE) Receiving Cyclophosphamide (CYC)
-
Abstract Number: 1511
B-Cell Recovery in a Randomized Controlled Trial of B-Cell Depletion with Obinutuzumab for the Treatment of Proliferative Lupus Nephritis
-
Abstract Number: 1512
Rituximab Objective Outcome Measures Trial in SLE (ROOTS): Randomised and Rescue Therapy Outcomes from a Randomised Controlled Trial
-
Abstract Number: 1513
Trends in Systemic Sclerosis- related Mortality by Age, Sex and Race in the United States, 1999-2019
-
Abstract Number: 1514
Phase I Study to Evaluate the Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for Interstitial Lung Disease in Patients with Connective Tissue Disorders
-
Abstract Number: 1515
Performance of the Revised CRISS in a Phase 3 Trial of Early Systemic Sclerosis
-
Abstract Number: 1516
Systemic Sclerosis Gastrointestinal Tract Vascular Biomarkers of Symptomatic Disease Activity
-
Abstract Number: 1517
Comparing Deep Neural Network to Modified Rodnan Skin Score in a Trial for Belumosudil in Systemic Sclerosis Patients
-
Abstract Number: 1518
Efficacy and Safety of Prostaglandins Analogues in Systemic Sclerosis-associated Raynaud’s Phenomenon. a Systematic Review and Meta-Analysis
-
Abstract Number: 1519
Renal Complications Following Autologous Stem Cell Transplantation for Systemic Sclerosis
-
Abstract Number: 1520
Identifying Core Domains for Clinical Trials in Systemic Sclerosis-Associated Raynaud’s Phenomenon and Digital Ulcers Using the Delphi Consensus Method
-
Abstract Number: 1521
Microvascular Remodeling After Autologous Stem Cell Transplant for Systemic Sclerosis
-
Abstract Number: 1522
Treatment of Pulmonary Arterial Hypertension in Patients with Connective Tissue Diseases: A Meta-analysis
-
Abstract Number: 1523
The Risk of Scleroderma Renal Crisis from Intraarticular Corticosteroid Injection in Systemic Sclerosis
-
Abstract Number: 1524
The Effectiveness of Nintedanib in Treating Fibrosing Interstitial Lung Disease in Both Scleroderma and Non-scleroderma Patients: A Systematic Review and Meta-analysis
-
Abstract Number: 1525
Chelation Therapy in the Management of Calcinosis Associated with Systemic Sclerosis
-
Abstract Number: 1526
Evusheld Efficacy and Safety in Autoimmune Rheumatic Diseases (AIRD) Treated by B Cell Depeting Therapy or Autologous Stem Cell Transplantation: A Prospective Observational Study
-
Abstract Number: 1527
Acute Effects of Intravenous Iloprost on Finger Power Doppler Ultrasound in Scleroderma Patients
-
Abstract Number: 1528
Intravenous or Subcutaneous Immunoglobulins as Potential Treatment for Gastrointestinal, Cutaneous and Vascular Involvement in Systemic Sclerosis: Data from an Italian Cohort of 65 Patients
-
Abstract Number: 1529
Mycophenolate Mofetil Use in Clinical Practice: Persistence on Therapy and Long-term Adverse Events in a Multicentric Cohort of Scleroderma Patients
-
Abstract Number: 1530
Outcomes in Patients with Systemic Sclerosis Following Lung Transplantation: An Italian Multicentre Experience
-
Abstract Number: 1531
A Retrospective Analysis of the Efficacy of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD): A TriNetX Database Study
-
Abstract Number: 1532
Safety and Microvascular Effects of Long-term Treatment with Aminaphtone in Systemic Sclerosis Patients: A Retrospective Analysis
-
Abstract Number: 1533
Long-term Use of Rituximab in Systemic Sclerosis: A Real-life Italian Multicentre Study
-
Abstract Number: 1534
ANCA-associated Vasculitis Incidence in a Norther Spanish Health Region
-
Abstract Number: 1535
Epidemiology and Treatment Outcome of ANCA-associated Vasculitis in South Korea: A Nationwide, Population-based Cohort Study
-
Abstract Number: 1536
The Impact of COVID-19 Vaccination on ANCA Vasculitis Hospitalisations: A Perspective from Sydney Australia
-
Abstract Number: 1537
Long-term Observational Study of Interstitial Lung Disease in ANCA-associated Vasculitis
-
Abstract Number: 1538
Large Vessel Involvement in Antineutrophil Cytoplasmic Antibody- Associated Vasculitis: A Single Center Experience over Two Decades
-
Abstract Number: 1539
Digital Ischemia, a Rare Manifestation in Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV)
-
Abstract Number: 1542
The Burden of Multimorbidity in ANCA-Associated Vasculitis: A Cohort Study
-
Abstract Number: 1543
The Association of Frailty with Outcomes in Patients with Vasculitis
-
Abstract Number: 1544
Increased Risk of Severe Infection in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitides: A Population-based Trend Analysis
-
Abstract Number: 1545
Validation of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria in Patients with ANCA-associated Vasculitis
-
Abstract Number: 1546
Eosinophilic Granulomatosis with Polyangiitis: Clinical Suspicion Red Flags Identification by a Systematic Literature Review and Multidisciplinary Expert Consensus
-
Abstract Number: 1547
Disease Burden of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
-
Abstract Number: 1548
Diagnosis Pathways in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
-
Abstract Number: 1549
Treatment Patterns for Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Retrospective Analysis of US Health Insurance Claims Data
-
Abstract Number: 1550
Importance of Shared Decision-Making for Patients with ANCA-Associated Vasculitis
-
Abstract Number: 1551
Measurement of Sinonasal Disease Activity in Granulomatosis with Polyangiitis
-
Abstract Number: 1552
Epidemiology and Outcome of Eosinophilic Granulomatosis with Polyangiitis in France
-
Abstract Number: 1553
Central Nervous System Involvement and Mimickers in ANCA Associated Vasculitis
-
Abstract Number: 1554
Therapeutic Approaches and Predictive Factors of Relapse in Severe Ocular Involvement in Behçet’s Disease: A Multicentre Retrospective Study
-
Abstract Number: 1555
Axial Spondyloarthritis in Patients with Gastrointestinal Involvement of Behçet Syndrome
-
Abstract Number: 1556
Abdominal Surgical Interventions Among Patients with Gastrointestinal Involvement of Behçet Syndrome
-
Abstract Number: 1557
De Novo Manifestations During Adalimumab Treatment in Behçet Syndrome
-
Abstract Number: 1558
Development of Posterior Uveitis in Behçet’s Syndrome Patients with Vitreous Cells Without Any Other Posterior Involvement
-
Abstract Number: 1559
Comparison of Treatment with Adalimumab, Infliximab and Certolizumab in Refractory Cystoid Macular Edema Due to Behçet Disease
-
Abstract Number: 1560
Decreased Level of Peripheral CLA+ Treg Is a Protective Factor of Nervous System Involvement in Behcet’s Syndrome: A Real-World Study in China
-
Abstract Number: 1561
Clinical Features and Quality of Life of Japanese Bechet’s Disease Patients with Arthritis: A Japanese Monocentric Study
-
Abstract Number: 1562
Behcet’s Disease Coagulopathy in a Racially Diverse Patient Population
-
Abstract Number: 1563
Methotrexate: A Safe and Effective Therapeutic Alternative in Behçet´s Disease
-
Abstract Number: 1564
Common Femoral Vein Wall Thickness Measurement as a Diagnostic Test in Suspected Behçet’s Disease
-
Abstract Number: 1565
Baseline Vascular Ultrasound of Polymyalgia Rheumatica Patients at Time of Diagnosis Predicts Clinical Outcomes at 3 Months
-
Abstract Number: 1566
Exposure-Response Analysis of Sarilumab in Patients with Polymyalgia Rheumatica
-
Abstract Number: 1567
Assessment of the Extent and Accrual of Damage in Takayasu’s Arteritis
-
Abstract Number: 1568
Comparison of Methotrexate and Azathioprine as the First Steroid-Sparing Immunosuppressive Agent in Patients with Takayasu’s Arteritis
-
Abstract Number: 1569
Efficacy and Safety of Tofacitinib and Tocilizumab in 84 Patients with Takayasu Arteritis: Single-Center Post-Hoc Analysis of a Prospective Study
-
Abstract Number: 1570
Prognostic Assessment of the 2022 ACR/EULAR Classification Criteria for Takayasu Arteritis: A Multi-centre International Study
-
Abstract Number: 1571
Tocilizumab in Pregnant Takayasu Arteritis – The Use of Tocilizumab at Conception and Throughout Pregnancy in Those with Takayasu Arteritis
-
Abstract Number: 1572
Long-term Efficacy and Retention Rate of Molecular Targeted Drugs in Takayasu Arteritis
-
Abstract Number: 1573
Inpatient Prevalence and Comorbidity of Takayasu’s Arteritis: Nationwide Inpatient Sample 2016-2020
-
Abstract Number: 1574
The Role of 18F-FDG PET/CT Scans in Takayasu Arteritis
-
Abstract Number: 1575
Takayasu Arteritis Is Associated with Worse Fatigue Than Healthy Controls Which Persists over Time – A Longitudinal Cohort Study
-
Abstract Number: 1576
Application of the 2022 ACR/EULAR Criteria for Takayasu Arteritis to Previously Diagnosed Patients Based on the 1990 ACR Criteria
-
Abstract Number: 1577
Analysis of Takayasu’s Arteritis as Risk Factor for Acute Coronary Syndrome
-
Abstract Number: 1578
Impact of Anxiety or Depression Status and Fibromyalgia on Adherence to Treatment of Patients with Takayasu Arteritis
-
Abstract Number: 1579
Sodium-Glucose Co-transporter-2 Inhibitors and the Risk of Cardiac and Renal Outcomes in Systemic Lupus Erythematosus
-
Abstract Number: 1580
CXCL13+ T Cell Differentiation in Systemic Lupus Erythematosus Is Controlled by Opposing Effects of Aryl Hydrocarbon Receptor and Type I Interferon
-
Abstract Number: 1581
Microbiome Transplantation Prevents Osteoarthritis in Mice and Is Associated with Immunophenotype Changes
-
Abstract Number: 1582
Non-TNFi b/tsDMARDs vs. TNFi in Rheumatoid Arthritis-Interstitial Lung Disease: An Active-Comparator, New-User, Propensity Score Matched Study Using National Veterans Affairs Data
-
Abstract Number: 1584
Effect of Trimethoprim Sulfamethoxazole Prophylaxis on Infections During Treatment of Granulomatosis with Polyangiitis with Rituximab: A Population-Based Study
-
Abstract Number: 1585
Defining Neutrophil-Mediated Renal Damage Triggered by Ultraviolet (UV) Skin Exposure
-
Abstract Number: 1586
Keratinocyte VISTA Suppresses Skin IFN-I Production by Regulating DNA Damage Repair and Cytosolic DNA Sensing
-
Abstract Number: 1587
Mitochondrial Z-DNA and ZBP1 Drive Autoimmune Photosensitivity
-
Abstract Number: 1588
Monocyte-derived Macrophages Accumulate in the Lungs in anti-MDA5+ Dermatomyositis with RP-ILD: Proinflammatory and Profibrotic Phenotype Revealed by Single-cell RNA Sequencing
-
Abstract Number: 1589
Epigenetic Regulation of DNMT3A by TFEB and DOT1L Through AMPK Signalling Orchestrates the Lysosomal Response of Macrophages During Gout and Clonal Hematopoiesis
-
Abstract Number: 1590
Autoimmune Pathway Blockade by a Potent Orally Bioavailable STING Antagonist
-
Abstract Number: 1591
Complement Factor D/Adipsin Knockout Mice Demonstrate Disparate Pain and Structural Damage Phenotypes in Obesity-induced Post Traumatic Osteoarthritis
-
Abstract Number: 1592
Memantine Attenuates the Development of Osteoarthritis by Blocking NMDA Receptor Mediated Calcium Overload and Chondrocyte Senescence
-
Abstract Number: 1593
Combining Single-cell RNA Sequencing and Population-based Studies Reveals Hand Osteoarthritis-associated Chondrocyte Subpopulations and Pathways
-
Abstract Number: 1594
Oral Delivery of Δ9-Tetrahydrocannabinol Provides Symptom and Disease Modification in a Mouse Model of Knee Osteoarthritis
-
Abstract Number: 1595
Pharmacological Modulation of Krüppel-like Factor 4 Reduces the Severity of Experimental Osteoarthritis via Tissue Protection and Regeneration
-
Abstract Number: 1596
A Cell and Transcriptomic Atlas of the Infrapatellar Fat Pad from Patients with Knee Osteoarthritis: Identification of an Obesity-Associated Transcriptomic Signature
-
Abstract Number: 1597
Staphylococcus Aureus Peptidoglycan Induces Pathogenic Autoantibody Production via Autoreactive B Cell Receptor Clonal Selection, Implications in Systemic Lupus Erythematosus
-
Abstract Number: 1598
Single-cell Spatial Proteomics Identifies Intraglomerular Myeloid Cells in Membranous Lupus Nephritis
-
Abstract Number: 1599
Single-Cell RNA Sequencing Reveals Cellular Drivers of UV-mediated Skin Injury in Cutaneous Lupus
-
Abstract Number: 1600
Transcriptomic Characterization of Class II Lupus Nephritis and Outcomes
-
Abstract Number: 1601
Interleukin-6 Disrupts Blood-cerebrospinal Fluid Barrier Permeability in Murine Neuropsychiatric Lupus
-
Abstract Number: 1602
NADPH Oxidase Exerts a B Cell-intrinsic Contribution to Lupus Risk by Modulating Endosomal Toll-like Receptor (TLR) Signals
-
Abstract Number: 1603
Infection-Associated Antiphospholipid Antibodies and Their Potential Role in Sepsis Outcomes
-
Abstract Number: 1606
Purinergic Signaling as a Potential Therapeutic Target for APS Thromboinflammation
-
Abstract Number: 1607
Autoantibodies to Transcription Factor a Mitochondria Link Mitochondrial Damage and Thrombosis in Systemic Lupus Erythematosus
-
Abstract Number: 1609
Associations Between SARS-Cov-2 Infection and Neuropathic Pain in Fibromyalgia Patients: A Cohort Study
-
Abstract Number: 1610
Digital Acceptance and Commitment Therapy Improves Fibromyalgia Outcomes: Results from a Pivotal, Multi-center, Randomized Controlled Trial
-
Abstract Number: 1611
Mitochondrial Structural Alterations in Fibromyalgia – A Pilot Electron Microscopy Study
-
Abstract Number: 1612
Design and Validation of a Comparator for Randomized Controlled Trials of a Digital Cognitive Behavioral Therapy
-
Abstract Number: 1613
Tetrodotoxin Sensitive Nav1.7 Sodium Channel SCN9A Gene Polymorphism rs6754031(T >G) Is Associated with Fibromyalgia
-
Abstract Number: 1614
Therapy Combining Millimeter Wave-based Neuromodulation with Coaching for the Improvement in Quality of Life of Patients with Fibromyalgia: A Prospective, Multicenter, Randomized, Controlled Trial
-
Abstract Number: 1615
Therapeutic Hydroxychloroquine Blood Levels Are Cost Effective and May Reduce Health Disparities by Reducing Lupus Hospitalizations
-
Abstract Number: 1616
Geographic and Demographic Representation in Industry-sponsored, US-based Clinical Trials of Systemic Lupus Erythematosus Therapies
-
Abstract Number: 1617
Comparing Uptake of Biosimilar Infliximab Among Patients with Medicare, Medicaid and Private Insurance in U.S. Rheumatology Practices 2016-2022
-
Abstract Number: 1618
Intervention to Improve Medication Adherence Among Patients with SLE
-
Abstract Number: 1619
Receipt of Antimicrobial Prophylaxis in U.S. Medicare Beneficiaries Initiating Immunosuppressive Medications for ANCA Vasculitis
-
Abstract Number: 1620
Cardiovascular Risk and Fracture Risk Among Women Initiating Treatment with Romosozumab or Denosumab
-
Abstract Number: 1621
Maxillofacial MRI Augments Detection of Non-CNS Abnormalities in Pediatric Craniofacial Scleroderma
-
Abstract Number: 1622
Myositis-associated Autoantibodies in Juvenile Myositis Are Associated with Severe Disease Features and Mortality
-
Abstract Number: 1624
Racial Disparities Impact Achieving LLDAS and Glucocorticoid Use in Pediatric Lupus: A CARRA Registry Study
-
Abstract Number: 1625
Identifying Potential Neuroimaging Biomarkers of Neuropsychiatric Lupus in Children Using Deep Learning
-
Abstract Number: 1626
Clinical Presentation, Disease Course and 12-month Outcomes in Childhood Polyarteritis Nodosa: A PedVas Study
-
Abstract Number: 1627
Methotrexate Use Associates with Ischemic Cardiovascular Risk Reduction in Males but Not Females with Rheumatoid Arthritis
-
Abstract Number: 1628
The Impact of Cardiovascular and Cerebrovascular Disease on the Risk of Dementia in Rheumatoid Arthritis. a Mediation Analysis
-
Abstract Number: 1629
Persons with Rheumatoid Arthritis and Long COVID Had Worse Pre-COVID RA Symptoms and Worse Non-RA Symptoms, as Well as Higher Rates of Fibromyalgia Compared with COVID Infected Long COVID Negative
-
Abstract Number: 1630
Patient-Reported Fatigue Associated with Joint Histopathology in Rheumatoid Arthritis
-
Abstract Number: 1631
Comparison of Peripheral Biomarker Profiles Across Unique Multimorbidity Patterns in Rheumatoid Arthritis
-
Abstract Number: 1632
Incident Malignancies in Patients with Rheumatoid Arthritis in Daily Rheumatological Care
-
Abstract Number: 1633
Dose Dependent Modulation of a B Cell Protein Signature by Ianalumab in Patients with Sjögren’s Disease
-
Abstract Number: 1634
Iscalimab (CFZ533) in Patients with Sjögren’s Disease: Week 24 Efficacy and Safety Results of a Randomized, Placebo-controlled, Phase 2b Dose-ranging Study
-
Abstract Number: 1635
Deep Learning Accurately Predicts Focus Score and Diagnosis of Primary Sjögren Syndrome Using Labial Salivary Gland Biopsies
-
Abstract Number: 1637
IgG-Fc-N-Sialylation and -Galactosylation in Primary Sjögren’s Syndrome (Pss) in Its Potential as Marker of Disease State and Disease Activity
-
Abstract Number: 1638
CD40L Inhibition with Dazodalibep Rapidly Reduces Blood Biomarkers of T and B Cell Costimulation in Subjects with Sjögren’s Having High Disease Activity or High Symptom Burden
-
Abstract Number: 1639
PsA Patients of Diverse Ethnic and Racial Backgrounds Experience More Skin Psoriasis, Increased Pain, and Higher Rates of Radiographic Axial Disease
-
Abstract Number: 1640
Psoriatic Disease Associated with Neuroconnectivity Alterations in the Default Mode Network
-
Abstract Number: 1641
The Window of Opportunity in Psoriatic Arthritis: Similar to Rheumatoid Arthritis?
-
Abstract Number: 1642
Identifying Distinct Phenotypes in Psoriatic Arthritis: A Study from the Psoriatic Arthritis Research Consortium (PARC) Cohort
-
Abstract Number: 1643
Exploring the Serum Metabolome for Potential Diagnostic Markers of Psoriatic Arthritis
-
Abstract Number: 1644
The EISER Study: Identifying Microbial Factors Associated with Subclinical Gut Inflammation in Spondyloarthritis Patients
-
Abstract Number: 1645
Aortic Dilatation and PET/CT Vascular Activity at Diagnosis and 5 Years in an Inception Giant Cell Arteritis (GCA) Cohort
-
Abstract Number: 1646
The Real-World Experience of Combined Cranial and Large Vessel FDG-PET/CT in the Investigation of Giant Cell Arteritis
-
Abstract Number: 1647
Association Between Vascular FDG Uptake at Diagnosis and Evolution in Aortic Dimensions in Giant Cell Arteritis: A Prospective Study
-
Abstract Number: 1648
EULAR Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice: 2023 Update
-
Abstract Number: 1649
Follow-up Ultrasound Examination in Patients with Newly Diagnosed Giant Cell Arteritis
-
Abstract Number: 1650
Optic Nerve Sheath Measurement as a Disease Activity Biomarker in Giant Cell Arteritis
-
Abstract Number: 1651
Beneficial Effect of Temporary Methotrexate Interruption on B and T Cell Responses upon SARSCoV-2 Vaccination in Patients with Rheumatoid Arthritis or Psoriatic Arthritis
-
Abstract Number: 1652
Lupus Research Action Network: Increasing Minority Clinical Trial Participation Through Peer Leaders
-
Abstract Number: 1653
Up or Down: Does Direction of Stair Climbing Difficulty Matter for Incident Functional Limitation and Knee Replacement in Knee Osteoarthritis?
-
Abstract Number: 1654
A Peer Health Coached Resilience-Based Energy Management Program Was Effective in Improving Fatigue and Other Outcomes in People with Systemic Sclerosis: Results of a Randomized Controlled Trial
-
Abstract Number: 1655
Usability Testing of JIActiv, an Instagram-Based Program Promoting Engagement in Physical Activity Among Young People Living with Juvenile Idiopathic Arthritis
-
Abstract Number: 1656
Nothing About Us Without Us: Top 10 Research Priorities from Patients – A James Lind Alliance Project for Public and Patient Involvement (PPI)
-
Abstract Number: 1657
Mapping the Network of Coordinated Immune Dysregulation in Juvenile Dermatomyositis at Single-cell Resolution
-
Abstract Number: 1658
Title: Inflammatory Arthritis Across the Age-Spectrum: Single-Cell Profiling of the Inflamed Synovium in Children with Juvenile Idiopathic Arthritis
-
Abstract Number: 1659
Cellular Deconstruction of Stromal and Myeloid Cell Compartments in the Inflamed Synovium of Juvenile Idiopathic Arthritis
-
Abstract Number: 1660
Still’s Disease Patients with High Interferon-stimulated Gene Expression Have Enrichment of Rare, de Novo and Recessive Protein Altering Variants in Innate Immune Pathways
-
Abstract Number: 1661
Spatial Transcriptional Alterations in the Cellular Landscape of Pediatric Scleroderma Skin
-
Abstract Number: 1662
Chronic Excess IL-18 Induces NK Deficiency, but Drives Hyperinflammation via CD8 T-cell Cytokine Overproduction and Selective Immunodeficiency
-
Abstract Number: 1663
Clinically Severe Systemic Sclerosis Skin Harbors Inflammatory Fibroblasts Associated with Lymphocytes and Plasmacytoid Dendritic Cells
-
Abstract Number: 1664
Fibroblast Specific Interferon Regulatory Factor 7 (IRF7) Expression Is a Key Link Between Type I Interferon Activation and the Exaggerated Dermal and Pulmonary Fibrosis in Systemic Sclerosis
-
Abstract Number: 1665
Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis
-
Abstract Number: 1666
TNF-mediated Pulmonary Hypertension Is Marked by Aberrant Bone Morphogenic Protein (BMP) and Integrin/Basement Membrane Ligand-Receptor Signaling
-
Abstract Number: 1667
Characterization of the Vascular Niches in Systemic Sclerosis (SSc) as a Prototypical Immune-mediated Fibrotic Disease with Prominent Vasculopathy Using Imaging Mass Cytometry
-
Abstract Number: 1668
Cell Specific Molecular Profiling of Scleroderma Associated Interstitial Lung Disease Subtypes
-
Abstract Number: 1669
High Incidence of Immune-mediated Inflammatory Diseases in Sepsis Survivors: A Nationwide Exposed-non-exposed Epidemiological Study
-
Abstract Number: 1670
Exacerbation of Immune-mediated Inflammatory Diseases in COVID19 Sequelae
-
Abstract Number: 1671
Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology Practice
-
Abstract Number: 1672
Association of COVID-19 Vaccinations with Flares of Systemic Rheumatic Disease: A Case-Crossover Study
-
Abstract Number: 1673
Immunomodulatory Treatment and Autoimmune Patient Responses to COVID-19 Booster Shots: Results from the Covid-19 VaccinE Response in Rheumatology Patients (COVER) Study
-
Abstract Number: 1674
Severe Infections in Patients with VEXAS Syndrome: A Study from the French VEXAS Group
-
Abstract Number: 1675
Survival in Patients with Rheumatoid Arthritis and Early Breast Cancer Treated with Tumor Necrosis Factor Inhibitors
-
Abstract Number: 1678
Comparative Safety of Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for Cancer in Rheumatoid Arthritis
-
Abstract Number: 1679
Effects of Janus Kinase Inhibitor on TNF-a and IL-6-Induced Osteoclasts and RANKL-Induced Osteoclasts in Peripheral Blood Monocytes from Patients with Rheumatoid Arthritis
-
Abstract Number: 1680
What Trade-offs Are Acceptable to Rheumatoid Arthritis Patients During Treatment Selection?
-
Abstract Number: 1681
Tacrolimus Use in SLE Pregnancy and Its Effect on Pregnancy Outcomes: Retrospective Study in Two Japanese Tertiary Referral Centers
-
Abstract Number: 1682
Prospective Evaluation of Anti-SSA/Ro Pregnancies Supports the Utility of High Titer Antibodies and Fetal Home Monitoring for the Detection of Fetal Atrioventricular Block
-
Abstract Number: 1683
Moving the ACR’s Reproductive Health Guidelines into Practice: Assessment of a Novel Reproductive Rheumatology ECHO
-
Abstract Number: 1684
The Impact of Pregnancy Timing on Outcomes in SLE
-
Abstract Number: 1685
SLE Disease Activity Is a More Important Risk Factor Than Immunosuppression for Acquiring Human Papillomavirus (HPV) Infection in Systemic Lupus Erythematosus Patients
-
Abstract Number: 1686
Adolescent and Young Adult Rheumatology Patient Reports of Reproductive Health Screening and Counseling in the Clinical Setting
-
Abstract Number: 1687
Sex of the Patient Affects Response to Advanced Therapies in Psoriatic Arthritis: Meta-analysis of Data from Randomized Controlled Trials
-
Abstract Number: 1688
Izokibep Demonstrates Major Disease Control on ACR70, PASI100 and Enthesitis Resolution in Patients with Active Psoriatic Arthritis Treated Through 46 Weeks
-
Abstract Number: 1689
Deep Cellular Immune Profiling in Psoriatic Arthritis Correlates with Imaging Phenotypes and Response to Targeted Advanced Therapy
-
Abstract Number: 1690
Apremilast Reduces Inflammation as Measured by MRI of the Hand in Patients with Psoriatic Arthritis: Primary Results from the Phase 4 MOSAIC Study
-
Abstract Number: 1691
16-Week Results from FOREMOST, a Placebo-Controlled Study Involving Oligoarticular Psoriatic Arthritis Treated with Apremilast
-
Abstract Number: 1692
Insights on the Use of JAK-inhibitors in Patients with Psoriatic Arthritis in an International Collaboration of Registers (the “JAK-pot” Study)
-
Abstract Number: 1693
Blood Immunophenotyping Distinguishes Three Subgroups of Lupus Nephritis Patients with Distinct Kidney Infiltrates and Interferon Signatures
-
Abstract Number: 1694
Transcriptomic Analysis of the Impact of Iberdomide on Patients with SLE
-
Abstract Number: 1696
Multi-Omic Profiling Reveals Immune Cell Priming Signature Linked to Systemic Lupus Erythematosus Prognosis
-
Abstract Number: 1697
Molecular Characterisation of Remission and Lupus Low Disease Activity State (LLDAS) by Whole-Blood Transcriptome-Based Pathways in a Pan-European Systemic Lupus Erythematosus Cohort
-
Abstract Number: 1698
High-throughput Proteomics Identities a Spectrum of Novel Serum Biomarkers of Lupus Nephritis
-
Abstract Number: 1699
Immunosuppression with Targeted Therapies Reduces Morbidity and Mortality in Pre-Capillary Pulmonary Hypertension Associated with Systemic Sclerosis: A EUSTAR Analysis
-
Abstract Number: 1700
Incidence and Risk Factors for New Onset of Interstitial Lung Disease in Systemic Sclerosis: A EUSTAR Analysis
-
Abstract Number: 1701
Treatment Regimens and Mortality in Systemic Sclerosis-associated Pulmonary Arterial Hypertension in Light of the 2022 ESC/ERS Guidelines
-
Abstract Number: 1702
Outcomes in Systemic Sclerosis Patients Treated with Rituximab and Mycophenolate Mofetil Combination Therapy Compared to Autologous Hematological Stem Cell Transplantation
-
Abstract Number: 1703
Increased Mortality and Cardiovascular Events in Male Patients with Systemic Sclerosis: Left Ventricular Global Longitudinal Strain as Possible Screening Tool
-
Abstract Number: 1705
Reduced DNASE1L3 Activity and Increased Anti-NET Protective Antibodies Contributes to Accumulation of Neutrophil Extracellular Traps in Pediatric SLE Patients
-
Abstract Number: 1706
Autoreactive B Cell Responses Are Enriched in Early-onset Oligoarticular Juvenile Idiopathic Arthritis
-
Abstract Number: 1707
PD1-Expressing Regulatory T Cells Found in Inflamed Joints Suppress Tph Cell-B Cell Interactions
-
Abstract Number: 1708
In Cis SOCS1 Variants Illustrate the Precise Regulation of Interferon Signaling Needed to Prevent Autoimmunity
-
Abstract Number: 1709
Tape Stripping Expression Signatures Identify Biologically Unique Juvenile Dermatomyositis Patient Subgroup Characterized by Increased Mitochondrial Dysfunction
-
Abstract Number: 1710
Genetic Associations in Juvenile Idiopathic Arthritis Determined with an Electronic Health Record Based Approach
-
Abstract Number: 1711
CD14+ Monocytes Demonstrate a Unique Transcriptional Signature in Macrophage Activation Syndrome, Highlighting a Role for Interferons and Identifying Putative Hemophagocytes in Circulation
-
Abstract Number: 1712
Identification and Functional Characterization of Eight CANDLE/PRAAS Causing Proteasome Variants in Five Unrelated Patients
-
Abstract Number: 1713
Prevention of Arthritis Development by Mechanical Unloading Through Inhibition of CCL2 and YAP-mediated Inflammation in the Rat Adjuvant-induced Arthritis Model
-
Abstract Number: 1714
Aberrant Myeloid Populations in the TNF-Transgenic Model of Pulmonary Hypertension Overexpress Interferon Pathways and Are Driven by TNFR1 Signaling
-
Abstract Number: 1715
Androgen Treatment Exhibits a Protective Role Against Focal Erosions in TNF-Induced Inflammatory Arthritis in Mice
-
Abstract Number: 1716
High-Throughput Semi-Automated Micro-CT Analysis Identifies the Cuboid Bone as a Sex-Dependent Biomarker of Inflammatory-Erosive Arthritis in TNF-Tg Mice
-
Abstract Number: 1717
Endothelial Cell Sphingosine 1-Phophate Receptor 1 Restrains VE-cadherin Cleavage and Attenuates Experimental Inflammatory Arthritis
-
Abstract Number: 1719
Exploring the Link Between Osteitis and Bone Microstructure Changes in Rheumatoid Arthritis: Role of JAK-STAT Signaling Pathway
-
Abstract Number: 1721
The Therapeutic Effects of Gingival Mesenchymal Stem Cells and Their Exosomes in a Chimeric Model of Rheumatoid Arthritis
-
Abstract Number: 1722
Fate-mapping of Synovial Monocytes and Macrophages
-
Abstract Number: 1723
3,3-dimethyl-1-butanol and Its Metabolite 3,3-dimethylbutyrate Ameliorate Arthritis Severity in CIA Independent of Choline TMA Lyase Activity
-
Abstract Number: 1724
Human Embryonic Stem Cell-derived Mesenchymal Stem Cells Attenuates Experimental Pulmonary Fibrosis Through Mitochondria Transfer Mediated Anti-apoptotic and Immunomodulatory Effects
-
Abstract Number: 1725
Distinct Perivascular and Intravascular Lymphatic Mast Cells and Their Role in Lymphatic Clearance, Joint Inflammation, and Bone Erosion in the TNF-Transgenic Murine Arthritis Model
-
Abstract Number: 1726
Therapeutic Effect of ICAM-1 Mimic on Experimental Axial Spondyloarthritis
-
Abstract Number: 1727
Arthritogenicity of Homocitrullinated Peptides in HLA-DRB1 Transgenic Mice
-
Abstract Number: 1728
A Novel Animal Model for Investigating the Effect of HLA-DRB1 on Atherosclerosis
-
Abstract Number: 1729
An Antibody-drug Conjugate of Anti-TNFα Antibody and a Novel Glucocorticoid Molecule Exerts Synergistic Anti-inflammatory Effects for Treatment of Autoimmune Diseases
-
Abstract Number: 1730
Gut Microbiota Dysbiosis Impact Autonomic Function in Rheumatoid Arthritis Patients
-
Abstract Number: 1731
A Competitive Inhibitor of MOART Showed Potent Therapeutic Effects in a Mouse Model of Collagen-induced Arthritis
-
Abstract Number: 1732
Immunopathogenesis and Preclinical Trials in a Humanized Mouse Model of Rheumatoid Arthritis(RA)
-
Abstract Number: 1733
Platelet-Derived Growth Factor Is a Mediator of Disease in an Animal Model of Rheumatoid-Associated Interstitial Lung Disease
-
Abstract Number: 1734
Serum PDGF-BB Levels Correlate with Lung Fibrosis in Mice Injected with Malondialdehyde-Acetaldehyde and/or Citrulline Modified Vimentin
-
Abstract Number: 1735
An Unorthodox HLA-DRhiCD15+ ‘Hybrid’ Population in Rheumatoid Arthritis Characterized Using Spectral Cytometry
-
Abstract Number: 1736
The Effect of Resolvin E1 and Resolvin D1 Specialised Pro-resolving Mediators on the Inhibition of Osteoclastogenesis
-
Abstract Number: 1737
ACPA, Anti-CarP and AAPA Can Be Detected in Saliva, but Not in Feces of Seropositive Rheumatoid Arthritis Patients – Support for Mucosal Involvement in Specific Locations in RA
-
Abstract Number: 1738
Identification of Homeostatic and Inflammatory Synovial Fibroblast Signatures in Synovial Tissue Biopsies of Healthy Controls and Patients with Rheumatoid Arthritis
-
Abstract Number: 1739
Mass Spectrometry Identified Rheumatoid Arthritis-Specific Modified Proteins and the Discovery of Antigen-Specific Hidden Autoantibodies
-
Abstract Number: 1740
Exploring Disease-Associated DNA Methylome Alterations in Rheumatoid Arthritis: Potential Diagnostic and Prognostic Biomarkers
-
Abstract Number: 1741
The Occurrence and Phenotype of Autoreactive T Cells in the At-Risk Phase of Rheumatoid Arthritis
-
Abstract Number: 1742
Sputum Citrullinated Proteins and Sputum Anti-Cit-S100A8/A9 IgG Antibodies Are Increased in Serum Anti-CCP-IgG Positive Individuals Who Developed RA
-
Abstract Number: 1743
Individuals At-risk for and with Rheumatoid Arthritis Have Elevated Fecal Concentrations of Arthritogenic Subdoligranulum didolesgii Correlating with CCP3 Antibodies
-
Abstract Number: 1744
Histological and Molecular Comparison in the Synovial Tissue of Patients with Active Rheumatoid Arthritis to Remission
-
Abstract Number: 1745
Chronic Inflammation and Collagen IV Fragment Canstatin Influence Rheumatoid Arthritis Synovial Fibroblast and Endothelial Cell Interactions in Vitro and in Vivo
-
Abstract Number: 1746
Smoking as a Risk Factor for Rheumatoid Arthritis: Exclusive Association with IgA Autoantibodies
-
Abstract Number: 1747
A Newly Described Cytokine interleukin-40 Is Increased in the Serum of Individuals At-risk of Rheumatoid Arthritis and Induces an Inflammatory Response in Mononuclear Cells
-
Abstract Number: 1748
Macrophage Extracellular Traps Require Peptidylarginine Deiminase 2 and 4 and Are a Source of Citrullinated Antigens Bound by Rheumatoid Arthritis Autoantibodies
-
Abstract Number: 1749
Fatty Acid Synthase Is a Critical Repressor of Ferroptosis in Rheumatoid Arthritis
-
Abstract Number: 1750
Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast-Like Synoviocyte Inflammatory Responses
-
Abstract Number: 1751
Profiling of Anti-PAD IgG and IgA in Patients from the Head-to-head Adalimumab vs Abatacept Rheumatoid Arthritis AMPLE Trial and Matched Healthy Controls
-
Abstract Number: 1752
Fibroblast Expression of Neurotransmitter Receptor HTR2A Associates with Inflammation in Rheumatoid Arthritis Joint
-
Abstract Number: 1753
Acylcarnitine Enrichment Is a Characteristic of Rheumatoid Arthritis Fibroblast-Like Synoviocyte Metabolic Fingerprint
-
Abstract Number: 1754
Novel and Unique Rheumatoid Factors Cross-React with Viral Epitopes in COVID-19
-
Abstract Number: 1755
Unique Pattern of Cadherin 6 Localization in Fibroblast-Like Synoviocytes
-
Abstract Number: 1756
Circulating CD4+CD25+CD127-FoxP3+CD39+ T Cells Predict the Response to Methotrexate Across Basal Disease Activity Strata in Early Rheumatoid Arthritis
-
Abstract Number: 1757
Quantitative Assessment of Synovial Vascularity Using Power Doppler Index in Rheumatoid Arthritis and Psoriatic Arthritis Patients with High Disease Activity
-
Abstract Number: 1758
Identification of Circulating Autoantibodies Associated with ACPA Status in Early Rheumatoid Arthritis
-
Abstract Number: 1759
Runx1 Is a Key Transcription Factor That Drives Synovial Fibroblast Pathogenicity in Rheumatoid Arthritis
-
Abstract Number: 1761
JAK/STAT Inhibition Modifies the Innate Lymphoid Cells 1 Immune Response in Patients with Rheumatoid Arthritis
-
Abstract Number: 1762
Single-cell RNA Sequencing Analysis and Immune Profiling of Antigen-specific T Cells in Patients with Rheumatoid Arthritis and Healthy Controls
-
Abstract Number: 1763
Asthma Severity Is Associated Increased Serum Anti-cyclic Antibody Level at Baseline and in Increase During Longitudinal Follow-up
-
Abstract Number: 1764
Antibody Responses to Citrullinated Type II Collagen and Vimentin Modified with Malondialdehyde-Acetaldehyde Differ in Rheumatoid Arthritis and Rheumatoid Arthritis-Interstitial Lung Disease
-
Abstract Number: 1765
Persistent Cigarette Smoking Is Associated with Rheumatoid Arthritis Onset and Neutrophil Activation in a Prospective Study of At-risk First-Degree Relatives
-
Abstract Number: 1766
Inflammatory Priming of the Joints via Pre-activation of Macrophages by Anti-MAA Antibodies in Rheumatoid Arthritis
-
Abstract Number: 1767
TNF-α Utilizes the TWEAK/Fn-14 Axis in Human Rheumatoid Arthritis Synovial Fibroblasts to Induce Inflammation
-
Abstract Number: 1768
The Dynamics of the Gut Microbiome in Rheumatoid Arthritis Susceptibility: A Cross-Sectional and Longitudinal Observational Study
-
Abstract Number: 1769
TNF-Stimulated Production of IL-15 by Fibroblast-Like Synoviocytes Mediates Human Resident Memory T Cells Development in Synovial Organoid Model
-
Abstract Number: 1770
Dual Inhibition of TNF-α and OX40L on Synovial Inflammation and Osteoclastogenesis in Rheumatoid Arthritis
-
Abstract Number: 1771
Role of Periostin in the Pathophysiology and Accurate Diagnosis of Interstitial Lung Disease Associated with Autoimmune Diseases
-
Abstract Number: 1772
Rheumatoid Arthritis-Specific Rheumatoid Factors Develop in Some COVID-19 Patients
-
Abstract Number: 1773
Integrated Analysis of Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS) Transcriptome and Chromatin Accessibility Identifies Mechanisms Associated with Location-specific Disease Severity
-
Abstract Number: 1774
Gut Microbiota and Permeability Biomarkers for Diagnosis and Prognosis in Rheumatoid Arthritis Associated Interstitial Lung Disease
-
Abstract Number: 1776
Macrophage Migration Inhibitory Factor May Help Maintain Tight Junctions in the Gut by Enhancing Occludin Expression
-
Abstract Number: 1777
The Effect of the Inflamed Joint Microenvironment on Endothelial Cell Function
-
Abstract Number: 1778
Role of GITR/GITRL Interaction in Modulating T Helper 9, T Helper 17 and T Regulatory Response in Psoriatic Arthritis
-
Abstract Number: 1779
A Novel Inhibitory Pathway of Synovial Inflammation Exerted by Glucocorticoids and TNF Inhibitors Through LAG-3 Up-Regulation
-
Abstract Number: 1780
Biomarkers Predicting Structural Progression of Axial Spondyloarthritis: A Pilot Study
-
Abstract Number: 1781
TNF Induces Neutrophil Elastase/Gasdermin D-mediated Neutrophil Extracellular Traps in Axial Spondyloarthritis
-
Abstract Number: 1782
The Stromal-cell Derived Cytokine interleukin-17D Attenuates Joint Inflammation
-
Abstract Number: 1783
Integrative Functional Genomics Points to Natural Killer Cells as Key Drivers in the Pathogenesis of Ankylosing Spondylitis
-
Abstract Number: 1784
Dendritic Cell-specific TNFR2 Depletion Reduces Psoriatic Arthritis-like Disease in a Mouse Model
-
Abstract Number: 1785
Machine Learning Models Identify Gut Microbiota That Predict Chronicity in Reactive Arthritis
-
Abstract Number: 1786
Newly Identified Gut Commensal Clostridium Fessum AM100 for Treating Ankylosing Spondylitis
-
Abstract Number: 1787
Regulatory Role of JAK-1/TYK2 Signaling on the Pannus Formation: Novel Mechanisms for JAK Inhibitors in Psoriatic Disease
-
Abstract Number: 1788
The Emerging Mechanism of TNF&IL-17A/WNT5a/ROR2 Axis in Pathological Bone Formation of Ankylosing Spondylitis
-
Abstract Number: 1789
Microtrauma Exacerbates Arthritis and Enthesitis in Curdlan-administered SKG Mice by Inducing FGF16 Expresssion
-
Abstract Number: 1790
Expansion of CD8+ TCRVβ9+ T Cells in the Peripheral Blood of HLA-B27+ Patients with Axial Spondyloarthritis
-
Abstract Number: 1791
Exploring the Mechanism of Anti-TNFα Therapy Non-response in Psoriatic Arthritis: The Role of TNF Receptor 2 Polymorphisms rs1061622
-
Abstract Number: 1792
Identifying Synovial Fluid Micro-RNA Signature That Distinguishes Psoriatic Arthritis from Osteoarthritis
-
Abstract Number: 1793
Goblet Cell Specific Anti-Apoptotic Role of Interleukin-24 in Spondyloarthritis-Associated Ileitis
-
Abstract Number: 1794
The Role of the Deubiquitinase ZRANB1/TRABID in Inflammation and Bone Formation in Spondyloarthritis
-
Abstract Number: 1795
Multi-Omics Analyses Identify Metabolic Pathways That Differentiate Psoriatic Arthritis from Psoriasis
-
Abstract Number: 1796
Safety & ImmUnogenicity of COVID-19 VaCcines in SystEmic immunE Mediated Inflammatory Diseases (SUCCEED)
-
Abstract Number: 1797
Factors Associated with Distress Related to Perceived Dignity in Patients with Rheumatic Diseases
-
Abstract Number: 1798
Association Between Knee Osteoarthritis and Mortality: A Serial Propensity Score-matched Cohort Study
-
Abstract Number: 1799
Association of Pregabalin vs Gabapentin with Incident Congestive Heart Failure in Patients with Non-Cancer Pain
-
Abstract Number: 1800
Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases
-
Abstract Number: 1801
Tixagevimab/Cilgavimab for the Prevention of COVID-19 in Vaccine-refractory Patients with Autoimmune Diseases: A Prospective Cohort Study
-
Abstract Number: 1802
Rheumatologic Disorder Diagnostic Testing Patterns:Real World Evidence from a National Laboratory Database
-
Abstract Number: 1803
Perceived Dignity in Patients with Rheumatic Diseases: An Unrecognized Source of Emotional Distress
-
Abstract Number: 1804
Plant-based Diet Quality and the Risk of Gout: Results from Two Prospective Cohort Studies of US Men and Women
-
Abstract Number: 1805
Longitudinal Changes in Serum Urate Associate Minimally with Changes in Daily Alcohol Intake
-
Abstract Number: 1806
The Prevalence of Cardiac Sarcoidosis – A Systemic Review and Meta-Analysis
-
Abstract Number: 1807
Hypothyroidism Impacts Clinical and Healthcare Utilization Outcomes After Primary Total Hip Arthroplasty
-
Abstract Number: 1808
Tobacco Smoking Reduces the Incidence and Delays the Progression of Knee Osteoarthritis: 10-year Retrospective Cohort Study Based on Korea National Health Insurance Service-Health Screening Database
-
Abstract Number: 1809
Clinical Outcome and Antibody Responses Following the Surge of SARS-CoV-2 Omicron Infection Among Patients with Systemic Autoimmune Diseases
-
Abstract Number: 1810
Alcohol Consumption Amount, Type of Beverage, and Gender, All Matters to Serum Uric Acid Levels
-
Abstract Number: 1811
Strong Relationships Between Body Component Changes and Serum Uric Acid Variability
-
Abstract Number: 1812
Duloxetine and the Risk for Cardiovascular Events in US Veterans with Non-Cancer Pain
-
Abstract Number: 1813
Assessing Immunogenicity of SARS-CoV-2 Vaccine Neoantigen S1 in Autoimmune Rheumatic Disease Patients: A Study on Cellular and Humoral Responses
-
Abstract Number: 1814
Silica and Other Exposures from Jobs and Hobbies Are Associated with Myositis Phenotype in a National Myositis Registry
-
Abstract Number: 1816
Hyperuricemia – Especially “Metabolic Hyperuricemia” – Is Independently Associated with Higher Risk of Fatty Liver
-
Abstract Number: 1817
Geographic Variability of Inflammatory Bowel Disease Related Mortality, 1999-2019; CDC WONDER
-
Abstract Number: 1818
Compliance with Romosozumab and Fracture Risk Among Postmenopausal Women in the U.S
-
Abstract Number: 1819
Clinical Indications Associated with New Opioid Use for Pain Management in the United Kingdom Using National Primary Care Data
-
Abstract Number: 1820
Statewide Burden of Osteoarthritis in United States Between 1990-2019: A Systematic and Comparative Benchmarking Study
-
Abstract Number: 1821
The “Weekend Effect” and Rheumatological Association in Patients with Diffuse Alveolar Haemorrhage
-
Abstract Number: 1823
Higher Body Mass Index and Older Age, Both of Which Are Linked to Immunothrombosis Are Associated with Improved Survival with Baricitinib Therapy in COVID-19 Pneumonia
-
Abstract Number: 1824
Breakthrough COVID-19 and Severity After Vaccination Among Pregnant Persons with Rheumatic Diseases
-
Abstract Number: 1825
Exploring the Health and Cannabis Use Among Young and Middle-Aged Adults with Rheumatologic Conditions in Alberta, Canada
-
Abstract Number: 1826
Investigating the Health Profiles and the Prevalence and Correlates of Cannabis Use Among Patients Accessing Rheumatologic Care in Alberta, Canada
-
Abstract Number: 1827
Revolutionizing Fibromyalgia Treatment: Exploring the Efficacy of a New FDA Cleared Photoceutical Device
-
Abstract Number: 1829
Blood-derived Extracellular Vesicles as Potential Diagnostic Biomarker in Fibromyalgia Syndrome
-
Abstract Number: 1830
Exploring Psychosocial Characteristics of Youth with Chronic Pain Across Gender Identities
-
Abstract Number: 1831
Effect of the COVID-19 Pandemic on Health Status of Fibromyalgia
-
Abstract Number: 1832
Prevalence of Musculoskeletal Manifestations in Post-acute COVID 19 Patients and Their Quality of Life at Kenyatta National Hospital
-
Abstract Number: 1834
Evaluation of Fibromyalgia, Clinical/Serologic Activity, and Patient Reported Outcomes in a Racially/Ethnically Diverse SLE Patient Cohort
-
Abstract Number: 1835
A Survey on Fibromyalgia-Related Knowledge Among Internal Medicine Residents
-
Abstract Number: 1836
Embracing a Biopsychosocial Approach to Fibromyalgia-like Symptoms in People with SLE: Insights from the Type 2 SLE Consortium
-
Abstract Number: 1837
Depression and Suicide Attempt in Systemic Lupus Erythematosus with and Without Fibromyalgia
-
Abstract Number: 1838
The Burden of Dysautonomia in Patients Suffering from Pathologies Associated with Generalized Joint Hypermobility
-
Abstract Number: 1839
Value of Small Fiber Neuropathy in Fibromyalgia Patients in a Rheumatological Setting
-
Abstract Number: 1840
Value of Various Intra-Articular Injections for Knee Osteoarthritis Management
-
Abstract Number: 1841
Clinical Trial Perceptions Among Male Patients with Systemic Lupus Erythematosus (SLE): Georgians Organized Against Lupus (GOAL) Cohort
-
Abstract Number: 1842
Reduction in the Concomitant Ordering of Erythrocyte Sedimentation Rate and C-Reactive Protein Within the Rheumatology Clinics at an Academic Medical Center
-
Abstract Number: 1843
Detection of Clinically Relevant Subgroups in Patients Undergoing Knee Replacement Using Machine Learning
-
Abstract Number: 1844
Are Patients with Inflammatory Rheumatic Diseases Ready for Studies with Medical Cannabis? – Results from a Digital Survey
-
Abstract Number: 1845
Development of a Scoring System for Accurate Lupus Nephritis Case Identification in Real-World Databases
-
Abstract Number: 1846
A Longitudinal Study: The Benefits of Non-Pharmacological Approaches to Improve Self-Reported Pain, Stiffness, and Fatigue in Individuals with Musculoskeletal Disorders
-
Abstract Number: 1847
Influence of Seasonal Changes on Adherence in Rheumatoid Arthritis Patients
-
Abstract Number: 1848
Demographic and Clinical Factors Associated with HPV Vaccination in Young Adults with Rheumatic Disease
-
Abstract Number: 1849
Impact of the First Three Waves of the Covid-19 Pandemic on Everyday Restrictions and Clinical Care of Patients with Spondyloarthritis Across Europe – Results from the EuroSpA Collaboration
-
Abstract Number: 1850
Long-term Glucocorticoid Use in a Cohort of Elderly Early Rheumatoid Arthritis Patients: A Joint Analysis of Medicare and the Rheumatology Informatics System for Effectiveness (RISE) Data
-
Abstract Number: 1851
Healthcare Providers’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar
-
Abstract Number: 1852
Human Papillomavirus Vaccine Uptakes in Ethnically Diverse Women Living with Systemic Lupus Erythematosus
-
Abstract Number: 1854
What Is Our Regional Delay to Diagnosis in Patients with Axial Spondyloarthropathy – Are We Hitting the Target? Data from a Multi-centre UK Patient Cohort
-
Abstract Number: 1855
Using a Whole-population Approach to Help Design More Effective and Efficient Healthcare Services for People with Fibromyalgia
-
Abstract Number: 1856
Improving Recombinant Zoster Vaccination Rates in Patients Receiving Immunosuppressive Therapy in the Rheumatology Clinic at the Orlando VA Healthcare System – a Quality Improvement Project
-
Abstract Number: 1858
How Did a Mandatory Switch Policy Influence the Uptake of Adalimumab Biosimilar and Other TNF Inhibitors?
-
Abstract Number: 1859
Examining Hydroxychloroquine Prescribing and SLE Damage in a Statewide Lupus Cohort
-
Abstract Number: 1860
Evaluation of the Receipt of Adequate Pharmacological and Psychological Treatment for Incident Depression and Anxiety in Individuals Living with Inflammatory Arthritis
-
Abstract Number: 1863
Immune-mediated Hypertrophic Pachymeningitis: Focusing on the Localization and Volume of Thickened Dura Mater Lesion
-
Abstract Number: 1864
Quantifying Inflammation: A Novel In-Vivo Total Body PET Imaging Tool to Determine the Kinetics of the Degree of Changes in Inflammation in Different Time Points
-
Abstract Number: 1865
Is Flexion Contracture in Knee Osteoarthritis Associated with MRI Pathologies over Time? Data from the Osteoarthritis Initiative
-
Abstract Number: 1866
MRI Confirms MRE Evidence of Sacroiliitis in Many with Crohn’s Disease: A Prospective Study for the Screening of axSpA in High-risk Populations
-
Abstract Number: 1869
FDG-PET/CT for Diagnosing Polymyalgia Rheumatica Before, During and After a Short-term Prednisolone Cessation – a Prospective Study of 101 Patients
-
Abstract Number: 1870
Assessing the Appropriateness of Imaging Modalities in Primary Care for Low Back Pain and Their Impact on Outcomes: A Retrospective Observational Study in a Single Center in Trenton
-
Abstract Number: 1871
Utility of Infrared Thermography in Patients with Digital Gangrene
-
Abstract Number: 1872
Performance Analysis of a Deep Learning Algorithm to Detect Positive SIJ MRI According to the ASAS Definition in axSpA Patients
-
Abstract Number: 1873
Cervical Spine Involvement in Axial Spondyloarthritis. Radiographic Characteristics and Associated Factors
-
Abstract Number: 1874
Cartilage Thickness Measures Are More Responsive Than Cartilage Area Loss Measures: A Comparison of Quantitative and Semi-quantitative Cartilage Assessments from the Osteoarthritis Initiative
-
Abstract Number: 1875
Inter and Intra-observer Reliability of Assessment for Nailfold Capillary Abnormalities in Rheumatic Patients with Raynaud’s Phenomenon
-
Abstract Number: 1876
A Deep Learning System for Automated Assessing Microcirculation Abnormalities in Nailfold Capillaroscopy Images of Systemic Sclerosis
-
Abstract Number: 1877
Diagnostic Yield of 18F-FDG PET-CT for Large Vessel Involvement in Patients with Suspected Giant Cell Arteritis and Negative Temporal Artery Biopsy
-
Abstract Number: 1878
MRI-determined Intramuscular Fat Changes During Oral Glucocorticoid Treatment: Findings from a Feasibility Study
-
Abstract Number: 1879
Artificial Intelligence for the Detection of Sacroiliitis on Magnetic Resonance Imaging in Patients with Axial Spondyloarthritis
-
Abstract Number: 1880
Performance of Machine Learning Algorithms in Discriminating Spondyloarthritis Features on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis
-
Abstract Number: 1881
Deep Learning Approaches to Rheumatoid Arthritis Severity Prognosis
-
Abstract Number: 1882
Imaging in Diagnosis, Monitoring and Outcome Prediction of Large Vessel Vasculitis: A Systematic Literature Review Informing the 2023 Update of the EULAR Recommendations
-
Abstract Number: 1883
Thalamocortical Mechanisms of a Remote Mind-body Intervention for Knee Osteoarthritis Pain
-
Abstract Number: 1885
The Frequency and Importance of Subchondral Radius Cysts in Rheumatoid Arthritis Patients Under B/tsDMARDs
-
Abstract Number: 1886
Costotransverse Joint Ankylosis and Association with Syndesmophyte Progression in Patients with Radiographic Axial Spondyloarthritis
-
Abstract Number: 1887
Total-body PET Quantitative Biomarkers Reveal Key Differences in Enthesitis Between Rheumatoid and Psoriatic Arthritis Patients
-
Abstract Number: 1888
Solving the Final Puzzle of Gout Detection in DECT via Machine Learning-Based Mitigation of Pseudolesion-Related Challenges: Enhancing Diagnostic Accuracy
-
Abstract Number: 1889
Utility of a Diagnostic Algorithm in the Assessment of Large Vessel Vasculitis
-
Abstract Number: 1890
Use of Artificial Intelligence to Diagnose Polymyalgia Rheumatica on 18F-FDG Whole Body PET/CT in Patients with Atypical Clinical Features
-
Abstract Number: 1891
Effect of Apremilast on Disease Interception in Patients with Psoriasis at Increased Risk of Developing PsA – Results of the Prospective Interventional Epos Trial
-
Abstract Number: 1892
Sacroiliac Bone Marrow Oedema on Postpartum MRI Does Not Result in Significant SpA-like Structural Lesions: Results of a 5-year Follow-up Study
-
Abstract Number: 1893
Abnormalities Detected with [18F]-FDG-PET/CT Imaging in VEXAS Syndrome
-
Abstract Number: 1894
3-Dimensional Regional Variation in Inter-rater Reliability of Bone Marrow Lesion Scoring in the Knee
-
Abstract Number: 1895
Comparative Analysis of Existing Tools in Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis: Exploring the Inadequacies
-
Abstract Number: 1896
Systematic Review and Analysis of Mobile Apps for Rheumatoid Arthritis Using the Mobile Application Rating Scale
-
Abstract Number: 1897
In Pursuit of Excellence: Improving Systemic Sclerosis Quality of Care
-
Abstract Number: 1898
Patient After Visit Instructions at a University Rheumatology Outpatient Clinic: Do They Make a Difference?
-
Abstract Number: 1899
Healthy People with Lupus 2030: Goals to Improve the Quality of Care and Health of All People with Lupus in the United States
-
Abstract Number: 1900
Assessment of Hospitalist Confidence Levels in Management of Rheumatic Conditions to Identify Potential Knowledge Gaps
-
Abstract Number: 1901
Which ASDAS-ESR Cut-offs for Disease Activity Correspond to ASDAS-CRP Cut-offs in Axial Spondyloarthritis? – Results from the EuroSpA Collaboration
-
Abstract Number: 1902
Improving the Sharing of Information from Reviews of Measurement Properties: The OMERACT Summary of Measurement Properties (SOMP) Table
-
Abstract Number: 1903
Assessing Disparities Through Missing Race and Ethnicity Data: Results from a Juvenile Arthritis Registry
-
Abstract Number: 1904
Treat-to-Target in RA Clinical Practice: Global Evidence of Practice Gaps and Educational Needs
-
Abstract Number: 1905
Implementation of the Clinical Disease Activity Index to Optimize Treat-to-Target Management of Rheumatoid Arthritis at the University of North Carolina Hospitals Rheumatology Specialty Clinic
-
Abstract Number: 1906
Implementation Practices for the 2022 American College of Rheumatology Guidelines for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis
-
Abstract Number: 1907
Selection of a Candidate Instrument to Assess Flare in Osteoarthritis with Content Matching with Endorsed Domains
-
Abstract Number: 1908
Clinic Protocol Boosts Blood Pressure Confirmatory Readings and Accuracy in an Academic Medical Center
-
Abstract Number: 1909
Identifying and Addressing Suboptimal Urate Lowering Therapy in Gout Patients with Chronic Kidney Disease
-
Abstract Number: 1910
Development of the American College of Rheumatology Toolkit for Implementation of Rheumatoid Arthritis Outcome Measures in Clinical Practice
-
Abstract Number: 1911
Using the Technology Acceptance Model to Assess Physician Perceptions and Experiences Using the Rheumatoid Arthritis-Patient-Reported Outcomes Dashboard: Mixed-Methods Study
-
Abstract Number: 1912
Impact of Pharmacist-Led Specialty Medication Management Service on Time-to-Dispense for Specialty Rheumatologic Medications in a University Health System
-
Abstract Number: 1913
Neurosarcoidosis Disease Epidemiology. University Hospital in Northern Spain 1999-2019
-
Abstract Number: 1914
Intravenous Immunoglobulins in the Treatment of Idiopathic Inflammatory Myopathies in a Region of Northern Spain: Analysis by Subtypes
-
Abstract Number: 1915
Scleritis and Development of Autoimmune Disease: A Case Series
-
Abstract Number: 1916
Clinical Features of the Patients with NLRP1 Gene Variants and a Systemic Autoinflammatory Phenotype
-
Abstract Number: 1917
Reducing Inadvertent Antifilarial Antibody Testing at an Academic Medical Center: A Quality Improvement Project
-
Abstract Number: 1918
Nationwide Analysis of Predictors of Sarcoid Inpatient Mortality
-
Abstract Number: 1919
Arthroplasty Outcomes in Immune Checkpoint Inhibitor-Treated Patients: A Single Center Series
-
Abstract Number: 1920
A Phase Ib/II Randomized, Double-blind, Placebo-controlled Study of Novel anti-IL-17A Monoclonal Antibody JS005 in Patients with Moderate to Severe Psoriasis
-
Abstract Number: 1921
Clinical Spectrum of VEXAS Syndrome in a Rheumatology Department
-
Abstract Number: 1923
Prevalence and Patterns of Comorbidities in Different Rheumatic Diseases: A Study from Tertiary Healthcare Centre
-
Abstract Number: 1924
Impact of the COVID-19 Pandemic on Clinical and Psychosocial Features of Patients with UCTD
-
Abstract Number: 1925
Importance of the Patient Pain Experience in Disease Activity Assessment in the Adult SAPHO and Chronic Nonbacterial Osteomyelitis Study
-
Abstract Number: 1926
Use of 18F-FDG PET in Assessing Response to Treatment in Adults with Pulmonary Sarcoidosis: A Systematic Literature Review
-
Abstract Number: 1927
Manifestations, Management and Outcomes of Interstitial Lung Disease Associated with Anti-synthetase Syndrome: A Systematic Literature Review
-
Abstract Number: 1928
Response to Sars-Cov2 Vaccination in Rheumatic and Neurological Patients Treated with Different Immunosuppressive Therapies
-
Abstract Number: 1929
Anakinra Treatment in Idiopathic Recurrent Pericarditis: A Single-center Experience
-
Abstract Number: 1930
Blue Digit Syndrome as the Initial Presentation of Various Diseases: A Case Series
-
Abstract Number: 1931
Anti-Ku Antibodies: A Case Series
-
Abstract Number: 1932
The Association Between Initial Ferritin and Complications from Adults Onset Stills Disease and Intensive Care Unit Admission
-
Abstract Number: 1933
Analysis of IgG4-Related Disease in a Diverse Long Island Population: Insights from the Rheumatology Clinic
-
Abstract Number: 1934
Pooled Safety Analysis from the VOLTAIRE Trials in Patients with Rheumatoid Arthritis, Crohn’s Disease, and Chronic Plaque Psoriasis
-
Abstract Number: 1936
Higher Rates of Disease Control During the Coronavirus Pandemic in Pediatric Patients with Autoinflammatory Periodic Diseases on Canakinumab Treatment – Interim Data from the RELIANCE Registry
-
Abstract Number: 1937
Efficacy of Different Treatment Approaches for Cardiac Sarcoidosis
-
Abstract Number: 1938
Cranial Nerve Manifestations in Sarcoidosis Associated with Lymphoma, Non-facial Paralysis, and Other Neurologic Disorders
-
Abstract Number: 1939
Sinonasal Sarcoidosis Associated with Chronic Pulmonary Disease, Deficiency Anemias, and Obesity
-
Abstract Number: 1940
A Single-center, Observational, Retrospective, Case Control Study of Rituximab for the Treatment of Interstitial Pneumonia Associated with Autoimmune Features
-
Abstract Number: 1941
Identification of VEXAS Syndrome in Mexican Patients with Inflammatory and Hematologic Manifestations
-
Abstract Number: 1942
Prevalence and Screening Strategy for Latent Tuberculosis Infection in Patients with Rheumatic Immune-Mediated Diseases
-
Abstract Number: 1943
IgG4-related Disease: 2010-2022 Case Review and Comparative Evaluation of Diagnostic Criteria
-
Abstract Number: 1944
Characterization of Interstitial Pneumonia with Autoimmune Features (IPAF) in a National Referral Centre
-
Abstract Number: 1945
Case Series of 6 Patients Exhibiting Myositis as a Rheumatologic Adverse Events Related to Cancer Immunotherapy in Two Spanish Hospitals
-
Abstract Number: 1947
National Incidence, Prevalence & Mortality in Idiopathic Inflammatory Myopathies & Associated Interstitial Lung Disease in England
-
Abstract Number: 1948
The Influence of Specific Myositis Antibodies on the Development of Interstitial Lung Disease
-
Abstract Number: 1949
Relapse of Rapidly Progressive Interstitial Lung Disease in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Autoantibody-Positive Dermatomyositis
-
Abstract Number: 1950
Thromboembolic Risk Associated with Intravenous Immune Globulin Use in Patients with Idiopathic Inflammatory Myopathy: A Large Database Study
-
Abstract Number: 1951
Valid and Reliable Physical Function Tests in Idiopathic Inflammatory Myositis
-
Abstract Number: 1952
Anti-MDA5 Associated Dermatomyositis: Clinical Features and Outcomes in a Predominantly African-American Case Series
-
Abstract Number: 1953
Mortality Trends in Polymyositis and Dermatomyositis in Mexico: A General Population-based Study from 2000 to 2019
-
Abstract Number: 1954
Evaluation of Cancer Screening Methods in Patients Diagnosed with Inflammatory Muscle Disease at Kansas University Medical Center
-
Abstract Number: 1955
Responsiveness and Minimal Important Difference of PROMIS Pain Interference, Fatigue, and Physical Function Forms in Adults with Idiopathic Inflammatory Myopathies
-
Abstract Number: 1956
Rituximab Treatment in Adult Patients with Idiopathic Inflammatory Myositis (IIM): A Systematic Review and Meta-analysis
-
Abstract Number: 1957
Non-Linear Mendelian Randomization Analyses Support a Role for Low Vitamin D Status in Sarcopenia Risk
-
Abstract Number: 1958
Validity, Responsiveness and Minimal Clinically Important Difference of EQ-5D-5L in Inflammatory Myositis: A Longitudinal Study
-
Abstract Number: 1960
From Clinical Amyopathy to Severe Oropharyngeal Dysphagia in Pure Dermatomyositis: A Greater Extent of Muscle Weakness Is Associated with a Higher Cancer Prevalence
-
Abstract Number: 1961
Anti-PM/Scl Autoantibodies in Juvenile Myositis Are Associated with a Distinct Phenotype Resembling Anti-synthetase Syndrome
-
Abstract Number: 1962
Toll-Like Receptor 7/8 Activation of Immune and Non-Immune Cells in Muscle by RNA-Containing Immune Complexes Can Contribute to Inflammation and the Pathogenesis of Myositis
-
Abstract Number: 1963
Effect of JAK-STAT Inhibition by Baricitinib and Tofacitinib on Disease Phenotype in a Mouse Model of Myositis
-
Abstract Number: 1964
Penn State Registry of Inflammatory Myopathies (PRIMO) Provides Insights into Disease Features and Co-Morbidity Screening Utilization
-
Abstract Number: 1965
Discordance Between Patient and Physician Perception of Disease Activity Among Patients with Idiopathic Inflammatory Myopathies: Results from the COVAD Study
-
Abstract Number: 1966
Investigating Esophageal Involvement in Anti-Synthetase Syndrome: How to Discover the Submerged?
-
Abstract Number: 1967
Infectious Myopathies in an Urban Inflammatory Idiopathic Myopathy Cohort: Frequency and Impact on Disease Course and Treatment
-
Abstract Number: 1968
Pregnancy Outcomes in Idiopathic Inflammatory Myopathies: A Comparison to the General American Population
-
Abstract Number: 1969
Multimorbidity and PROMIS Health Outcomes in Patients with Idiopathic Inflammatory Myopathies: Analysis from the COVAD Study
-
Abstract Number: 1970
Impaired Health-Related Quality of Life in Patients with Idiopathic Inflammatory Myopathies: A Cross-Sectional Analysis from the COVAD Dataset
-
Abstract Number: 1971
Muscle Pathology in Patients with Primary Biliary Cholangitis
-
Abstract Number: 1972
Evaluation of Myositis Autoantibodies as Predictors of Response to IVIG: Post-hoc Analysis of a Large Randomized, Double-Blind, Placebo-Controlled Phase III Trial
-
Abstract Number: 1973
Work-related Impact in Young Patients with Chronic Back Pain Awaiting a Magnetic Resonance Imaging
-
Abstract Number: 1974
Comparison of Gait Spatiotemporal Measures Between Patients with Insertional Achilles Tendinopathy or Midportion Achilles Tendinopathy
-
Abstract Number: 1975
Do You Believe in Exercise for Osteoarthritis? Exploring Differences in Participant Characteristics with Treatment Beliefs in Exercise for Knee Osteoarthritis
-
Abstract Number: 1976
Distribution and Validity of Proposed Disability Categories from the Short-Valued Life Activities Questionnaire
-
Abstract Number: 1978
Infrapatellar Fat Pad Size and Subcutaneous Fat in Knee Osteoarthritis Radiographic Progression: Data from the Osteoarthritis Initiative
-
Abstract Number: 1979
Weight Loss Induced by Anti-obesity Medications and All-cause Mortality Among Patients with Knee or Hip Osteoarthritis
-
Abstract Number: 1980
Movement Evoked Pain as an Outcome Measure in Patients with Knee Osteoarthritis
-
Abstract Number: 1981
The Association Between X-ray Progression and Clinical Outcomes in Patients with Hand Osteoarthritis with 5-year Follow-up
-
Abstract Number: 1982
Effect of Denosumab on Knee Pain and Bone Marrow Lesions in Symptomatic Knee Osteoarthritis
-
Abstract Number: 1983
Heated Mittens for Patients with Hand Osteoarthritis: A Randomized Trial
-
Abstract Number: 1984
Therapeutic Effects of Pentosan Polysulfate Sodium on Clinical and Disease Modifying Outcomes in Subjects with Knee Osteoarthritis
-
Abstract Number: 1985
Preliminary Results for the Total Knee Replacement Coaching Program for Patients Preparing to Undergo Total Knee Arthroplasty, a Pilot Randomized Trial
-
Abstract Number: 1987
Clinical and Imaging Characteristics of Individuals Who Underwent Knee Replacement During Years 3 to 5 in the FORWARD Study: A Post Hoc Analysis
-
Abstract Number: 1988
Extended-Release versus Immediate-Release Triamcinolone Acetonide for Osteoarthritis of the Knee with Comorbid Diabetes Type 2 Diabetes Mellitus: A Post Hoc Analysis
-
Abstract Number: 1989
Shared Variation Among Cartilage Thickness Change Maps and Baseline Clinical Features at the Initiation of Structural Knee Osteoarthritis
-
Abstract Number: 1990
Effects of Exercise on Movement-Evoked Pain in People with Knee Osteoarthritis
-
Abstract Number: 1991
Therapeutic Efficacy of Intra Articular Injection of Human Bone Marrow Derived Mesenchymal Stem Cells in Knee Osteoarthritis; Randomized, Double-blind, Placebo-controlled Clinical Trial
-
Abstract Number: 1992
Association Between Knee Osteoarthritis Pain and Concomitant Drug Use: A Post-hoc Analysis of Two Phase 3 Clinical Trials
-
Abstract Number: 1993
Impact of Metabolic Syndrome on Ultrasonographic Findings and Quality of Life in Patients with Early Osteoarthritis
-
Abstract Number: 1994
How Is Paracetamol Prescribed in Low Back Pain and Osteoarthritis in France? Paracetamol Prescription Patterns in the Real-World General Practice
-
Abstract Number: 1995
Cross-cultural Adaptation, Reduction, and Validation of the Turkish Versions of the Flare-OA Questionnaire for Hip and Knee Osteoarthritis
-
Abstract Number: 1996
Variation in Dual-energy X-ray Absorptiometry Reporting: A National Survey of Veterans Health Administration Clinics
-
Abstract Number: 1997
A Randomized, Double-blind, Phase III Study to Compare SB16 (Proposed Denosumab Biosimilar) to Reference Denosumab in Patients with Postmenopausal Osteoporosis
-
Abstract Number: 1998
How to Tailor Osteoporosis Therapies in Patients with Advanced Liver Disease? Variations of Renal Function by Creatinine and Cystatin C
-
Abstract Number: 1999
One-year Incidence of Clinical Fragility Fractures After Implementing an Osteoporosis Care Protocol in Patients Eligible for Liver Transplantation
-
Abstract Number: 2000
Efficacy of Romosozumab for Glucocorticoid-induced Osteoporosis in Patients with Rheumatic Diseases; A Prospective Study
-
Abstract Number: 2001
Burden of Metabolic Bone Disease in Patients with IgG4-Related Disease with and Without Autoimmune Pancreatitis
-
Abstract Number: 2002
Cost-Effectiveness Analysis of Sequential Treatment with Abaloparatide Followed by Alendronate in US Women and Men with Multiple Previous Fractures
-
Abstract Number: 2003
Effects of Abaloparatide on Cortical and Trabecular Compartments by 3D-DXA in Men with Osteoporosis
-
Abstract Number: 2004
Bone Health Following Bariatric Surgery: A Single Center Quality Improvement Study
-
Abstract Number: 2005
Secondary Prevention of Osteoporosis in Hip Fracture Care for Elderly Patients. Clinical and Functional Profile of Users
-
Abstract Number: 2006
Improvement of Care: Osteoporosis Screening in a Resident-led Primary Care Clinic
-
Abstract Number: 2007
Effects of IL-17 Blockade on Skeletal Microarchitecture in Patients with Axial Spondyloarthritis: An HR-pQCT Study
-
Abstract Number: 2008
Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the U.S. Medicare Program
-
Abstract Number: 2009
Screening and Treatment of Low Bone Mineral Density in Allogeneic Hematopoietic Cell Transplant Patients
-
Abstract Number: 2010
B-FROST: Chronic OBstructive Pulmonary Disease and Vertebral FRacture of OSTeoporotic Origin: Results of a Real-life Cohort
-
Abstract Number: 2011
Predicting Fractures in Patients with Isolated Lumbar Spine Osteoporosis Compared to Those with Isolated Hip Osteoporosis
-
Abstract Number: 2012
Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab
-
Abstract Number: 2013
Clinical Characteristics and Risk Factors Associated with Fragility Fractures in Patients with Primary and Idiopathic Mast Cell Activation Syndromes
-
Abstract Number: 2014
The Role of Orosomucoid 2 in the Regulation of Bone Remodeling by Inhibiting Osteoclastogenesis and Promoting Osteogenesis
-
Abstract Number: 2015
Synergistic Effect Between Denosumab and Immune Checkpoint Inhibitors : A Retrospective Study of 268 Patients with Bone Metastases
-
Abstract Number: 2016
Generation of a Human 3D in Vitro Bone Model That Mimics Glucocorticoid-induced Osteoporosis
-
Abstract Number: 2017
Lupus Nephritis Is Strongly Associated with Low Bone Mineral Density and Osteoporosis in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 2018
Development of an Osteoporosis Treatment Gap Dashboard
-
Abstract Number: 2019
2023 EULAR Recommendations for the Management of Fatigue in People with Inflammatory Rheumatic and Musculoskeletal Diseases
-
Abstract Number: 2020
Exploring Experiences and Perspectives of Canadian Patients with Lupus Nephritis Through Photovoice
-
Abstract Number: 2021
Beliefs, Attitudes, and Preferences of Patients with Rheumatoid Arthritis (RA) and Concomitant Cancer with Respect to RA Therapy
-
Abstract Number: 2022
Development of an mHealth App for Lupus: Insights from a Human-Centered Design Approach
-
Abstract Number: 2023
Transition Readiness over Time in a Rheumatology Transition Clinic
-
Abstract Number: 2024
Patient-Reported Outcomes in Patients with Lupus Nephritis: A Post Hoc Analysis of Control Arm Data from Two Completed Phase III Randomized Clinical Trials
-
Abstract Number: 2025
Osteoporosis Treatment Attributes and Levels for an Online Decision-Making Tool for Patients: Findings from Adaptive Choice-Based Conjoint Analysis
-
Abstract Number: 2026
Developing a Guided Joint Self-Exam for Rheumatoid Arthritis Patients to Use in Telehealth-Delivered Care
-
Abstract Number: 2027
Developing and Implementing a Pilot Educational Intervention to Improve Readiness for Self-Management Among Patients with Rheumatic Diseases in Uganda
-
Abstract Number: 2028
Endorsement of Core Domain Definitions to Measure the Impact of Glucocorticoids in Patients with Rheumatic Diseases: A Report from the OMERACT Working Group on Glucocorticoid Impact
-
Abstract Number: 2029
Health-Related Quality of Life in Idiopathic Inflammatory Myopathies: How to Act for Improving the Disease Burden of Patients?
-
Abstract Number: 2030
Positive Psychosocial Factors May Protect Against Perceived Stress in a Multiethnic Cohort of People with SLE with and Without Trauma History
-
Abstract Number: 2031
Involving Patients Research Partners in Research in Rheumatology: Where Do We Stand? A Scoping Review of Recent Randomized Controlled Trials and Translational Science Studies
-
Abstract Number: 2032
Goal Concordance in Rheumatoid Arthritis Patients with Depression – What Do Patients Prioritize?
-
Abstract Number: 2033
Sex Differences in Patient-Reported Outcomes in Patients with Rheumatoid Arthritis After Starting a New Disease-Modifying Antirheumatic Medication
-
Abstract Number: 2034
Assessment of the Immediate and Short-term Impact of an Information Course on Patients’ Knowledge About Rheumatoid Arthritis: Evaluation Using a Self-prepared and Validated Assessment Questionnaire
-
Abstract Number: 2035
Intimate Partner Violence Is Associated with a Poorer Health-Related Quality of Life (HR-QoL) in Women with Systemic Lupus Erythematous
-
Abstract Number: 2036
Switch or Stay the Same? Preferences of People with Autoimmune Disease on Rituximab for Different Types of COVID-19 Vaccine Boosters
-
Abstract Number: 2037
Assessing Risk of Depression in Common Rheumatologic Disorders Using Diagnostic Codes, Survey Scores, and Propensity Score Matching Methodology
-
Abstract Number: 2038
Impact of COVID-19 Pandemic on Preventative Health Screenings in Rheumatology Outpatients
-
Abstract Number: 2039
Clinical, Immunologic, and Genetic Characteristics in Patients with Syndrome of Undifferentiated Recurrent Fevers (SURF)
-
Abstract Number: 2040
Distinguishing Multisystem Inflammatory Syndrome in Children from Typhus Using Artificial Intelligence: MISC vs. Endemic Typhus (AI-MET)
-
Abstract Number: 2041
An Analysis of Recurrent Parotitis Patients Referred to Rheumatology Clinic
-
Abstract Number: 2042
Intraocular Cytokine Profiling of Autoimmune Uveitis
-
Abstract Number: 2043
Phenotype of Musculoskeletal Manifestations in a Canadian Inception Cohort of Pediatric Patients with Inflammatory Bowel Disease
-
Abstract Number: 2044
Monogenic Interferon Mediated Diseases: Novel Phenotype and Genotype Characteristics from Saudi Population
-
Abstract Number: 2045
Treatment Response in a Cohort of Pediatric Patients with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV)
-
Abstract Number: 2046
Implementation of an Automated Transition Readiness Assessment in a Pediatric Rheumatology Clinic
-
Abstract Number: 2047
Safety of Baricitinib for COVID-19 Related Hyperinflammation in Pediatric Patients: A Large Tertiary Care Center Experience
-
Abstract Number: 2048
Development and Usability Testing of Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO)
-
Abstract Number: 2049
Vaccination Coverage and Caregiver Perspectives for Children with Rheumatic Diseases Compared to Healthy Controls
-
Abstract Number: 2050
Variability in Vaccination Practices in Children with Rheumatic Diseases: Results of a Rheumatology Provider Childhood Arthritis and Rheumatology Research Alliance (CARRA)-wide Survey
-
Abstract Number: 2051
Screening Multisystem Inflammatory Syndrome in Children: Accuracy of SickKids Screening Pathway Compared to ACR Algorithm
-
Abstract Number: 2052
Risk Factors for Hospitalization for SARS-CoV-2 in Pediatric Patients with Rheumatic Diseases: A Systematic Review and Meta-analysis
-
Abstract Number: 2053
Predictive Factors Associated with Treatment Response in Chronic Nonbacterial Osteomyelitis
-
Abstract Number: 2054
Superiority of Adalimumab in Treating Childhood Chronic Idiopathic Uveitis: Evidence from a Multicentre Experience
-
Abstract Number: 2055
A Randomized Controlled Trial of Two Hepatitis a Vaccine Doses Among Adolescents with Juvenile Idiopathic Arthritis and Crohn’s Disease on Immunosuppressive Therapy: A Pilot Study
-
Abstract Number: 2056
Pediatric Acute-onset Neuropsychiatric Syndrome: Markers of Inflammation/autoimmunity at Clinical Presentation and Eventual Development of Arthritis and Other Autoimmune Diseases
-
Abstract Number: 2057
Medical Trauma and Its Association with Pain and Disability Risk in Children with Inflammatory Arthritis
-
Abstract Number: 2058
IL-1 Blocking Treatment Slows the Progression of Sensorineural Hearing Loss in Patients with NOMID
-
Abstract Number: 2059
Management of Iatrogenic, Recombinant Interleukin-1 Receptor Antagonist-type Amyloidosis on NOMID in Patients on Anakinra
-
Abstract Number: 2060
Creation of a Standardized and Collaborative Transfer Process from Pediatric to Adult Rheumatology
-
Abstract Number: 2061
Evaluation of a Tool to Enhance Training of the Physical Examination of the Temporomandibular Joint (TM Joint) in Juvenile Idiopathic Arthritis (JIA)
-
Abstract Number: 2062
A Mental Health Workshop for Pediatric Rheumatology Fellows
-
Abstract Number: 2063
Training to Increase Minority Enrollment in Lupus Clinical Trials with CommunitY Engagement (TIMELY): Assessing Behavioral Predictors of Clinical Trial Referrals Among Healthcare Providers
-
Abstract Number: 2064
Perceptions of Rheumatology Fellows on Mentorship Quality After Implementation of a Formalized Mentorship Program
-
Abstract Number: 2065
Exploring the Power of Ultrasound in Rheumatology: Insights from Young Rheumatologists in Mexico
-
Abstract Number: 2066
Ultrasound Guided